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ABSTRACT

Strauss, Kevin. M.S., Purdue University, August 2016. Metal‐Promoted Self‐Assembly of
Collagen Mimetic Peptides into Biofunctional Scaffolds for Stem Cell Delivery with the
Aim of Tissue Regeneration. Major Professor: Jean Chmielewski.

Collagen is a strong, sturdy, but malleable, protein found abundantly in the
extracellular matrix. Consequently, it has become an invaluable biomaterial for use in
regenerative medicine. However, natural collagen poses difficulties when it comes to
customization and structural control, as well as the risk of infectious prions from animal
sources. Our approach utilizes shorter, synthetic collagen mimetic peptide sequences.
These peptides retain the incredible triple helical stability of natural collagen but can be
modified with versatile metal‐binding ligands. In the presence of an appropriate metal
ion, the peptides self‐assemble into diverse, three‐dimensional morphologies. The
peptide NCoH, functionalized with N‐terminal NTA and C‐terminal dihistidine, self‐
assembles into ruffled spheres called microflorettes that can be selectively
functionalized internally and / or externally with biomolecules containing a His tag. A
novel fluorophore, Rho‐(Gly)3‐(His)6, was synthesized to enable high‐quality visualization
of NCoH microflorette interactions with cells.

Fluorescent confocal microscopy

confirmed that NCoH microflorettes sequester HeLa and human mesenchymal stem

xxx
cells. Moreover, these microflorettes were shown to bind to human epidermal growth
factor.
The peptide NCoH alone holds great possibilities for use in biomedicine, but such
possibilities could be expanded ever more by mixing NCoH with other collagen mimetic
peptides. Self‐assembly of mixtures of NCoH with the cross‐linked peptide HBN in the
presence of various divalent metal ions resulted in integrated mesh / florette systems.
Joint metal‐promoted self‐assembly of NCoH mixed with its analogs HisCol and / or
IdaCol results in an array of highly intricate morphologies, including and especially
novel, spiraled “horned” bundles with well‐ordered periodicity that form within minutes
and under neutral conditions. Moreover, such assemblies can be carried out on a glass
surface, producing structures with a high degree of order on both the micro‐ and
nanoscales that could potentially be exploited for future biochemical applications. The
vast array of structures that can be produced through metal‐promoted self‐assembly of
collagen mimetic peptides holds great potential for the development of highly
customizable tissue engineering therapies.

1

CHAPTER 1 . BIOPOLYMER‐BASED MICROPARTICLES AS CELL‐ADHESIVE SUBSTRATES
FOR TISSUE ENGINEERING
1.1 Introduction
Presently, there is a high demand for organ transplants. In the United States
alone, at least 25% of patients waiting for an organ perish before an appropriate donor
can be found1. The demand for transplants simply far outpaces the supply, with many
thousands of new patients being added to the wait list every year. In their 2011 annual
report, the most optimistic statement that the U.S. Department of Health and Human
Services was able to make regarding the growing demand for organs was that, for a few
organ types, this growth “has lessened slightly.2”
In order to resolve this escalating crisis, recent research3 has focused on the
transplantation of isolated cell clusters as opposed to whole organs. Smaller samples of
donor tissue are removed and then separated into individual cells. Since most cell lines
can be expanded in a laboratory setting, only a very small number of donor cells need to
be collected for transplantation, expanding the prospects for donations by living
individuals. In this way, the cells are cultured until they reach the appropriate cell
density. However, tissue formation requires specific microenvironments. Moreover,
many stem and somatic cells are anchorage‐dependent. Without a scaffold to which
they

can

adhere,

they

rapidly

perish

in

suspension3‐4.
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Consequently, tissue engineering (TE) has emerged as a rapidly growing field
within the biosciences. The primary motivation of TE is to adhere cells to a customized
three‐dimensional scaffold for the purpose of tissue transplantation into a live patient5.
Artificial tissue production already has shown great promise for medical use, including
prostheses for cartilage6, bone7, liver4, the gastrointestinal tract8, and nerves9. In 1990,
a product supplying bioartificial skin for burn treatment was introduced as the first
commercial TE product10. Other commercial products for applications such as cartilage
repair and cancer therapy have since been introduced10.

1.2 The Extracellular Matrix
Successful TE requires an understanding of the extracellular matrix (ECM). The
ECM is the region between and around the cells that compose the many tissues that

Figure 1.1. Cartoon depicting the complex interactions between the myriad proteins
and polysaccharides that make up the ECM, as well as the cells that lie therein
(adapted from Reference 12)
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make up the human body. However, it is far from empty space. In fact, it is made up of
thousands of proteins and polysaccharides whose complex interactions are still not fully
understood (Figure 1.1). Some, such as collagen and fibronectin, serve as structural
support for the cells. Others, such as vascular endothelial growth factors (VEGFs) and
bone morphogenic proteins (BMPs), are signaling molecules that enable intercellular
communication and nutrient transport11. The various constituents of the ECM work
together to provide an environment to facilitate the attachment, growth, proliferation,
and differentiation of cells11b, 12. Tissue engineering seeks to emulate these features of
the ECM in order to supply cells with a synthetic support structure for transplantation.
Many of the structural proteins that compose the ECM contain the important
cell adhesion sequence RGD (Arg‐Gly‐Asp) or its derivative RGDS (Arg‐Gly‐Asp‐Ser).
More than 50% of the integrin proteins found on cell membranes recognize and bind to
this peptide sequence13. The biological purpose of the RGDS sequence is to help cells to
bind to the structural framework of the ECM to aid in their maturation. This effect can
be replicated in synthetic scaffolds by covalently or non‐covalently incorporating the
RGDS sequence into the scaffold13. In fact, RGDS‐containing scaffolds have been shown
to have better cell attachment, spreading and differentiation than the equivalent
scaffolds lacking the RGDS motif14.
Another crucial component of the ECM is the small proteins known as growth
factors (GFs). As their name suggests, these signaling proteins help to regulate the
growth and differentiation of cells. The appropriate signal transduction cascade can be
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initialized by both anchored and soluble GFs11b. However, anchored GFs have greater
bioavailability and a prolonged lifespan in vivo due to the fact that they are protected
from solution‐dwelling proteases15. Additionally, immobilization of GFs onto a scaffold
is highly advantageous for TE applications as it increases the likelihood that the GFs will
reach the intended target, instead of accumulating in other tissues16. GFs can be
immobilized by both covalent and non‐covalent means. Covalent attachment to
scaffolds can be accomplished by means of a PEG linker125 or through amide
formation126. Non‐covalent immobilization techniques range from physical entrapment
to electrostatic interactions17.

1.3 Natural and Synthetic Biomaterial
The most critical component of TE is the design of the scaffold. Successful
scaffold design revolves around a few important properties. First, the scaffold must be
biocompatible, as it must facilitate the attachment and survival of cells, at least for the
short term. Second, it must be of the right size and shape to provide the appropriate
amount of mechanical stress for the growing cells. Third, it must be porous and have
enough surface area and volume to support and sustain cells of the appropriate
density5.
In light of these strict design parameters, the choice of scaffolding material is
crucial.

Surgical implants have typically relied on biocompatible metals, such as

stainless steels and cobalt and titanium‐based alloys18, and ceramics, such as alumina,
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zirconia, calcium phosphate, and bioglass19. However, such materials are a very poor
choice for TE scaffolds as they are not sufficiently biodegradable, and they are limited in
the ways that their structures can be modified and accurately reproduced on an
industrial scale. For these reasons, polymeric materials have shown far more promise.
Natural polymers, such as chitin, chitosan, starch, and glycosaminoglycan, are
advantageous for the fact that they are the most accurate representations of the
cellular microenviroment.

At the same time, however, their use has been very

problematic for TE applications due to their extensive batch‐to‐batch variability and
poor malleability20. A variety of synthetic polymers have been developed to combat
these issues. The most common synthetic polymeric scaffolds have designs based
around polylactic acid (PLA), polyglycolic acid (PGA), and polyethylene glycol (PEG). Like
their natural counterparts, such scaffolds are able to mimic the mechanical properties of
the ECM, but they can also be readily functionalized with GFs and adhesion sequences21.
However, because the synthesis of these scaffolds often requires multiple steps and
sometimes harsh conditions (i.e, U.V. illumination and immersion in organic solvents),
the viability of the associated cells and the bioactivity of bound GFs can suffer
significantly22. This problem can be resolved by adding the cells and GFs after scaffold
formation, but, in so doing, the scaffold is reduced to a two‐dimensional plane for
growing cells. To truly emulate the rich microenvironment of the ECM, one requires a
highly customizable, three‐dimensional scaffold that can be synthesized simply and
under biocompatible conditions.
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1.4 Small Particles as Cell Delivery Vehicles
Solid

biomaterial

scaffolds,

while

often

providing

an

advantageous

microenvironment for cell proliferation and differentiation, cannot easily be injected
through a small, thin needle. Moreover, they are usually not malleable enough to adopt
to the host tissue architecture, resulting in further tissue damage. Thus, they can be
troublesome to work with in practice. A useful solution to this dilemma is to utilize a
collection of small, readily‐injectable, cell‐adhesive particles, as opposed to a larger
scaffold.

1.4.1 Polymeric Microparticles
The majority of existing therapies for repair of damaged neural tissue involve the
injection of cellular suspensions for widespread distribution of cells23 Other strategies
have relied on the encapsulation of neural cells within specially‐designed beads prior to
transplantation24. However, in the absence of an ECM‐like structural support system,
these therapies fail to deal with the effects of chronic tissue damage25. Bible et. al.26
devised an efficient protocol for injection‐based cell replacement therapy to promote
neural tissue regeneration using cell‐adhesive poly(D,L‐lactic‐coglycolic) acid (PLGA)
microspheres. PLGA microspheres are useful tools for tissue replacement therapies
because they have been shown to be biocompatible and biodegradable, and they
promote significant cell attachment27. The microspheres used for this protocol were
generated from an 85:15 mixture of lactic acid: glycolic acid through a single‐emulsion
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hardening process involving agitation of DCM‐solvated polymer solution in the presence
of an aqueous layer. Microspheres produced in this way possessed a rough surface to
promote cell attachment. The PLGA microspheres were then subjected to a plasma
polymerization process with allylamine (in which highly‐energized plasma electrons
collide with the pi bond to generate reactive radicals that rapidly polymerize) in order to
increase the surface hydrophilicity as well as provide amine “handles” for covalent
surface decoration. To further instill cell adhesion, the microspheres were also coated
with fibronectin, a crucial cell‐surface glycoprotein found in the ECM28. These PLGA
microspheres were then incubated with MHP36 neural stem cells29. Following exposure
to May‐Grunwald stain and Giemsa stain (which label DNA / nuclei)30, visualization of
the particles revealed significant cell attachment and spreading after both 24 hours
(Figure 1.2 A) and 48 hours (Figure 1.2 B). Uniform attachment of cells was achieved
through alternating cycles of movement (i.e., shaking) and rest during the incubation
period. After four days of culture, live / dead cell staining revealed that 90% of the
adherent cells remained viable (Figure 1.2 C). Immunohistological staining following in
vivo neural transplantation (in rats) revealed an abundant and well‐spread web of
neural tissue, supported by the PLGA microsphere scaffold26 (Figure 1.2 D).

8

A

B

C

D

Figure 1.2. Visualization of MHP36 neural stem cells adhering to and spreading across
PLGA microparticles with May‐Grunwald and Giemsa stains after (A) 24 hours and (B)
48 hours; (C) Fluorescent live / dead cell stain, (D) Visualization of the web‐like network
of cells spreading across the PLGA microparticle scaffold (modified from Reference 26)

Liu et. al.31 designed an injectable cell carrier system utilizing nanofibrous hollow
microspheres, which self‐assemble from star‐shaped poly(L‐lactic acid) (SS‐PLLA). SS‐
PLLA was synthesized from low‐generation poly(amidoamine) (PAMAM) dendrimer
initiators, as such dendrimers have been shown to be non‐toxic and non‐
immunogenic32.

Microsphere formation was induced through emulsification of

tetrahydrofuran‐solvated SS‐PLLA in glycerol. The nanofibrous surface texture was
generated from phase separation through quenching in liquid nitrogen in the absence of
any pre‐fabricated template31.

The size of the resulting microspheres could be

controllably varied from a few microns to a few hundred microns simply by adjusting
the stirring speed of the emulsion. Faster stirring resulted in a smaller average particle
size. Moreover, microspheres produced in this way possessed a distinct, hollow interior,
with a clearly visible central hole (Figure 1.3 B).
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Figure 1.3. SS‐PLLA‐based nanofibrous microspheres as scaffolds for cartilage
regeneration. (A) Chondrocyte adhesion rate, measured as a function of the Hoescht
33248 dye concentration, for nanofibrous hollow microspheres in comparison with
nanofibrous PLLA microspheres and solid‐interior microspheres, (B, C) SEM
visualization of the 3D morphology of nanofibrous hollow microspheres seeded with
chondrocytes, (D) SEM visualization of the 3D morphology of solid‐interior
microspheres, (E) De novo cartilage tissue formation (in the shape of a rat femoral
condyle) after four weeks of culture (tick marks = 1 mm), (F) Safranin‐O stain (scale bar
= 100 µm) (adapted from Reference 31)

The intricate surface morphology of the SS‐PLLA microspheres was hypothesized
to be an effective cell scaffold due to its mimicry of the ECM. The nanofibers present in
the microspheres were structurally analogous to the abundant collagen fibers found in
cell‐cell junctions. Additionally, the variously‐sized pores and channels present in the
hollow microspheres were designed to promote cell spreading and proliferation, as well
as mass transport.

The ability of nanofibrous hollow microspheres to serve as a

bioadhesive scaffold was examined in parallel to microspheres assembled from linear‐
PLLA (lacking the hollow interior) as well as solid‐interior microspheres (lacking a
nanofibrous surface). Chondrocytes adhered equally well to both the hollow and non‐
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hollow microspheres at every time point tested (as measured by the concentration of
Hoescht 33248, a DNA‐labeling dye), but the solid‐interior spheres retained 60% less
cells than did the nanofibrous spheres (Figure 1.3 A). Moreover, SEM visualization of
the three types of spheres revealed that the chondrocytes attached to both types of
nanofibrous spheres had a rounded morphology (Figure 1.3 B, C), whereas those
adhered to the solid‐interior spheres had a more flattened and elongated morphology
(Figure 1.3 D). It has been established that a rounded morphology helps cells to
maintain

their

chondrocyte

phenotype,

whereas

elongated

cells

favor

dedifferentiation33. In addition, it was found that nanofibrous hollow microspheres
contained a significant number of chondrocytes inside their central hole (Figure 1.3 B).
Also, as expected, the cells adhered to the two types of nanofibrous microspheres had
far greater rates of proliferation than those on the solid‐interior microspheres.31
As a proof‐of‐concept test of the ability of this system to engineer functional
cartilage, chondrocyte‐containing, SS‐PLLA‐based nanofibrous hollow microspheres
were injected into a mold in the shape of a rat femoral condyle. After four weeks of in
vitro incubation, smooth, shiny, soft new cartilage shaped like a rat femoral condyle was
attained (Figure 1.3 E). Safranin‐O and immunohistological staining demonstrated the
accumulation of GAG and type II collagen around nanofibrous hollow microspheres,
offering further support that chondrogenesis had indeed occurred (Figure 1.3 F). More
astoundingly, when each of these microsphere / chondrocyte systems was
subcutaneously injected into nude mice, it was found that the in vivo ectopic cartilage
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generated from nanofibrous hollow microspheres had substantial greater tissue mass
and GAG content than did those extracted from the nanofibrous microsphere and the
solid‐interior microsphere samples. While new cartilage was generated in all three
cases, that produced from solid‐interior microspheres had an extremely high cell
density, while that produced from nanofibrous hollow microspheres and nanofibrous
microspheres had a more uniform cell distribution, more like natural cartilage.
Moroever, in a critical‐size rabbit osteochondrial defect‐repair model, injection of
chondrocyte‐adhered nanofibrous hollow microspheres resulted in substantially
improved cartilage repair than did injection of chondrocytes alone.31
Wen et. al.34 developed a novel, nanocomposite polymeric cell and drug delivery
platform with an intriguing additional layer of structural complexity. As an initial proof‐
of‐concept, the researchers fabricated nanospheres on the order of 270‐300 nm from
semi‐crystalline poly(L‐lactide / D,L‐lactide) (PLDL70) and poly(L‐lactide‐co‐glycolide)
(PLGA85) using a double‐emulsion solvent evaporation process34‐35. These nanospheres
were then loaded with thrombin receptor activator peptide‐6 (TRAP‐6)36. The release of
this cargo was tracked over 30 days. It was found that the PLDL70 nanospheres
exhibited a sustained release profile, with only 30% release of TRAP‐6 observed after 15
days, while the PLGA85 nanospheres displayed a far more rapid release profile, with
80% TRAP‐6 released after the first 15 days. Thus, the release mechanism of the cargo
correlated with the degree of crystallinity and composition of the nanosphere vessel34.
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Figure 1.4. Nanocomposite mPEG‐PLGA microspheres‐PLDL70 nanospheres as a
bioadhesive cell scaffold. (A) SEM visualization of nanocomposite microspheres
(scale bar = 100 µm), (B) Zoom‐in showing the microsphere surface porosity (scale
bar = 1 µm), (C) SEM visualization of nanocomposite microspheres and human
fibroblasts after three days of culture (scale bar = 100 µm), (D) Zoom‐in depicting cell‐
microsphere junctions (scale bar = 10 µm) (modified from Reference 34)

With these results in mind, the authors went on to synthesize nanocomposite
mPEG‐PLGA microparticles containing PLDL70 nanospheres through ultrasonic
atomization37. These microparticles were observed to be on the order of 80‐100 µm
(Figure 1.4 A) and had a nanoporous surface (Figure 1.4 B).

Furthermore, the

nanocomposite microparticles were found to have an identical, sustained TRAP‐6
release profile to that of the PLDL70 nanospheres alone, as contrasted with
conventional mPEG‐PLGA microparticles which exhibited a “burst” release profile (70%
release in the first day). Moreover, SEM visualization of mPEG‐PLGA nanocomposite
microparticles cultured with human fibroblasts for three days revealed extensive cell
attachment (Figure 1.4 C), with fibroblasts growing in the spaces between
microparticles, drawing them together into tightly‐packed cell‐microparticle aggregates
(Figure 1.4 D).

Furthermore, after four days of incubation, fibroblasts grown on

nanocomposite microparticles exhibited four‐fold greater proliferation than did
analogous fibroblasts grown in suspension34.

The dual capabilities of mPEG‐PLGA
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nanocomposite microparticles to bind and sustain human cells while simultaneously
accommodating the sustained release of a bioactive cargo make this a significant step
forward in the development of tissue regenerative therapies.
Another strategy for the generation of injectable cell‐polymeric nanoparticle
scaffolds relies on the crucial biotin‐avidin interaction, one of the strongest in nature
and which previously has been used to mediate the assembly of rods and spheres38.
Krishnamachari et. al.39 generated microspheres with an average diameter of 1.4 µm
from a biotinylated poly(lactic acid)‐poly(ethylene glycol)‐biotin (PLA‐PEG‐biotin) co‐
polymer through the double emulsion solvent evaporation process described earlier34.
These

biotinylated

microspheres

were

then

incubated

with

excess

tetramethylrhodamine‐conjugated avidin. Subsequent incubation of avidin‐conjugated
microspheres with biotinylated cells results in cell‐microparticle aggregate formation
(Figure 1.5 A). Human embryonic kidney 293 (HEK 293) cells were biotinylated in a
simple, two‐step process. First, mild sodium iodate solution was used to generate
aldehydes from native cell‐surface sialic acid residues. Completion of biotinylation
occurred when these aldehyde ends were allowed to react with biotin‐hydrazide. After
two days of incubating biotinylated HEK293 cells with avidin‐conjugated PLA‐PEG‐biotin
microspheres, various cell‐microsphere aggregates were observed by light microscopy
(Figure 1.5 B) and SEM (Figure 1.5 C). Moreover, it was found that at least 70% of the
available biotinylated cells adhered to microspheres, while less than 40% of cells
adhered to the microparticles in the absence of biotin treatment, suggesting that the
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biotin‐avidin interaction was indeed the critical factor supporting cell adhesion to the
particles. Furthermore, each cell bound to an average of eight microspheres, ensuring
that an adequate support structure was present to maintain the cells39.

A

B

C

Figure 1.5. HEK293 cells adhering to biotinylated PLA‐PEG microspheres (A)
Schematic cartoon of the cell adhesion process, mitigated by the biotin‐avidin
interaction; (B) Light microscopy (scale bar = 25 µm) and (C) SEM visualization of
avidin‐conjugated microspheres with biotinylated HEK293 cells after incubation for
two days (scale bar = 1.5 µm) (modified from Reference 39)

Yet another method for the generation of injectable, biofunctional cell‐particle
aggregates is through the use of cellular “backpacks,” micrometer‐sized particles of
nanoscale thickness that can non‐cytotoxically bind to the membrane of a living cell40.
Swiston et. al.41 were able to achieve this type of adhesion by making use of a B cell
lineage particularly abundant in the cell surface receptor CD44, whose native ligand is

15

hyaluronic acid (HA)40. Thus, cell attachment could be realized using a cellular backpack
with a multilayer on one face infused with HA. These cellular backpacks were readily
generated using the well‐established photolithographic lift‐off methodology42.

The

release region of the backpack was made from poly(methacrylic acid) (PMAA) and
poly(vinylpyrrolidone) (PVPON), which dissolves at pH > 6.4, readily releasing the
backpack from the substrate on which it was fabricated43. Free‐floating backpacks,
upon incubation for 1.5 hours with CH27 B‐lympocytes, result in cell‐backpack
aggregates. The cells were shown to interact with backpacks in various ways. In some
cases, a single backpack adhered to as many as three cells (Figure 1.6 A), and, in other
areas, one cell bound to multiple backs (Figure 1.6 B). No evidence of internalization of
backpacks was observed. Samples were prepared with cell: backpack ratios (R) ranging
from 1 to 0.1. As expected, aggregate size increased with higher relative concentrations
of cellular backpacks. In fact, when the cell: backpack ratio = 0.1, only a single, massive
aggregate was observed (Figure 1.6 C, top). Flow cytometry confirmed these results, as
the population of cells in the far right quadrant increased with decreasing cell: backpack
ratios41 (Figure 1.6 C, bottom).

The ability of cellular backpacks to form dense

aggregates with cells, despite their small size, is advantageous because a greater portion
of the cell surface is left open to interact with endogenous ligands than would be the
case for aggregates formed with larger particles. Moreover, this methodology presents
an attractive alternative to traditional solid scaffold‐based approaches for the
generation of artificial, injectable lymphoid organoids44.
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(c)

Figure 1.6. PLGA‐based, HA‐coated cellular “backpacks” generate aggregates with
CH27 B‐lymphocytes. (A) Fluorescence confocal microscopy image of one backpack
aggregating with three cells (scale bar = 10 µm), (B) Fluorescence confocal microscopy
image of one cell interacting with multiple backpacks in an aggregate, (C)
Fluorescence confocal microscopy images of samples with cell: backpack ratios (R) of
1, 0.33, 0.3, and 0.1 (scale bar = 100 µm and 20 µm for inset) with accompanying flow
cytometry plots (Backpacks stained green with FITC) (modified from Reference 41).

More exotic substrate materials have also been used to fabricate polymeric
microparticle‐cell aggregates.

Oliveira et. al.45 made use of genetically‐engineered

polymers46 called elastin‐like recombinamers (ELRs)47. As the name suggests, ELRs
contain many amino acid residues found in natural elastin45, a key component of the
ECM11, and retain the mechanical properties and biocompatibility of native elastin48.
However, because these polymers are recombinant in nature, additional sequences can
be inserted to instill other useful properties, most especially the well‐characterized cell
adhesion sequence Arginine‐Glycine‐Aspartic Acid (RGD)49. Greater stability has been
instilled in ELR scaffolds through cross‐linking via γ‐irradiation50, chemical cross‐linking
(with hexamethylene diisocyanate (HDI), for instance51), and enzymatic cross‐linking52.
ELR has also been mixed with chitosan to yield an osteoconductive hydrogel53. A more
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recent and novel development, however, has been the use of ELR to generate injectable
cell‐adhesive microparticles45. For this study, the authors made use of an ELR known as
H‐RGD6, which has six repeats of the RGD sequence and a terminal His tag49 (Figure 1.7
A). As expected, H‐RGD6 was shown to promote a greater degree of adhesion and a
higher rate of proliferation of the osteoblast cell line SaOs‐2 than does the equivalent
domain lacking the RGD sequence49. Microspheres were generated through careful
deposition of aqueous H‐RGD6 onto a superhydrophobic (SH) polystyrene (PS)‐based
surface, previously prepared through phase inversion54. Larger particles (1000‐1400
µm) were generated under controlled volume conditions, while smaller particles (500‐
1000 µm) were produced through manual extrusion of the polymer with repeated
dabbing of the pipet against the SH surface. The resulting microspheres were cross‐
linked via exposure to HDI, which readily forms covalent linkages with the free ε‐amino
groups of the 24 lysines in the H‐RGD6 sequence51. The extent of cross‐linking of these
particles was varied through differing the duration of exposure to HDI. Both the more
highly cross‐linked particles (R2 = 2 hours of incubation with HDI) and the less cross‐
linked particles (R1 = 30 minutes of incubation with HDI) were incubated with SaOs‐2
cells. After 7 days, both sets of microspheres displayed extensive cell adhesion, but the
osteoblasts attached to the R2 particles were shown to be more viable than those on
the R1 spheres, likely due to the greater surface area available for attachment and
spreading. Environmental Scanning Electron Microscopy (ESEM) visualization of R2
microspheres after 7 days of culture with SaOs‐2 osteoblasts revealed the presence of
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cells that formed linkages between two microspheres (Figure 1.7 B, C), suggesting
extensive interaction between the cells and the particles in scaffold formation.
Fluorescent confocal microscopy (Figure 1.7 D) and photography (Figure 1.7 E) revealed
similar tight cell‐microsphere junctions after 14 days of culture45. Thus, genetic
engineering of polymers can also lead to the production of viable, customizable,
injectable, cell‐adhesive microparticles for tissue engineering and cell replacement
therapy.

A
B

C
D

E

Figure 1.7. Elastin‐like recombinamer (ELR) microparticles with adhered SaOs‐2
osteoblasts (A) Schematic of the primary sequence of H‐RGD6, (B, C) ESEM
visualization of R2‐crosslinked H‐RGD6 microspheres after 7 days of incubation with
SaOs‐2 cells (arrows indicate cells joining two microparticles), (D) Fluorescent
confocal microscopy visualization of R2 microparticle junction after 14 days of
culture, (E) Photograph of cell‐R2 microparticle cluster after 14 days of culture
(modified from Reference 45)
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1.4.2 Gelatin Microparticles
While much work has been done with polymeric microparticle systems as
injectable cell carriers, other classes of materials have been utilized for this purpose as
well. Gelatin, a hydrolyzed form of collagen, a protein found extensively in the ECM,
holds great potential for use as a biomaterial scaffold and has already been used
extensively in biomedicine and in the food industry55. Gelatin is advantageous for tissue
engineering because it is fully biodegradable, and it contains cell‐adhesive RGD motifs56.
Moreover, gelatin‐based particles solubilize in water more readily than do most
polymers57. While gelatin has been used extensively as a component of hydrogels to
encapsulate cells and particles58, the use of gelatin microparticles as cell scaffolds
presents a more elegant, intricately‐designed, and easily‐customizable system for tissue
engineering.
Singh et. al.57 designed porous gelatin microspheres that bind to human lung
cells and release Ephedra gerardiana, an herbal medicine used to treat lung disorders,
such as asthma and bronchitis59. The ability to bind to and transplant human lung cells
is useful, as native cells have highly limited regeneration capabilities and cannot repair
themselves on the scale of whole tissues60. Microparticles were fabricated from 10%
gelatin through a standard oil‐water emulsion process57. The particles were then cross‐
linked with 1% glutaraldehyde for added stability61. The resulting particles averaged 824
nm in diameter when dry and 3.4 µm after swelling in water. Upon loading of the
microparticles with water‐solvated Ephedra gerardiana extract, the particles exhibited a
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sustained release profile over six days. Following two weeks of incubation of the gelatin
microparticles with human lung cells, it was found that cells grown with the particles
exhibited a higher rate of proliferation than did the control 2D culture. Moreover, SEM
visualization revealed significant cell attachment to and spreading across the gelatin
microspheres (Figure 1.8 A), with significantly greater cell adhesion to gelatin particles
loaded with Ephedra extract (Figure 1.8 B) than to gelatin particles alone (Figure 1.8 C),
confirming the bioactive nature of Ephedra gerardiana. Fluorescent live / dead cell
staining confirmed the viability of human lung cells grown on Ephedra‐loaded gelatin
microparticles after 7 days57 (Figure 1.8 D, E).

A

C

B

D

E

Figure 1.8. Human lung epithelial cells adhering to gelatin microspheres. (A, B) SEM
visualization of human lung cells cultured on gelatin microparticles loaded with
Ephedra gerardiana, (C) SEM visualization of lung cells on gelatin microparticles
without Ephedra, (D, E) Fluorescent microscopy visualization of human lung cells on
Ephedra‐loaded gelatin microparticles stained with live / dead cell stain (Calcein AM
and ethidium bromide, green = live cells) (scale bar = 100 µm) (modified from
Reference 57)
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Gelatin microparticles have also been used extensively to support the growth
and differentiation of chondrocytes. Fan et. al.62 utilized Transforming Growth Factor‐
β3 (TGF‐β3)‐loaded gelatin microparticles to trigger the differentiation of human
mesenchymal stem cells into functional chondrocytes. However, in this study, a minimal
amount of microparticles was used in comparison to cells in order to maintain the
crucial cell‐cell contacts required for chondrogenesis. Han et. al.63 accomplished the
same feat using a blend of gelatin and chitosan microparticles. Other strategies have
made use of hydrogels to encapsulate the cells and gelatin microparticles64. Spinner
flasks have also been used to promote chondrocyte expansion65. Gelatin has even been
used to functionalize PLGA microparticles to further improve cell adhesion66.
More recently, Garcia Cruz et. al.67 made use of gelatin microspheres as a fully‐
functioning 3D scaffolding system without the need for encapsulation in a hydrogel.
Gelatin microspheres were produced using a standard emulsion‐solvent extraction
protocol68 and cross‐linked with genipin69. The resulting microspheres exhibited a
mostly smooth surface morphology and measured 6‐24 µm in diameter (Figure 1.9 A),
comparable in size to the average chondrocyte67. Following encapsulation of TGF‐β1, a
release profile was generated for the gelatin microparticles in PBS. After an initial burst
release of 24% of the TGF‐β1 in the first day, a more sustained release was observed,
with only 50% of the initial TGF‐β1 released by day 14. The viability of chondrocytes
seeded onto gelatin microspheres remained equivalent for microspheres that contained
TGF‐β1 and those that did not until day 21 when the viability of cells grown on TGF‐β1‐
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loaded microspheres increased relative to microspheres lacking TGF‐β1. This was likely
due to the fact that enough growth factor had been released by that point to contribute
significantly to the bioactivity of the chondrocytes. SEM visualization of TGF‐β1‐loaded
gelatin microspheres after one day of incubation with chondrocytes revealed large cell‐
particle aggregates with evidence of cells linking two or more particles (Figure 1.9 B).
After fourteen days, the cell‐microparticle scaffold appeared much more homogenous,
with only a few rounded cells visible on the surface (Figure 1.9 C). Moreover, after
fourteen days of incubation, fluorescent confocal microscopy revealed that the resulting
tissue contained abundant aggrecan67 (Figure 1.9 D), a proteoglycan found extensively
in native cartilage70.

Thus, this work effectively demonstrated that gelatin

microparticles can be utilized as an extensive 3D scaffold to promote and maintain
chondrogenesis for potential tissue engineering applications.

A

B

C

D

Figure 1.9. TGF‐β1‐loaded gelatin microspheres form a biofunctional 3D scaffold with
chondrocytes. (A) SEM visualization of gelatin microspheres with encapsulated TGF‐β1
(scale bar = 30 µm), (B) SEM visualization of TGF‐β1‐loaded gelatin microspheres after
one day of incubation with chondrocytes (scale bar = 40 µm), (C) SEM visualization of
TGF‐β1‐loaded gelatin microspheres after 14 days of incubation with chondrocytes
(scale bar = 40 µm), (D) Fluorescent confocal microscopy visualization of cell‐
microsphere scaffold after 14 days, stained for cartilage markers (scale bar = 100 µm)
(modified from Reference 67)
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1.4.3 Chitosan Microparticles
Chitosan‐based microparticles have also been used as injectable, bioactive cell
scaffolds. Chitosan is a linear polysaccharide composed of distinct N‐glucosamine and
N‐acetylglucosamine units71. It is derived from chitin, one of the most prominent
biopolymers found in nature72.

Chitosan is therefore biodegradable and

biocompatible73. Moreover, the free amino and hydroxyl groups along the chitosan
backbone enable covalent modification with a variety of biomolecules73c,

74

.

Consequently, chitosan‐based carriers have been used extensively as cell and drug
delivery systems75. However, there are relatively few cases in which free chitosan
microparticles, as opposed to solid scaffolds or hydrogels, have been used to form
injectable, biofunctional cell delivery vehicles.
Recently, Custodio et. al.76 designed chitosan microspheres whose surfaces were
modified with biotinylated antibodies to bind to highly specific cell types, taking
advantage of the potent biotin‐streptavidin interaction77. Chitosan microparticles were
generated from droplet formation and subsequent hardening in NaOH solution. The
resulting spherical particles measured 80‐140 µm in diameter (Figure 1.10 B) and
displayed a rough surface morphology (Figure 1.10 C). The free amines on the surface of
the chitosan microspheres were then conjugated with NHS‐biotin, which, in turn, was
conjugated with streptavidin. The resulting assembly was conjugated with the desired
biotinylated antibody, which specifically targeted the cell line of interest76 (Figure 1.10
A).
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Figure 1.10. Selective binding of hASCs and HUVECS to biotinylated chitosan
microspheres. (A) Schematic of the assembly process, (B) SEM visualization of a
chitosan microsphere (scale bar = 10 µm), (C) Zoom‐in of (B) depicting the surface
morphology (scale bar = 5 µm); Fluorescent confocal microscopy visualization of anti‐
CD90‐conjugated chitosan microspheres incubated with hASCs after (D) 3 days and
(E, F) 7 days; Fluorescent confocal microscopy visualization of anti‐CD31‐conjugated
chitosan microspheres incubated with HUVECs after (G) 3 days and (H, I) 7 days (scale
bar = 100 µm for (D), (E), (G), and (H); scale bar = 50 µm for (F) and (I)) (Cells stained
with DAPI and phalloidin) (modified from Reference 76)

As a proof‐of‐concept study, HUVECs and hASCs were used, due to the fact that
they express CD31 and CD90 cell markers78, respectively. Optical microscopy revealed
extensive attachment of HUVECs to anti‐CD31‐conjugated chitosan microspheres and
adhesion of hASCs to anti‐CD90‐conjugated chitosan microspheres.

Fluorescent

confocal microscopy with phalloidin staining confirmed that the cells rearranged their

25

cytoskeletons around the chitosan microspheres. This was the case for hASCs adhered
to anti‐CD90‐conjugated microspheres at 1, 3 (Figure 1.10 D), and 7 (Figure 1.10 E, F)
days, as well as for HUVECs adhered to anti‐CD31‐conjugated microspheres at 1, 3
(Figure 1.10 G), and 7 (Figure 1.10 H, I) days76. As a proof‐of‐concept for in‐situ scaffold
formation, hASC‐CD90 particle aggregates were injected into a mold containing a small
(1 mm) cylindrical cavity. After three days, a 3D tubular cell / particle scaffold was
produced.76
To improve the stability of chitosan microparticles, the free amine functionalities
are typically chemically cross‐linked using agents such as glutaraldehyde75c, 75d; however,
the residual, unreacted material can be cytotoxic. Malafaya et. al.79 discovered that
when chitosan‐hydroxyapatite scaffolds were cross‐linked with glutaraldehyde, the cell
viability of the resulting assembly dropped by as much as 85%. This was the case even
when glutaraldehyde was used at the extremely low relative concentration of 0.01%.
While methods such as dialysis can be used to extract unreacted material, complete
removal of the cross‐linking agent is often not feasible and cell viability suffers
accordingly.

An alternative to chemically‐cross‐linking chitosan is to expose the

polycationic chitosan to a polyanionic biopolymer in order to form a stable
polyelectrolyte complex (PEC) through the resulting electrostatic interaction80, thereby
refraining from the use of potentially toxic organic precursors and catalysts.
Fang et. al.81 designed porous microspheres from a PLGA / chitosan PEC that
serve as cell microcarriers for the generation of new cartilage. As discussed previously,
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the polymer PLGA is advantageous for use as a biomaterial due to its biocompatibility,
biodegradability, lack of cytotoxicity, low immunogenicity, and its hydrophilic character,
improving upon the hydrophilicity of chitosan80c,

80d, 82

. Moreover, addition of PLGA

served to substantially improve the degree of cell adhesion when compared to chitosan‐
only microparticles, and it improved the overall biodegradability of the scaffold as
well82b, 83. The PLGA / chitosan polyelectrolyte complex microspheres were generated
through an adjusted phase separation methodology81, in which the resulting oil‐water
emulsion was rapidly cooled and then lyophilized, yielding porous chitosan
microspheres. These microspheres were then coated with PLGA to form the PEC84. The
resulting particles measured 200‐355 µm in diameter. The average pore size of the
particles varied substantially with the cooling temperature used during fabrication, as
colder temperatures were shown to generate smaller pores. Fluorescent confocal
microscopy of the PEC microspheres confirmed a uniform distribution of PLGA and
chitosan along the pore walls. After 7 days of incubation with chondrocytes, SEM
visualization confirmed the presence of cell‐PEC microsphere aggregates, with cells
adhering to the pore walls and thin layers of ECM coating the particles (Figure 1.11 A, B).
Fluorescent confocal microscopy confirmed significant cell adhesion to the PEC
microspheres after 1 and 3 days of incubation (Figure 1.11 C, D).

Moreover,

chondrocytes were observed in the interior of the spheres at days 5 and 7 (Figure 1.11
E, F). Furthermore, after 14 days of incubation, PEC microspheres had significantly
greater numbers of adhered cells than did analogous microspheres made from chitosan
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only. Thus, stable particles can be generated from a polyelectrolyte complex which, in
turn, result in a biocompatible, cell‐supporting, in vitro microenvironment.

A

C

D

B

E

F

Figure 1.11. PLGA / chitosan polyelectrolyte complex microspheres with adhered
chondrocytes. (A) SEM visualization of PEC microspheres after 7 days of incubation
with chondrocytes (scale bar = 500 µm), (B) Zoom‐in of (A) showing surface
morphology (scale bar = 50 µm; Fluorescent confocal microscopy of chondrocytes
incubated with PEC microspheres for (C) 1 day, (D) 3 days, (E) 5 days, and (F) 7 days
(scale bar = 50 µm for all, live cells shown in green) (modified from Reference 81)

1.4.4 Collagen
While microparticles made from synthetic polymers, gelatin, and chitosan have
shown great promise as injectable, cell‐adhesive scaffolds, much attention, of late, has
turned to collagen due to its potential for great structural diversity, allowing for tailor‐
made applications. Collagen is a strong, sturdy protein found in the ECM, as well as in
bone and ligaments. In nature, it exists as a left‐handed polyproline type II (PPII) helix,
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characterized by three‐amino acid repeats, the third of which is always glycine. Of these
Xaa‐Yaa‐Gly repeats, proline‐hydroxyproline‐glycine (POG) is the most abundant and
most responsible for the stability of natural collagen. Three of these individual PPII
helices combine to form a highly stable triple helix. The stability of the triple helix
comes from hydrogen‐bonding interactions between the amide hydrogens on glycine
and other nearby main‐chain carbonyl moieties85. It has also been proposed that the
hydroxyl group of hydroxyproline forms hydrogen bonds with surrounding water
molecules in solution86. In addition, the triple helix is stabilized by the steric repulsion
between the bulky pyrrolidine rings on proline and hydroxyproline, as the extreme
repulsion between these rings causes them to orient outwards, forcing the main chains
of the individual helices to form tighter, more cohesive bundles87 (Figure 1.12).

Figure 1.12. Ball‐and‐stick diagram of the currently accepted triple helix
model of collagen. Each PPII helix is shown in a different color, with the
pyrrolidine rings all oriented outward, contorting other parts of the helix
inward (adapted from Reference 87b)
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Natural ECM‐dwelling collagen consists of interwoven fibril networks. It has
diverse morphology, with 28 known types88. Of these, some form fibrils, some form
networked structures, and others form fibril‐associated collagens with interrupted triple
helices (FACITS).

Still others form multiple triple helix domains and interruptions

(MUTLIPLEXINS) and membrane‐associated collagens with interrupted triple helices
(MACITS)89. The inherent strength and the wide‐ranging functionality of collagen make it
ideal for use as a scaffold for tissue engineering.
Yao et. al.90 made use of microspheres fabricated from natural collagen to
support the growth and differentiation of oligodendrocyte progenitor cells (OPCs), as a
potential therapy for spinal cord regeneration91. Microspheres were generated through
emulsification of bovine Achilles tendon Type I collagen in paraffin oil, followed by EDC‐
promoted assembly with stirring92. The resulting spheres ranged from 70‐190 µm in
diameter, depending on the speed at which they were stirred during assembly. The
smallest spheres resulting from the highest stirring speed. Collagen microspheres were
cultured with OPCs labeled with anti‐A2B5 antibody. After three days, fluorescent
confocal microscopy revealed that the OPCs did indeed associate with the
surface of the microspheres.

Moreover, narrow cellular branches were visible,

extending from the neuronal cell body to the collagen microparticles, a positive sign of
interaction between the cells and the microspheres (Figure 1.13 A, B, C). The cell /
microparticle culture was then transferred to differentiation medium. After eight days,
oligodendrocytes were visible throughout the sample (Figure 1.13 E, F). These cells
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formed many branch‐like extensions that surrounded the collagen microspheres.
Moreover, with these branches, the oligodendrocytes reached out into the surrounding
media and formed connections with other oligodendrocytes. The oligodendrocytes
cultured on collagen microparticles appeared very similar to those grown on a culture
plate by traditional means (Figure 1.13 D). More crucially, the behavior of ODCs grown
on collagen was then examined in co‐culture with dorsal root ganglions (DRGs). When
ODCs and DRGs were jointly cultured on a plate without collagen, after eight days, the
ODCs were observed to form an outer coating of myelin sheath around the DRG nerve
fibers. When collagen microspheres, pre‐seeded with ODCs, were cultured with DRGs, a
very similar effect was observed (Figure 1.13 G). The ODCs extended branches to the
DRGs and began to coat them (Figure 1.13 H). Thus, microspheres fabricated from Type
I collagen were able to support the growth and differentiation of neuronal stem cells
and successfully transplant living, biofunctional oligodendrocytes onto endogenous
neurons to initiate tissue repair.90
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Figure 1.13. Collagen microspheres support the growth and differentiation of
oligodendrocyte progenitor cells (OPCs). Fluorescent confocal microscopy visualization
of OPCs cultured on collagen microspheres in basal media for three days: (A)
Transmittance image, (B) Red channel, (C) Overlay (Cells stained with anti‐A2B5, scale
bar = 50 µm). Fluorescent confocal microscopy visualization of OPCs when cultured in
differentiation media (D) on a cell plate (scale bar = 200 µm), (E, F) with collagen
microspheres (E = red channel only, F = overlay) (Cells stained with anti‐MBP antibody,
scale bar = 200 µm). (G) Fluorescent confocal microscopy visualization of OPC‐seeded
collagen microspheres cultured with dorsal root ganglions (DRGs) for eight days, (H)
Zoom‐in of (G) showing branching extensions (DRG axons labeled with anti‐IIIβ‐tubulin
antibody and OPCs stained with anti‐MEB antibody) (modified from Reference 90)

Matsunaga et. al.93 utilized cell‐adhesive collagen beads to generate a
macroscopic 3D tissue structure of millimeter thickness when placed in a pre‐shaped
mold. Uniform beads ranging from 50‐300 µm in diameter were produced on a large
scale from bovine neutral type I atelocollagen using axisymmetric flow‐focusing devices
(AFFDs), a type of microfluidic technology94. The precise size of the beads was carefully
controlled by varying the rate of flow through the device. The beads were then
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incubated with a variety of cell types. Within two hours, it was found that NIH 3T3
fibroblasts, HepG2 cells, MIN6M9 cells, primary neurons, primary rat hepatocytes, and
human umbilical endothelial cells (HUVECs) all independently attached to the collagen
beads. After 17 hours of culture, an extensive population of monocultured beads was
observed by bright field microscopy (Figure 1.14 E, F).

Importantly, it was also

discovered that when the cell culture was agitated, after 17 hours, cells had begun to
penetrate the interior of the collagen beads in addition to covering the surface. Also,
the beads had considerably shrunk in size, likely due to exposure to cell‐secreted
proteases and to the fact that the beads were beginning to be “squeezed” by the
surrounding cells. When the same cell culture was kept stationary while incubated with
collagen beads, it was found that cell adhesion was minimal, and no cells had reached
the interior of the beads. Co‐cultures were also generated. This was accomplished
through encapsulation of one cell line during the initial microfluidic bead formation,
followed by incubation with a second, distinct cell line. After 17 hours, fluorescent
confocal microscopy confirmed the presence of one cell line inside each bead and
another cell line covering the surface (Figure 1.14 G, H). These monocultured and
cocultured cell‐collagen beads were then used as building blocks for the construction of
various 3D tissue morphologies (Figure 1.14 A). Upon formation, the desired bead
components were placed in a silicone mold in the shape of the target (Figure 1.14 B).
The cell beads readily adhered to one another. The rounded shape of the beads was
designed to allow enough space for crucial nutrients to diffuse among the cell
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populations (Figure 1.14 C). After the tissue had formed, it could be ejected from the
mold and analyzed (Figure 1.14 D). As a proof‐of‐concept of this methodology, 100 µm
beads seeded with NIH 3T3 fibroblasts were deposited into a mold in the shape of a
humanoid figure (Figure 1.14 I). Closer inspection confirmed the presence of distinct
gaps between the beads (Figure 1.14 J). After 17 hours, it was found that the tissue had
shrunk considerably with respect to the surrounding mold (Figure 1.14 K). Closer
inspection revealed that the beads had coalesced into a single homogenous tissue, with
no visible cavities (Figure 1.14 J). Moreover, the tissues remained viable for at least 30
hours after ejection from the mold. When 300 µm beads were used instead for the
molding process, the resulting tissue was found to be viable for at least 120 hours, due
to the presence of larger cavities allowing prolonged nutrient flow during tissue
formation. The authors similarly formed ring and rod‐shaped tissues. Heterogeneous
tissues were also formed using NIH 3T3, HUVECs, and HepG2 cells. When a 3D robotic
dispensing printer was employed, precise layer‐by‐layer structural control of the tissue
architecture was realized. Elementary vasculature was visualized as well when HUVECs
were seeded93.
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Figure 1.14. Cell‐adhesive collagen microbeads generate 3D tissues when
placed in a surrounding mold. (A, B, C, D) Schematic of the tissue assembly
process, (E, F) Bright field microscopy of NIH 3T3 fibroblast monocultured
collagen beads after 17 hours of incubation (scale bars = 400 µm and 50 µm,
respectively), (G, H) Fluorescent confocal microscopy visualization of collagen
beads co‐cultured with NIH 3T3 fibroblasts and HepG2 cells (scale bars = 20 µm
and 10 µm, respectively), Visualization of NIH 3T3 microbeads in a human‐
shaped mold (I, J) immediately after bead deposition (scale bars = 1 mm and
500 µm, respectively; yellow arrows indicate the presence of cavities) and (K, L)
17 hours after placement in the mold (scale bars = 1 mm and 500 µm,
respectively) (modified from Reference 93)

Yamada et. al95. generated collagen microparticles with a rough surface
morphology that enabled spheroid formation96 with primary rat hepatocytes. Spheroid
formation is believed to be an important stage in the production of embryonic tissue97.
Consequently, spheroids have been used as effective models of in vivo drug screening98,
as well as models for larger tissue functionality93, 99. Microparticles were generated
from Type I rat tail tendon collagen using a novel microfluidic device that produced
droplets in a non‐equilibrium state100. In short, a dilute solution of collagen was
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pumped into a continuous phase of polar organic solvent (methyl acrylate) and passed
through a small orifice, resulting in droplet formation. The droplets passed singly
through a microchannel, gradually shrinking the farther along they moved.

The

shrunken droplets were then stabilized with the cross‐linker glutaraldehyde before
being collected (Figure 1.15 A). SEM visualization of the resulting collagen particles
revealed that they averaged 17.0 µm in diameter and possessed a distinct, disc‐like
morphology (Figure 1.15 B). Closer inspection revealed that the surface was rough in
nature, emulating the fibrous ECM (Figure 1.15 C). The collagen microparticles were
then incubated with rat hepatocytes in suspension in a non‐adhesive microchamber
containing an agarose hydrogel. Spheroids were visible after one day and continued to
evolve until they were harvested on day 7 (Figure 1.15 D). Fluorescent microcopy
visualization of the FITC‐labeled collagen revealed that the microparticles were
randomly dispersed throughout each spheroid (Figure 1.15 E). Immunofluorescence
staining at day 14 confirmed the presence of albumin‐producing hepatocytes (Figure
1.15 F).
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Figure 1.15. Collagen microparticles, produced on a microfluidic device, generate
spheroids with primary rat hepatocytes. (A) Schematic of microfluidic production of
collagen microparticles, (B) SEM visualization of disc‐like collagen microparticles (scale
bar = 10 µm), (C) Zoom‐in of (B) showcasing the surface morphology (scale bar = 2
µm); Rat hepatocyte spheroids grown on collagen microparticles after 7 days as
visualized through (D) Bright field microscopy (scale bar = 100 µm),(E) Fluorescence
microscopy (collagen stained green with FITC) (scale bar = 100 µm), (F)
Immunofluorescence staining after 14 days (albumin stained red, cell nuclei stained
blue with DAPI, collagen stained green with FITC) (scale bar = 50 µm) (modified from
Reference 95)

Natural collagen is advantageous as a biomaterial due to its ability to mimic the
fibrous components of the ECM, and collagen can be formed into monodisperse
spherical particles through the use of technologies such as microfluidics and
emulsification95. Moreover, cells readily adhere to collagen microparticles, and, under
the right conditions, collagen can support the growth and differentiation of stem cells
into functional tissue90. Additionally, as we have seen, collagen beads, when placed in a
properly shaped silicone mold, can be used as building blocks for the construction of
carefully controlled, customizable 3D tissue architectures93.
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However, collagen also suffers from a number of disadvantages. First, it is very
difficult to introduce chemical diversity into the collagen triple helix. Consequently,
researchers are very limited in their ability to control the functionality and morphology
of the scaffold. Moreover, collagen obtained from pigs or other animals can trigger an
immunogenic response in humans. It can also contain a number of toxic agents, such as
prions. Lastly, natural collagen is readily broken down by collagenases found in the
ECM. Thermal and / or photochemical cross‐linking has been shown to improve the
stability of the triple helix, but this improved stability is coupled with a corresponding
rise in toxicity88.

1.5 Peptide Mimetics
A good scaffold for tissue engineering would be one with precise structural
control, without, at the same time, sacrificing its structural stability and its
immunocompatibility. To this end, recent research has focused on the design of a new
set of scaffolds based on peptide mimetics, short sequences (15‐45 residues) that
closely imitate the sequences of natural proteins88,
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. Such scaffolds are of great

interest because they jointly incorporate the diverse functionality of natural, protein‐
based scaffolds with the consistency in performance of synthetic scaffolds. Collagen‐
mimetic peptides (CMPs) are particularly noteworthy in that they replicate the best
features of natural collagen, while also minimizing cytotoxicity and enabling greater
structural control102.
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1.6 Self‐Assembly Strategies for Collagen Mimetic Peptides (CMPs)
In order to emulate natural collagen, all CMPs contain a (POG)n backbone. This
enables them to form a triple helical structure in solution. However, CMPs can be made
to form higher‐order structures by applying external stresses and / or further modifying
the peptide structure.

In one instance, nanoscale branched structures were self‐

assembled from an unmodified (POG)10 peptide sequence after a thermal annealing
process103. Also, poly‐condensation of (POG)10 resulted in nanometer and micrometer‐
sized fibers104. Native chemical ligation of (POG)9 sequences also formed such fibers105.
CMPs with cysteine knots have self‐assembled into a variety of structures as well. These
range from nanorods and micron‐sized fibrils, to fibers exceeding 400 nm in length, to
particles of up to 14 µm in size106. Collagen‐like gels have also been produced107.
Another method of inducing higher‐order assembly from CMPs is to make
modifications at the N‐ and C‐terminus.

Micron‐sized fibers resulted from the

placement of aromatic residues at the termini of CMPs. The resulting hydrophobic
interactions between the end groups of the triple helix served to promote fiber
formation108. Substituting a cationic residue at the N‐terminus, while retaining an
aromatic residue at the C‐terminus formed micon‐sized fibrils through a head‐to‐tail
assembly process resulting from cationic‐π interactions109. Periodically‐banded fibers
resulted from CMPs containing arginine (Arg) and glutaminic acid (Glu) residues at the
N‐ and C‐terminus. The fibers formed from a combination of head‐to‐tail electronic
effects and lateral assembly110. Replacement of the N‐terminal Arg residues with the
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noncanonical imino acid(2S,4S)‐4‐amino‐proline (Amp), a structural analog of
hydroxyproline (Hyp), led to the formation of nanosheets composed of repeating triple
helical units. The thickness of these nanosheets was correlated to the chain length and
solution concentration of the peptide111. The addition of lysine (Lys) and aspartic acid
(Asp) residues to the termini of CMPs formed both fibers and hydrogels112. Hydrogels
and fibers also formed from the placement of single‐tailed amphiphilic moieties at the
N‐terminus113.
While exploiting electrostatic interactions between terminal residues has shown
some promise for self‐assembly applications, great strides have also been made using an
alternative strategy. This method places metal‐binding ligands at various points along
the (POG)n backbone. Chelation with one or more metal ions induces higher order
assembly.

A diverse array of structures have been produced though this metal‐

promoted self‐assembly methodology, such as nano‐and micro‐sized fibers114, disks115,
hollow spheres116, florettes117, and three‐dimensional matrices117c, 118. In addition to the
great potential for structural diversity, metal‐promoted self‐assembly is quite
advantageous for the fact that florettes and 3D scaffolds can form at room temperature
and at physiological conditions (pH 7.1 buffered aqueous solutions and serum‐
containing cell culture media).

Moreover, the many unsatisfied metal‐ligand

interactions throughout these structures readily allow for the incorporation of His‐
tagged growth factors, dyes, and adhesion sequences118.
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Three essential design strategies have been developed for metal‐promoted self‐
assembly88 (Figure 1.16). The first is linear design, in which metal‐binding ligands are
placed at the N and C‐terminus of the (POG)n backbone. Peptides designed in this
fashion include NCoH, which forms microflorettes in the presence of an array of divalent
metals117a, and HisCol and IdaCol, which self‐assemble into intricate, banded meshes114b.
In radial design, ligands are placed at the center of the (POG)n backbone. This strategy
was employed to produce the H(byp) series.

H(byp), which consists of a (POG)9

backbone with a centrally‐placed bipyridal ligand, self‐assembles into a long fiber upon
incubation with Fe (II)114a. H(byp)2, which consists of a (POG)9 backbone with two
bipyridal ligands placed in the region around the center, forms round disks when
presented with Fe (II)115. H(byp)3, which contains three bipyridine moieties spaced
throughout the backbone, self‐assembles into curved disks and then undergoes Fe(II)‐
promoted supramolecular assembly into hollow spheres116, which can be used
biomolecular delivery119. H(byp)4, which contains four bipyridines spaced throughout
the (POG)9 backbone in a triad fashion for added stability, forms domed, stacked disks,
which undergo further Fe(II)‐promoted self‐assembly into puckered microspheres120.
Lastly, a cross‐linked design approach can also be taken, in which metal‐binding ligands
are placed at both the termini and the center of the peptide. This approach was used to
produce HBN, which consists of a (POG)9 backbone with a di‐histidine ligand at the C‐
terminus, a nitrilotriacetic acid (NTA) moiety at the N‐terminus, and a bipyridal ligand at
the center. Incubation with Zn2+, Co2+, Cu2+, or Ni2+ produces a thick, interwoven,
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fibrous mesh118. This strategy has also been used to create HRGDSN and HBRGDS.
HRGDSN consists of the same backbone as HBN with (His)2 at the C‐terminus, an NTA
moiety at the N‐terminus, and an RGDS motif at the center. HBRGDS is created with a
(His)2 ligand at the C‐terminus, an RGDS motif at the N‐terminus, and a bipyridal ligand
at the center. All three of these peptides form a 3D scaffold when incubated with Ni
(II)121.

Figure 1.16. Three design strategies for metal‐promoted self‐assembly. Linear design
produces NCoH, which self‐assembles into microflorettes, and HisCol and IdaCol,
which jointly assemble into an exquisite, banded mesh. Radial design produces the
H(byp) series, which self‐assembles into round disks and hollow spheres. Cross‐
linked design produces NHbipy, which self‐assembles into a 3D mesh (modified from
References 88, 114b, 115, 117a, and 118)

42

1.7 NCoH and Microflorette Formation
The linearly‐designed peptide NCoH is of particular interest to the work in the
chapters that follow. NCoH contains a (POG)9 backbone, which enables it to form the
highly stable collagen triple helix. It has a (His)2 ligand at the C‐terminus and an NTA
moiety at the N‐terminus. When the triple helix forms, three NTA ligands are clustered
at the N‐terminus, and three (His)2 ligands are clustered at the C‐terminus (Figure 1.17).
Incubation with Zn2+ causes NCoH to self‐assemble into spherical particles called
florettes. These florettes tend to be approximately 5‐20 µm in diameter and have a
deeply ruffled surface made up of tightly bundled collagen fibers117a (Figure 1.18).

(A)

Figure 1.17. (A) Metal‐promoted head‐to‐tail self‐assembly of NCoH. (B) NCoH sequence
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Figure 1.18. SEM of NCoH microflorette (scale bar = 5 µm) (adapted from Reference
117a)

NCoH microflorettes should contain unsatisfied metal‐ligand pairs (i.e., free NTA) on
both the surface and the interior. This is a particularly attractive feature as it allows for
the possibility of decoration by biomolecules containing a His fusion tag117b. His tags
have a long history of serving as “handles” for proteins. In particular, the NTA / His‐tag
system has been used for protein labeling122, surface patterning123, and as an artificial
cell‐surface receptor124.

Moreover, a previous study117b demonstrated that NCoH

microflorettes can be selectively decorated by molecules containing a His tag. The core
of the florettes was labeled by adding the His‐tagged molecule during the formation of
the florettes from NCoH, i.e., just before addition of the metal. The outside of the
florettes was labeled by adding the His‐tagged molecule after the formation of the
florettes. Coating the surface of the florettes with Ni2+ made them particularly receptive
to the His‐tagged moiety (Figure 1.19 A). The selectivity of the modifications was made
clear when this methodology was used to decorate the core of florettes with His‐tagged
red fluorescent protein (RFPHis) and the surface with His‐tagged green fluorescent
protein (GFPHis). Fluorescent confocal microscopy revealed that the red color was found

44

exclusively on the inside of the florettes, while the green color was found solely on the
outer surface. An overlay of both the red and the green channel further demonstrated
that both the surface and the core of a single florette can be decorated simultaneously,
greatly expanding the possibilities of microflorette modification117b (Figure 1.19 B).

A)
(i)

(ii)

NCoH
His-GFP

Zn(II)

B)

Figure 1.19. (A) Scheme demonstrating selective decoration of the (i) surface (post‐
florette formation) and (ii) inner core (pre‐florette formation) of an NCoH
microflorette. (B) Fluorescent confocal microscopy images depicting core‐localized
RFP‐(His)6 (left), surface‐mounted GFP‐(His)6 (middle), and an overlay depicting both
simulatenously (right) (adapted from Reference 117b)

45

1.8 Conclusions
To alleviate the rapidly growing shortage of healthy organs, artificial tissue
engineering has developed as an alternative to full organ transplants.

Cells in

suspension cannot survive for long and cannot develop into fully functional tissues
without a solid support that effectively mimics the native extracellular matrix (ECM). A
wide variety of bulky, continuous solid scaffolds have emerged to facilitate the growth
and differentiation of stem cells into mature tissues, such as segments of bone, nerves,
cartilage, and more. However, such scaffolds require direct surgical implantation at the
site containing the damaged tissue, a tedious and highly risky procedure. A viable
alternative to solid scaffolds is the use of discrete, cell‐adhesive microparticles that can
be injected at the site of action. Such particles have been constructed from many of the
same biodegradable and biocompatible materials used to make more traditional solid
scaffolds: polymers (such as PLGA), gelatin, chitosan, and collagen. Each of these
materials, independently and in combination, have been shown to viably support the
growth and development of functional tissue through a variety of means, including the
use of cell‐adhesive ligands (i.e., RGD) and (strep)avidin‐biotin surface antibody
interactions and the encapsulation and gradual release of cell‐supportive growth
factors.

However, PLGA, gelatin, collagen, and chitosan‐based microparticles are

typically fabricated through an emulsification process or with the use of microfluidics
devices, which can be quite time‐consuming and costly for large‐scale fabrication. A far
more simple and elegant manner of particle generation is through self‐assembly. A
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wide range of collagen mimetic peptides (CMPs) have been self‐assembled into a variety
of highly‐customizable and biocompatible architectures via electrostatic interactions, π‐
π stacking interactions, native chemical ligation, and hydrophobic interactions. One
particularly attractive mechanism of CMP self‐assembly is through the exploitation of
the interaction between metal ions and metal‐binding ligands installed at various
positions along the backbone of the collagen triple helix. This strategy has been
successfully utilized to generate fibers, microflorettes, disks, meshes, and hollow
spheres, all of which hold great potential to support cell adhesion and / or
encapsulation for tissue engineering applications.
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CHAPTER 2 . METAL‐PROMOTED SELF‐ASSEMBLY OF CELL‐ADHESIVE COLLAGEN
MIMETIC PEPTIDE‐BASED SCAFFOLDS FOR REGENERATIVE MEDICINE

2.1 Introduction
A cell line of particular importance for tissue engineering is human mesenchymal
stem cells (hMSCs). hMSCs are adult stem cells extracted from bone marrow. When
presented with the appropriate growth factors (GFs) in a suitable microenvironment,
they are able to selectively differentiate into a wide range of cell types, including
osteocytes (bone), chondrocytes (cartilage), and adipocytes (fatty tissue)1 (Figure 2.1).
Selective, controlled, and reliable differentiation of precursor cells is a key prerequisite
for tissue transplantation.
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Figure 2.1. Differentiation schema for human mesenchymal stem cells (hMSCs).
(Adapted from Reference 1)

In the body, the growth and differentiation of hMSCs into functional tissue is
supported by the extracellular matrix (ECM), a complex mesh‐like network of fibrous
proteins, polysaccharides, growth factors, and signaling molecules2. A significant
component is collagen, a sturdy biopolymer that can adapt a variety of morphologies3.
Hence, synthetic collagen mimetic peptides (CMPs) have been developed that, given the
right chemical cues, self‐assemble into cell‐supporting scaffolds4.
The peptide HBN has a (POG)n backbone to enable triple helix formation (like
natural collagen), but it is also modified with metal‐binding ligands: a dihistidine moiety
at the C‐terminus, a NTA ligand at the N‐terminus, and a bipyridine in the central
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portion of the backbone. Overnight incubation of HBN with NiCl2 results in metal‐
promoted self‐assembly to form a thick, cross‐linked mesh. Moreover, the peptide HBN
was combined with its analogs HRGDSN and HBRGDS that contain the cell‐adhesive
sequence RGDS at the central region and N‐terminus of the peptide, respectively, to
self‐assemble in the presence of metal ions into a mesh that encapsulates live cells5.
More recently, it was shown that growth factors such as hEGF can bind to the
HBN mesh via a His tag and that the HBN mesh exhibits a sustained release profile for
hEGF‐(His)6 in cellular media (Figure 2.2I). Consequently, when a mesh formed from
HBN and HBRGDS (5 : 1) was incubated with MCF10A cells in the presence of hEGF,
spheroids were observed within six days6 (Figure 2.2C, F, G, H). This result is significant
because formation of spheroids is a crucial precursor to the formation of embryonic
tissue7, and spheroids have been utilized as models for the effects of drugs in vivo8.
Interestingly, while spheroids formed in both cases, far more spheroids were observed
when the HBN: HBRGDS mesh was incubated with free‐floating hEGF (Figure 2.2C) than
in the case when hEGF was bound to the mesh (Figure 2.2F). Also, no MCF10A
spheroids formed when analogous experiments were performed with the HBN mesh
alone (Figure 2.2A, D) and with an HBN and HRGDSN (5 : 1) mesh (Figure 2.2B, E),
regardless of whether hEGF was free or bound6.
Furthermore, the HBN mesh has been shown to encapsulate and support the
differentiation of hMSCs. Bound cells remained viable for up to 24 days. Following
seeding onto the scaffold, the system was incubated in osteogenesis‐inducing media.
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RT‐PCR analysis of key osteocyte genetic markers confirmed the initiation of
osteogenesis within the first eight days, a process which continued until at least day 24.
Chondrogenesis was likewise observed upon extended incubation in chondrogenesis‐
inducing media. Curiously, while cells encapsulated on the HBN mesh formed tight
aggregates, those seeded onto a 1.0 : 0.2 HBN : HBRGDS mesh displayed branch‐like
extensions but still underwent osteogenesis and chondrogenesis under analogous
conditions to the HBN mesh alone. It was hypothesized that the spindle morphology
observed with RGDS could accommodate additional differentiation pathways9.

I
G
I

H

Figure 2.2. Fluorescent confocal microscopy images of MCF10A cells (green) after six
days of incubation with the HBN mesh with (A) free hEGF‐(His)6 and (D) bound hEGF‐
(His)6, 1.0 : 0.2 HBN: HRGDSN mesh with (B) free hEGF‐(His)6 and (E) bound hEGF‐
(His)6, and 1.0 : 0.2 HBN: HBRGDS mesh with (C) free hEGF‐(His)6 and (F) bound hEGF‐
(His)6 (all stained green with Calcein AM); confocal overlay image of a single spheroid
embedded in HBN: HBRGDS mesh with (G) free hEGF‐(His)6 and (H) bound hEGF‐(His)6
(stained with calcein AM (green) and Hoechst 33342 (blue)); (I) Release profile for
hEGF‐(His)6 from the HBN mesh in PBS (blue) and cellular media with horse serum
(red) (modified from reference 6)
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The linearly‐designed collagen mimetic peptide NCoH has a (POG)9 backbone
with a NTA ligand at the N‐terminus and a (His)2 moiety at the C‐terminus. In the
presence of a variety of divalent metal cations, it self‐assembles into small (10‐20 µm),
ruffled spherical particles called microflorettes. These NCoH microflorettes have been
shown to bind to HeLa cells and, more significantly, hMSCs by fluorescent confocal
microscopy.

Cryo‐SEM also confirmed adhesion of hMSCs to small clusters of

microflorettes10 (Figure 2.3).

Figure 2.3. Bright field and fluorescent confocal microscopy of aggregates formed
from hMSCs and NCoH microflorettes, as well as NCoH microflorettes and HeLa cells
(scale bars = 10 µm) (cells stained blue with DAPI, florettes dyed green with GFP);
Cryo‐SEM visualization of hMSC‐NCoH microflorette aggregates (modified from
reference 10).

However, these images, while intriguing, fail to capture the true solution‐phase
morphology of the aggregates formed from NCoH microflorettes and hMSCs. Cryo‐SEM
can only capture the surface morphology of the system. The fluorescent confocal
microscopy images were captured in a media suspension; however, the choice of
fluorophores (DAPI (blue nuclear stain for cells) and GFP (green dye for florettes)) fails
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to visualize the surface contacts between the NCoH microflorettes and the cells. The
most information that can be gleaned from these images is that the cells and florettes
occupy the same general vicinity. Thus, this chapter will explore the development of a
new type of fluorophore in order to more effectively utilize fluorescent confocal
microscopy to confirm interactions between various cell lines and NCoH microflorettes.

2.2 Linearly‐Designed Peptide NCoH
The studies described in this chapter make use of NCoH, a collagen mimetic
peptide designed for assembly in a linear fashion. This peptide possesses a (POG)9
backbone to ensure that it emulates the triple helix conformation of natural collagen.
However, it is prepared with an NTA moiety positioned at the N‐terminus and
dihistidine at the C‐terminus to enable metal‐promoted self‐assembly in a head‐to‐tail
fashion (Figure 2.4B). The NTA ligand of one helix forms a metal‐mediated complex with
the dihistidine on another helix. This process is repeated for every strand of each triple
helix, resulting in a highly extended, microscale assembly11 (Figure 2.4A). We have
hypothesized that these extended segments curl inward on themselves to form the
observed microflorette morphology11‐12.
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Figure 2.4. (A) Metal‐promoted head‐to‐tail self‐assembly of NCoH. (B) NCoH
complete sequence

2.3 Results and Discussion

2.3.1 Synthesis of NTA
Nitrilotriacetic acid (NTA) was synthesized in two straightforward steps (Figure
2.5).

First, the amino acid derivative H‐Glu(OBzl)‐OtBu, 1, was coupled with t‐
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butylbromoacetate in an overnight reaction with heating (70°C) in an oil bath, affording
2 with 69% yield after flash column purification. Then the benzyl ether moiety in 2 was
converted to a benzoic acid motif through a Pd‐catalyzed hydrogenolysis reaction,
resulting in the formation of NTA, 3, with 95% yield.

Figure 2.5. Two‐step synthesis of NTA from H‐Glu(OBzl)‐OtBu.

2.3.2 Synthesis and Purification of NCoH and Rho‐(Gly)3‐(His)6
The peptide NCoH was prepared through a standard Fmoc‐based solid‐phase
synthesis. First, H‐Rink Amide Chemmatrix Resin was coupled with first Fmoc‐protected
amino acid, Fmoc‐His(trt)‐OH in the presence of the coupling reagent N,N,N′,N′‐
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tetramethyl‐O‐(1H‐benzotriazol‐1‐yl)uronium

hexafluorophosphate

(HBTU)

and

diisopropylethylamine (Hunig’s Base, DIEA) through a well‐characterized mechanism20.
Coupling was verified with the Kaiser Test13, with a negative result being indicative of a
successful coupling due to the presence of the Fmoc protecting group. Next, the resin
was agitated with 25% piperidine in DMF in order to remove the Fmoc protecting group.
Successful deprotection was determined with the Kaiser Test, with the desired result
being a positive indicator (purple color) due to the presence of the now free amine. The
next amino acid (also Fmoc‐His(trt)‐OH) was then loaded in the same way. This process
was continued for all twenty‐nine amino acid couplings. For the secondary amines,
proline and hydroxyproline, coupling was confirmed with the Chloranil Test14 in place of
the Kaiser Test. The final coupling was performed with NTA (synthesized as described
above and in Figure 2.5).
Lastly, the peptide was cleaved from the resin using a trifluoroacetic acid (TFA)
cocktail, consisting of 95% TFA, 2.5% H2O, and 2.5% triisopropylsilane (TIPS). The TFA
was removed by rotary evaporation, and the peptide was precipitated with cold, diethyl
ether. Crude NCoH was purified by RP‐HPLC (Figure 2.7A). The analytical HPLC trace
demonstrated that the resulting NCoH was 98% pure (Figure 2.7B). Mass verification of
the peptide NCoH was accomplished through MALDI‐TOF mass spectrometry (Figure
2.7C). The expected masses for NCoH was 2938.02 Da. The observed masses was
2936.7 Da.
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Figure 2.6. Solid‐phase synthesis of NCoH

B)

A)

C)

Figure 2.7. (A) Semi‐prep HPLC trace of NCoH. The red arrow points toward the
collected product‐containing fraction. (B) Analytical trace of pure NCoH. The red arrow
points toward the product peak. Both traces were monitored at 214 nm (Gradient: 5‐
25% ACN / H2O with 0.1% TFA, Luna C18 column); (C) MALDI‐TOF MS chromatogram
of pure NCoH (red arrow indicates the desired molecular mass fragment)
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The fluorescent peptide Rho‐(Gly)3‐(His)6 (Figure 2.8A) was manually prepared using
a standard Fmoc‐based solid phase synthesis from H‐Rink Amide Chemmatrix Resin (as
described in Figure 2.6). The final coupling was performed using 1.5 equivalents of the
fluorescent dye NHS‐Rhodamine and twelve equivalents of DIEA in DMF. This coupling
was promoted via the displacement of N‐hydroxysuccinimide (NHS), an excellent leaving
group (Figure 2.8B). Crude Rho‐(Gly)3‐(His)6 was purified via RP‐HPLC. The analytical
HPLC trace, monitored at both 214 nm (peptides) and 254 nm (aromatics), revealed that
the Rho‐(Gly)3‐(His)6 was 92% pure (Figure 2.9A, B). MALDI‐TOF MS confirmed the mass
of the product peptide (Figure 2.9C). The expected mass for Rho‐(Gly)3‐(His)6 was
1424.46 Da, respectively. The observed mass was 1423.79 Da.
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Figure 2.8. (A) Sequence of Rho‐(Gly)3‐(His)6 (B) Mechanism of Rhodamine coupling to
the N‐terminus of the growing peptide chain

A)
C)

B)

Figure 2.9. Analytical HPLC trace of pure Rho‐(Gly)3‐(His)6 with monitoring at (A) 214
nm and (B) 254 nm. The red arrow marks the product‐containing peak (Gradient: 5‐
45% ACN / H2O with 0.05% TFA); (C) MALDI‐TOF MS chromatogram of pure Rho‐(Gly)3‐
(His)6 (the red arrow indicates the desired molecular mass fragment)

75
2.3.3 Confirmation of the Helicity of NCoH
Circular dichroism (CD) spectroscopy was performed to assess the peptide
secondary structure of NCoH. The standard CD curve of molar ellipticity, θ, versus
wavelength revealed a maximum at 225 nm (Figure 2.10A). This is characteristic of a
left‐handed polyproline type II (PPII) helix, which corresponds to the secondary
structure of collagen. A second curve was generated by plotting the first derivative of
the molar ellipticity with respect to temperature (dθ / dT) against the temperature
range (Figure 2.10B). This revealed that the sample had a melting point of 49°C. The
melting point of NCoH reported in the literature11 is 50°C. These results, taken in
combination, signify that the NCoH that was produced does indeed form a triple helix in
solution.
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Figure 2.10. (A) CD spectrum and (B) first derivative of the melting curve for 167 µM
NCoH

2.3.4 Formation of NCoH Microflorettes
Microflorettes were formed in solution (Figure 2.11) from the peptide NCoH.
Assemblage occurred in 1.5 mL eppendorf tubes. The buffer used was 3‐(N‐
morpholino)propanesulfonic acid (MOPS) at pH 7.1. Zn2+ was used to trigger self‐
assembly.

Microflorette formation was verified by light microscopy and SEM the

following day (Figure 2.11). SEM confirms the presence of a ruffled surface morphology
(Figure 2.11D).

It has been hypothesized that this ruffled surface facilitates cell

adhesion through a gecko‐type interaction10, in which the cells insert themselves into
the many grooves on the surface of the florettes, much like how a gecko adheres to
surfaces by means of the grooves on its feet.
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Figure 2.11. Bright field microscopy images of NCoH microflorettes formed in
aqueous solution with 500 nM ZnCl2 at (A) 10X (scale bar = 200 µm) and (B) 40X
magnification (scale bar = 100 µm); (C) SEM visualization of a single florette (scale bar
= 10 µm), (D) Close‐up showing the surface morphology (scale bar = 1 µm)

2.3.5 Selective Decoration of Microflorettes
Using a previously‐reported methodology15, the NCoH microflorettes were
selectively decorated for cell studies (Figure 2.12A, B). Due to the nature of the
mechanism of assembly, there should be unsatisfied metal‐ligand pairs both at the
surface and at the inner core of the microflorettes. These unfilled ligands can be
exploited for selective decoration with His‐tag‐containing small molecules. For core
decoration, the biomolecule of interest is added to the peptide mixture just prior to
addition of the divalent metal ion. The microflorette thus forms with the biomolecule,
effectively encapsulating it. The biomolecule remains bound as a result of the affinity of
its His tag with uncoupled NTA ligands extending from the microflorette walls. For
surface decoration, the biomolecule is added post‐synthesis of the NCoH microflorettes.
Prior to addition of the His‐tagged biomolecule, the microflorette is coated with Ni2+,
which has a high affinity for surface‐dwelling NTA. The His tag on the biomolecule then
forms a stable complex with Ni2+‐NTA. As a proof‐of‐concept, florettes were also
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created with Rho‐(Gly)3‐(His)6 exclusively in their cores (Figure 2.12C) and on their outer
surface (Figure 2.12D). For all of the work involving cells, the florettes were designed to
incorporate 500 nM Rho‐(Gly)3‐(His)6 in their cores. Certain studies also required the
florettes to be surface‐decorated with RGDS (Figure 2.12A). This was accomplished by
first coating the florettes with excess NiCl2 for one hour, followed by incubation with 10
µm RGDS‐(His)7 for three hours at room temperature.

A)

B)

NCoH
+
Rho‐HIS

2+

Zn

Core
Modification

Rho‐HIS
Outer
Modification

Core
C)

Outer
D)

Figure 2.12. (A) Cartoon depicting an NCoH microflorette with core‐localized rhodamine
dye (red) bound by a His tag, and the peptide sequence RGDS bound to the outside of
the florette, also by a His tag, (B) Schematic protocol of core and surface‐selective Rho‐
HIS decoration, Fluorescent confocal microscopy image of (C) NCoH microflorettes with
core‐localized 360 nM Rho‐(Gly)3‐(His)6 (scale bar = 20 µm)and (D) NCoH microflorettes
with an outer coating of 360 nM Rho‐(Gly)3‐(His)6 (scale bar = 200 µm)
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RP‐HPLC was used to confirm binding of RGDS‐(His)7 to NCoH microflorettes.
Microflorettes were prepared with surface‐bound RGDS‐(His)7 as described above. The
florettes were then washed three times with water with centrifugation at 10,000 g.
After each wash, the supernatant was removed and retained and the solid residue (or
“pellet”) was resuspended in 50 µL of water. After the final wash, both the pellet and
the collected supernatant were incubated with 20 mM EDTA overnight to dissociate the
florettes. The next day, RP‐HPLC traces were generated for RGDS‐(His)7 alone, the NCoH
+ RGDS‐(His)7 pellet, and the NCoH + RGDS‐(His)7 wash. The RGDS‐(His)7 only trace
revealed that RGDS‐(His)7 elutes at 6‐7 minutes (Figure 2.13A). As expected, the trace of
the pellet had a large peak for NCoH at around 18 minutes (Figure 2.13B), and the
supernatant trace had a very small peak at this location (Figure 2.13C). Also, the pellet
trace had a small peak at 6.3 minutes, and the supernatant trace had a peak at 6.3
minutes, both corresponding to RGDS‐(His)7. The relative areas under this peak in the
pellet was compared to the one in the supernatant, and, from this, it was determined
that 72% of the RGDS‐(His)7 remained bound to the NCoH microflorettes after washing
(Figure 2.13D).
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Figure 2.13. RGDS‐(His)7 binds to the surface of NCoH microflorettes. (A) Analytical
RP‐HPLC trace of 10 µM RGDS‐(His)7 only, (B) Analytical RP‐HPLC of 1.0 mM NCoH + 10
µM RGDS‐(His)7 pellet, (C) Analytical RP‐HPLC of 1.0 mM NCoH + 10 µM RGDS‐(His)7
supernatant (all traces obtained using a gradient of 5‐25% ACN / H2O on a Luna C18
column; blue arrow indicates RGDS‐(His)7, red arrow indicates NCoH) (D) Computed
proportions of RGDS‐(His)7 in pellet and supernatant using relative areas under the
peak corresponding to RGDS.
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2.3.6 NCoH Microflorettes – HeLa Cell Aggregate Studies
As stated previously, the primary motivation of this research is to successfully
attach human mesenchymal stem cells (hMSCS) to NCoH microflorettes to serve as a
tissue delivery vehicle for use in tissue engineering. To further this end, the common
breast cancer cell line known as HeLa was used as a test case for this type of cell‐florette
interaction. HeLa cells were cultured in a T‐75 flask using DMEM Complete Media (10%
FBS) and were trypsinized at 70‐80% confluency. Solutions of NCoH florettes with core‐
localized Rho‐(Gly)3‐(His)6 were assembled. These florette solutions were washed
through centrifugation at 10,000g and resuspended in PBS. 100,000 HeLa cells were

A

C

B

D

Figure 2.14. Z‐stacked confocal image of HeLa cells (1.0 x 105) with NCoH
microflorettes (1.0 x 105) in media suspension: (A) Overlay, (B) Green channel
showing Calcein AM‐stained cells, (C) Red channel showing Rho‐labeled florettes, (D)
Transmittance image (scale bar = 20 µm)
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placed in a 1.5 mL eppendorf tube with 100,000 NCoH florettes in RPMI serum‐free
media (total solution volume = 500 µL). Each sample was incubated at 37°C in 5% CO2
for three hours, with mixing through inversion every thirty minutes. After this time, the
cell samples were labeled with Calcein AM (1.0 µM) and visualized through fluorescence
confocal microscopy (Figure 2.14).
Confocal microscopy is much like traditional fluorescence microscopy, except for
the fact that it images the sample in terms of a series of flat layers or “slices” and then
reassembles these slices to form a composite pseudo‐three‐dimensional image. Many
potential HeLa cell‐florette interactions were observed in this way, as the green cells
appear to fit between the red florettes, forming many points of contact. Additionally,
the red and the green channels appear to be of the same intensity, indicating that the
cells and the florettes occupy the same layer in the sample. This is further confirmed by
the zoomed‐in image of a single cluster in the sample (Figure 2.15).

Figure 2.15. Z‐stacked fluorescent confocal image of HeLa cells (green) with Rho‐His‐
labeled NCoH microflorettes (red). (5X zoom‐in of Figure 2.15). (Scale bar = 20 µm)
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2.3.7 NCoH Microflorette ‐ MCF10A Cell Aggregate Studies
Following the encouraging results from the HeLa cell attachment study, NCoH
florettes were incubated with the non‐tumorigenic breast cell line MCF10A. Numerous
studies16 have shown that MCF10A forms well‐ordered spheroids in the presence of a
3D scaffold or basement membrane. Taking this into account, a study was designed to
determine whether MCF10A cells would also adopt such a morphology in the presence
of NCoH microflorettes. MCF10A cells were cultured in a T‐75 flask with MCF10A
Complete Media (5% horse serum, 0.01% EGF) until 80% confluency. A stock solution of
Rho‐(Gly)3‐(His)6 labeled NCoH florettes were prepared as described above.
As a positive control, MCF10A cells were incubated with the HBN: HBRGDS
scaffold, which was previously shown to induce spheroid formation6. After three days,
spheroids were observed through fluorescent confocal microscopy (Figure 2.16A). Live
cells were stained green with Calcein AM (1.0 µM) while dead cells were identified by
the red DNA intercalator dye propidium iodide (PI) (600 nM). A confocal slice through
the middle of an individual spheroid revealed that multiple live cells made up the
outside of the spheroid, while dead cells were concentrated in the interior of the
spheroid (Figure 2.16B).
As a negative control, MCF10A cells were incubated with a scaffold made from
HBN only, which was previously shown to exhibit poor interaction with MCF10A6. After
three days, no spheroids were observed, and many of the MCF10A cells were swollen
and dying, indicating that they did not interact with the scaffold (Figure 2.17).
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Figure 2.16. MCF10A cells (22,400) forming spheroids with HBN: HBRGDS after 3 days
of incubation in media suspension at 37°C. (A) 10X z‐stacked confocal (scale bar = 100
µm) (B) Middle confocal slice of an individual spheroid. Live cells are stained green
with Calcein AM. Dead cells are stained red with PI (scale bar = 50 µm).

Figure 2.17. Z‐stacked confocal image of MCF10A cells (22,400) with HBN in media
suspension (scale bar = 100 µm). Live cells are stained green with Calcein AM, and
dead cells are indicated with red PI.
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MCF10A cells (50,000) were combined with 50,000 NCoH microflorettes in MCF10A
complete media in a 24‐well plate, pre‐treated with 2% poly(2‐hydroxyethyl
methacrylate) (pHEMA) solution to inhibit cell interactions with the plate19. After three
days, the sample was visualized using fluorescent confocal microscopy (Figure 2.18). No
definite interaction between the cells and the florettes was observed, as the red
florettes and the green cells appeared, for the most part, in entirely different regions of
the sample as small clumps or isolated particles and exhibited no change in morphology.
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Figure 2.18. Confocal image of MCF10A cells (50,000) with NCoH microflorettes
(50,000) in media suspension. (A) Overlay, (B) Green channel depicting Calcein AM‐
stained cells, (C) Red channel depicting Rho‐labeled NCoH microflorettes, (D) Zoom‐
in of (A) (scale bar = 100 µm)
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To further encourage interaction between the florettes and the cells, RGDS, a
well‐established cell‐binding peptide sequence17, was attached to the outside of the
microflorettes via a His Tag, using the protocol described earlier (Section 2.3.5 and
Figure 2.13). 50,000 Rho‐tagged NCoH florettes containing the RGDS sequence were
mixed with 50,000 MCF10A cells and visualized with fluorescent confocal microscopy as
before (Figure 2.19). While some potential cell‐florette interactions were observed,
individual confocal slices through the middle revealed that at least 50% of the florettes
in solution existed as individual, free‐floating particles, indicating that such interactions
were not representative of the sample as a whole.

A

B

C

Figure 2.19. Confocal image of MCF10A cells (50,000) with RGDS‐containing NCoH
microflorettes (50,000) suspended in media. (A) Z‐stacked confocal, (B) Middle
confocal slice, (C) Expanded field of view showing lack of interaction (scale bar = 100
µm). Live cells are stained green with Calcein AM, and NCoH florettes are stained red
with Rho‐(Gly)3‐(His)6.
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Thus, under the conditions tested in this study, NCoH microflorettes, for unclear
reasons, failed to induce spheroid formation or any definitive binding interaction with
MCF10A cells, unlike the results observed with minimalistic 3D scaffolding proteins like
HBN: HBRGDS.

2.3.8 NCoH Microflorette – hMSC Aggregate Studies
As previously stated, the goal of this investigation was to use NCoH florettes as a
means of both inducing the differentiation of human mesenchymal stem cells (hMSCs)
(via growth factors bound through a His tag) and transporting the resulting tissue (by
syringe) through a cell‐florette interaction. Despite the discouraging results of the
MCF10A cells: NCoH florette binding studies, it was decided to advance to testing on
human mesenchymal stem cells (hMSCs), the focal point of this investigation.
hMSCs were cultured in a T‐75 flask, using Mesenchymal Stem Cell Growth
Medium (MSCGM), formed from a mixture of Mesenchymal Stem Cell Basal Medium
(MSCBM), Mesenchymal Stem Cell Growth Supplement (MSCGS), L‐glutamine, and GA‐
1000 antibiotic, and trypsinized at 90‐100% confluency.
As with the MCF10A cells, hMSCs were first incubated with the HBN: HBRGDS
and the HBN scaffold. An earlier study9 demonstrated that hMSCs readily interact with
the HBN: HBRGDS scaffold, but they do not interact well with the HBN scaffold alone.
After 24 hours of incubation at 37°C with 5% CO2, the scaffolds were visualized by
fluorescent confocal microscopy (Figure 2.20). As before, live cells were stained green
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with Calcein AM, and dead cells were labeled with the red DNA intercalator dye
propidium iodide (PI). As expected, the hMSCs positively interacted with the RGDS‐
supplemented scaffold, as evidenced by the flat, branching cellular morphology, while
the hMSCs had minimal interaction with the HBN scaffold alone, as the cells were still
round within the scaffold.

A

B

Figure 2.20. Z‐stacked fluorescent confocal microscopy image of hMSCs (10,000)
incubated for 24 hours at 37°C and 5% CO2 with (A) the HBN: HBRGDS scaffold and (B)
the HBN scaffold alone, suspended in media. Live cells were stained green with
Calcein AM, and dead cells appeared red with PI. (Scale bar = 100 µm)

hMSCs were then tested to assess their response to NCoH microflorettes. First,
50,000 hMSCs were combined with 50,000 non‐RGDS‐containing NCoH microflorettes,
stained internally with Rho‐(Gly)3‐(His)6, on a 24‐well plate, pretreated with 2% pHEMA
solution. After 24 hours of incubation, the cells and florettes were visualized in
suspension by fluorescent confocal microscopy (Figure 2.21). The NCoH microflorettes
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seemed to exhibit some sort of interaction with the hMSCs; however, the florettes
appeared to be very indistinct and malformed, as opposed to neat, individual spheres,
as they had with the earlier HeLa studies. This is likely due to the destructive effects of
the media serum, as has previously been reported10.

A

B

C

Figure 2.21. Fluorescent confocal image of hMSCs (50,000) and NCoH microflorettes
(50,000) in media suspension, presented as (A) a Z‐stacked “true” confocal, and (B) a
confocal slice through the middle. Cells were stained green with Calcein AM, and
NCoH microflorettes appeared red due to the presence of Rho‐(Gly)3‐(His)6 (scale bar
= 100 µm), (C) 50,000 hMSCs only in suspension (live cells stained green with Calcein
AM, dead cells stained red with propidium iodide (PI)) (scale bar = 100 µm)

To combat this problem, hMSCs were next mixed with NCoH florettes with the cell‐
binding RGDS peptide motif decorating their outer surface to encourage tighter binding
interactions to reinforce the stability of the florettes. After 24 hours of incubation, the
results were again visualized using fluorescent confocal microscopy (Figure 2.23). While
the rhodamine‐staining of the NCoH florettes was not as bright as it was for the HeLa
and MCF10A studies (possibly due to an aging stock solution or to interference from the
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media), the florettes still appeared far more distinct and round than those found from
hMSC incubation with florettes lacking RGDS (Figure 2.22).

A However, the hMSCs were
B forming clusters that areC far too large to be of practical

use, as the cell‐florette clusters need to be sufficiently small to fit into a human capillary
for tissue transplantation. Moreover, the hMSCs were forming very large clusters alone,
independent of the influence of the NCoH florettes.

Figure 2.22. (A) Z‐stacked confocal and (B) Middle confocal slice of hMSCs (50,000)
with RGDS‐tagged NCoH microflorettes (50,000), suspended in media. Live cells are
stained green with Calcein AM, florettes are red from Rho‐staining; (C) 50,000 hMSCs
only (live cells stained green with Calcein AM, dead cells stained red with PI (Scale bar
= 100 µm)

In an attempt to reduce cellular clumping and more clearly illustrate the
interaction between the florettes and the cells, a new sample was prepared using five‐
fold less cells and florettes. After 24 hours, a fluorescent confocal image was taken
showing the interaction between 10,000 hMSCs and 10,000 NCoH florettes (Figure
2.23). Under these conditions, there is a clear interaction occurring between the red
NCoH florettes and the green hMSCs, as the florettes appear to be firmly embedded in
the center of a clump of cells. Moreover, the hMSCs and florettes are forming smaller
clumps that are more manageable for possible injection.
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Figure 2.23. Middle confocal slice of hMSCs (10,000) and NCoH florettes (10,000) in
media suspension. (A) Overlay, (B) Green channel showing live cells, (C) Red channel
showing NCoH florettes, (D) Transmittance image. (Scale bar = 25 µm)

The question then arose as to whether or not a 1:1 ratio of cells: florettes was
truly optimal for inducing a gecko‐type interaction, as this ratio had been chosen
arbitrarily. Consequently, another sample containing a 1:2 cell: florette ratio was grown
in suspension in a 24‐well plate, pretreated with 2% pHEMA. The number of cells was
fixed at 10,000, as this appeared to be the optimal cell count for observing a cell:
florette interaction with minimal clumping. After 24 hours, this sample was visualized
(Figure 2.24). Again, the NCoH florettes appeared to be strongly associated with the
hMSCs in relatively small, stable clusters, with the majority of the florettes being
concentrated at the center of each cluster. Moreover, these florettes, for the most part,
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retained their spherical structure, while other, free‐floating florettes appeared to be far
more distorted, indicating that the cells played a role in shielding the florettes from the
deleterious effects of the serum‐containing media.

A
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D

Figure 2.24. Middle fluorescent confocal slice of hMSCs (10,000) and NCoH
microflorettes (20,000) in media suspension. (A) Overlay, (B) Green channel showing
living cells, (C) Red channel showing NCoH florettes, (D) Transmittance. (Scale bar = 25
µm)

Following this, the ratio of cells to florettes was raised to 1:3, and the resulting
interaction was visualized after 24 hours of incubation (Figure 2.25). Among the larger
clumps in the sample, the interaction between the florettes and the cells seemed weak
at best, as a middle confocal slice revealed that the cells and the florettes appeared to
be in different layers. In such a slice, the florettes were wholly visible, but only portions
of cells were visible in the vicinity of the florettes.
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Figure 2.25. Middle confocal slice of hMSCs (10,000) and NCoH florettes (30,000) in
media suspension. (A) Overlay, (B) Green channel showing live cells, (C) Red channel
showing NCoH florettes, (D) Transmittance image. (Scale bar = 50 µm)

However, other, much smaller clumps in the sample did show potential for
interaction (Figure 2.26). The cluster depicted in Figure 2.27 contains 3 florettes and 4
cells. If such clusters can be reliably reproduced, then this would be an ideal sample for
an injection‐based tissue transplant.
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Figure 2.26. Middle confocal slice of hMSCs (10,000) and NCoH florettes (30,000). (A)
Overlay, (B) Green channel showing live cells, (C) Red channel showing NCoH
florettes, (D) Transmittance image. (Scale bar = 25 µm)

Continuing this study, another sample was prepared with a 1:4 ratio of cells:
florettes and again visualized by fluorescence confocal microscopy (Figure 2.27). While
there is still evidence of interaction occurring between the hMSCs and the NCoH
florettes, it appears that the florettes are beginning to overwhelm the cells. In the
cluster depicted in Figure 2.28, there are 6 cells and 16‐20 florettes. Ideally, a cell‐
florette cluster would contain a more equal distribution of cells and florettes in order to
maximize efficiency for tissue transport.
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Figure 2.27. Middle confocal slice of hMSCs (10,000) and NCoH microflorettes (40,000),
suspended in media. (A) Overlay, (B) Green channels showing live cells, (C) Red channel
showing NCoH florettes, (D) Transmittance image (scale bar = 25 µm).

With the previous findings in mind, a time‐course study was conducted with a
freshly prepared stock of Rho‐(Gly)3‐(His)6 in order to evaluate the morphology of
hMSC‐NCoH microflorette aggregates over both shorter and longer intervals (the
previous samples were all visualized over a 24‐hour incubation period). Both 1:2 and
1:3 ratios of hMSCs: NCoH microflorettes were examined. The results of this study are
summarized in Figure 2.28.
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Figure 2.28. Fluorescent confocal microscopy images of (A) 10,000 hMSCs: 20,000
NCoH microflorettes (scale bar: 25 µm) and (B) 10,000 hMSCs: 30,000 NCoH
microflorettes (scale bar: 10 µm) after incubation at 37°C and 5% CO2 for 3 hours, (C)
10,000 hMSCs: 20,000 NCoH microflorettes (scale bar: 20 µm) and (D) 10,000
hMSCs: 30,000 NCoH microflorettes (scale bar: 20 µm) after incubation for 6 hours,
and (E, F) 10,000 hMSCs: 20,000 NCoH microflorettes (scale bars: 25 µm) after
incubation for 24 hours demonstrate hMSC‐microflorette interaction in suspension
in hMSC serum‐containing media; 10,000 hMSCs only after (G) 3 hours, (H) 6 hours,
and (I) 24 hours (scale bars = 25 µm, 100 µm, and 50 µm, respectively)
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hMSC‐microflorette aggregates were observed at all three time points, with
larger clusters predominating at later time points.

In as little as three hours of

incubation in serum‐containing media, small hMSC‐florette clusters, of the ideal size for
injectable transplantation, were observed. More astoundingly, branch‐like projections
emanating from a cell body, indicative of an hMSC spreading out across a solid scaffold,
could be observed across the surface of multiple microflorettes (Figures 2.28A, 2.29),
providing more concrete evidence of a positive binding interaction. Moreover, cells and
florettes could be seen interacting edge‐to‐edge in the same plane (Figure 2.28B and
2.28C). Somewhat larger clusters dominated at 24 hours of incubation, suggesting that
isolation for injection after shorter time frames may be best.
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Figure 2.29 Spindle formation observed in hMSC‐NCoH microflorette
interactions in media suspension in a sample of 10,000 hMSCs: 20,000 florettes
at 3 hours: (A, B) Sample overlays, (D, E) Green channel only, (G, H) 10,000
hMSCs only, and 24 hours: (C) Overlay, (F) Green channel only; (I) 10,000 hMSCs
only (Live cells stained green with Calcein AM, florettes stained red with Rho‐
(Gly)3‐(His)6) (scale bar = 50 µm for (I), all other scale bars = 25 µm)
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These hMSC studies have demonstrated that there is an interaction occurring
between the hMSCs and the NCoH microflorettes, as the florettes are present in highest
abundance in the immediate vicinity of the hMSCs, forming tight clusters after 24 hours
of incubation in suspension at 37°C and 5% CO2. Moreover, the majority of these
florettes are found in the center of these clusters (as evidenced from the individual
slices that make up each Z‐stacked confocal image), and these florettes retain their
spherical geometry, while other, free‐floating florettes appear fragmented and
deformed, a direct result of the deleterious effect of the serum in the surrounding
media. Thus, it appears that the hMSCs are able to shield the associated florettes from
the destructive effects of the serum, making it likely that said florettes would survive
longer‐term (i.e., multi‐day) studies. Also, the results obtained so far indicate that the
optimal cell count for minimizing interference by cell‐cell clumping and for reducing the
overall size of the cell‐florette clusters is 10,000. Additionally, the best cell: florette
ratio, both in terms of the greatest overall number of cell‐florette interactions and the
formation of the smallest, most tightly packed clusters, is between 1:2 and 1:3.

2.3.9 Use of NCoH Microflorettes, a Cancer Cell Lineage, and an Epithelial Cell Line to
Emulate a Mixed Cancer Cell Environment
Thus far, we have demonstrated that NCoH microflorettes interact with several
cell lineages, some of which are cancerous in nature and others which are native to the
human body. We subsequently sought to examine whether these microflorettes could
be used to simulate a mixed cancer cell environment. In recent years, researchers have
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been fascinated by the nature of the interface between a rapidly growing region of
cancer tissue and the body’s endogenous tissue, with many studies attempting to
produce such an environment in vitro18. This environment is characterized by unique
cellular protrusions or “nodules”18b, as well as spheroid formation18a, 18d. If this diverse
microenvironment could readily be reproduced in culture, far more precise treatments
could be developed for cancer therapy.
We believed that we could generate a mixed cancer cell environment in cellular
media suspension by combining NCoH microflorettes with MCF‐7, a breast cancer cell
line, and NIH / 3T3, a human fibroblast lineage. To test this hypothesis, we needed to
modify our standard confocal protocol in order to distinctly visualize each component.
To do so, each component was initially placed in a separate pHEMA‐coated well of a 24‐
well plate in an appropriate volume of media. NIH / 3T3 fibroblasts were immediately
treated with Calcein AM, a green cytoplasmic dye, while MCF‐7 cells were exposed to
Hoescht3352, a blue DNA intercalator, for 30 minutes. Following this, the two cell
suspensions were rapidly mixed with Rho‐coated NCoH microflorettes and incubated for
the designated time period, enabling unique visualization of each component by
monitoring the green, blue, and red fluorescence channels. However, we first sought to
characterize the interaction between the microflorettes and each of these cell types
independently.

Initially, 50,000 MCF‐7 cells, pre‐stained with Hoescht3352, were

incubated with 50,000 NCoH microflorettes, pre‐coated with Rho‐(Gly)3‐(His)6, for three
hours and visualized in suspension by fluorescent confocal microscopy (Figure 2.30A, B,
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C). Unfortunately, while some co‐localization between the blue cells and red florettes
was observed, the MCF‐7 cells greatly outnumbered the florettes in all observed
aggregates.

Moreover, even in close‐ups, no clear cell‐florette surface‐to‐surface

contact points were visualized (Figure 2.30D), suggesting that the interaction between
MCF‐7 cells and florettes was very weak under these conditions. Similar results were
observed upon 3‐hour incubation of 50,000 NIH / 3T3 fibroblasts, pre‐stained green
with Calcein AM, and 50,000 NCoH microflorettes, pre‐coated with Rho‐(Gly)3‐(His)6.
Under these conditions, many green cells but very few red microflorettes were observed
(Figure 2.30E).

Furthermore, in this microenvironment, the florettes appeared to

rapidly decay, as little to no unbound florettes were visualized.
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Figure 2.30. (A) Z‐stacked fluorescent confocal microscopy image of 50,000 MCF‐7
cells (stained blue with Hoescht3352) and 50,000 NCoH microflorettes (stained red
with Rho‐(Gly)3‐(His)6) after 3 hours of incubation at 37°C and with 5% CO2, (B) Blue
channel only, showing cells (C) Red channel only, showing NCoH microflorettes, (D)
Zoom‐in of (A); (E) Z‐stacked fluorescent confocal microscopy image of 50,000 NIH /
3T3 fibroblasts (stained green with Calcein AM) with 50,000 NCoH microflorettes
(dyed red with Rho‐(Gly)3‐(His)6) (scale bar = 25 µm).

Despite these discouraging results, an attempt was made to create a mixed cell
cancer environment by combining 100,000 NCoH microflorettes, pre‐coated with Rho‐
(Gly)3‐(His)6, with 50,000 MCF‐7 cells, pre‐treated with Hoescht3352, and 50,000 NIH /
3T3 fibroblasts, pre‐treated with Calcein AM. After three hours of incubation, very large
(>75 µm in diameter) fibroblast / MCF‐7 / florette clusters were observed (Figure 2.31).
However, despite adding a large number of microflorettes to the initial mix, these
aggregates ultimately contained very few red florettes compared to the surrounding
green and blue cells. Moreover, these cell / florette clumps appeared to be generally
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disordered in nature, with no nodule or spheroid formation evident. However, a slice
through the middle of one such cluster revealed that some fibroblasts, MCF‐7 cells, and
NCoH microflorettes did indeed occupy the same layer (Figure 2.31E), as opposed to
merely occupying the same three‐dimensional space.
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Figure 2.31. Z‐stacked fluorescent confocal microscopy visualization of 50,000 NIH /
3T3 fibroblasts (stained green with Calcein AM), 50,000 MCF‐7 cells (stained blue
with Hoescht3352), and 100,000 NCoH microflorettes (stained red with Rho‐(Gly)3‐
(His)6) after 3 hours of incubation at 37°C with 5% CO2: (A) Blue channel only,
showing MCF‐7 cells, (B) Green channel only, showing fibroblasts, (C) Red channel
only, showing NCoH microflorettes, (D) Overlay, (E) Middle slice (scale bar = 25 µm)

Because very large aggregates containing minimal florettes were observed after
three hours of incubation, it was thought that reducing the incubation time would result
in smaller aggregates with a more even distribution of florettes and cells. Thus, 50,000
MCF‐7 cells, 50,000 NIH / 3T3 fibroblasts, and 100,000 Rho‐labeled NCoH microflorettes
were pre‐stained and mixed together using the same protocol as above and incubated
at 37°C and 5% CO2 in serum‐containing media for only one hour. Upon visualization,
smaller aggregates were indeed observed; however, these aggregates still contained an
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extremely low proportion of florettes compared to cells (Figure 2.32). Moreover, in
many of these clusters, a few isolated microflorettes were spotted only at the periphery
(Figure 2.32 left, middle), suggesting that the presence of the microflorettes may not
have been the mitigating factor behind aggregate formation.

Figure 2.32. Z‐stacked fluorescent confocal microscopy images of 50,000 NIH / 3T3
fibroblasts (stained green with Calcein AM), 50,000 MCF‐7 cells (stained blue with
Hoescht3352), and 100,000 NCoH microflorettes (stained red with Rho‐(Gly)3‐(His)6
after one hour of incubation at 37°C with 5% CO2 (scale bar = 25 µm)

As a control, 50,000 MCF‐7 cells (pre‐stained with Hoescht3352) and 50,000 NIH
/ 3T3 fibroblasts (pre‐stained with Calcein AM) were combined in a single PHEMA‐
coated well in the absence of any NCoH microflorettes. After one hour, they were
visualized by fluorescent confocal microscopy. Sure enough, extensive co‐localization of
green fibroblasts and blue MCF‐7 cells was observed (Figure 2.33). Thus, it appears that
the cancerous MCF‐7 and the epithelial NIH / 3T3 cell lines display a strong affinity for
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each other in suspension culture without the need for any mediating solid scaffold.
Another possible explanation for this phenomenon, however, is that the two
fluorophores used to label cells are not mutually exclusive. Despite extended pre‐
incubation in separate wells, it is conceivable that some Hoescht3352 (or Calcein AM)
remained behind in the media and thus stained the other cell line upon mixing of the
two suspension cultures. It is also possible that some fluorophores leaked out from the
membranes of dead or dying cells and entered other, live cells. This would pose a
significant setback for the selective staining process, as it would no longer allow for
unique identification of cell type.
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A)

B)

C)

Figure 2.33. Fluorescent confocal microscopy visualization of 50,000 NIH / 3T3
fibroblasts (stained green with Calcein AM) and 50,000 MCF‐7 cells (stained blue
with Hoescht3352) after one hour of incubation at 37°C with 5% CO2: (A) Overlay,
(B) Blue channel only, showing MCF‐7 cells, (C) Green channel only, showing
fibroblasts (scale bar = 25 µm)

Despite the initial high hopes for emulating a mixed epithelial / cancer cell
environment in an in vitro suspension culture, thus far, the cell lines tested (MCF‐7 and
NIH / 3T3) have not been interacting with NCoH microflorettes as projected. In as little
as one hour, the cells begin to aggregate on their own. Moreover, within the first three
hours, no obvious changes in cellular morphology are observed. Each of the cells in the
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aggregates continues to display a mostly round morphology. Longer time frames were
not examined due to the extreme decline in the number of florettes observed after
three hours, and their general lack of incorporation into cellular clusters.

Earlier

studies10 revealed that NCoH microflorettes were stable in serum‐containing media for
1‐2 days. Furthermore, studies previously performed with other cell lines (i.e., HeLa and
hMSCs) revealed prevalent and persistent cell‐florette interactions for up to 24 hours in
media containing the same proportion of fetal bovine serum (10%). Thus, the reason for
the rapid breakdown of florettes in the present study is not clear. Perhaps, these
particular cell lines (MCF‐7 and NIH / 3T3) are somehow more toxic to microflorettes
than those tested previously, possibly due to a rapid release of proteases.

In any case,

it would seem that a continuous solid scaffold, such as the HBN: HBRGDS mesh, holds
more promise for simulating a mixed cell environment for long‐term studies. The use of
lower fluorophore concentrations for staining cells, as well as the removal and
replacement of a portion of the media could also help to minimize the potential for non‐
selective cell staining.

2.3.10 Attachment of Human Epidermal Growth Factor to NCoH Microflorettes
One of the primary motivations of this research project is to induce cellular
differentiation by attaching one or more growth factors to NCoH microflorettes by
exploiting the interaction between the His‐tag and unsatisfied ligands on both the
surface and interior of the florette. To further this end, an initial study was performed to
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determine whether the addition hEGF‐(His)6 to a sample of NCoH would hinder florette
formation. 50 µL solutions of unmodified NCoH and NCoH with surface‐bound hEGF‐
(His)6 (400 ng / mL) were prepared in duplicate, incubated for 18 hours, and visualized
using bright field microscopy to confirm florette formation (Figure 2.34). The florettes
from both samples appeared to be of roughly the same size and shape.

A)

B)

B)

B)

Figure 2.34. Bright field microscopy of unwashed microflorettes formed from (A)
NCoH alone and (B) NCoH with hEGF‐(His)6 bound to the outer surface (scale bar =
200 µm)

110
Each sample was then washed thrice through centrifugation at 10,000 g, and the
pellet and the supernatant from each sample was collected in separate 1.5 mL
eppendorf tubes. Next, 20 mM of the strong, bidentate metal chelator
ethylenediaminetetraacetic acid disodium salt (EDTA) was added to each solution to
dissociate the florettes. Each solution was then diluted to 1 mL and injected onto a Luna
C18 Analytical HPLC column. The solvent gradient was 5‐25% acetonitrile / H2O with
0.05% TFA. The resulting HPLC traces were compared to determine the effect of hEGF‐
(His)6 on microflorette formation from NCoH (Figure 2.35).
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Pellet

NCoH 7183872 4292829
+
hEGF

60%

40%

NCoH 8395808 8526202
ONLY

50%

50%

Figure 2.35. Quantification of the proportion of NCoH that formed florettes in the
presence and absence of hEGF‐(His)6: analytical HPLC traces for (A) NCoH + hEGF‐
(His)6 pellet and (B) NCoH + hEGF‐(His)6 supernatant. Gradient: 5‐25% ACN / H2O with
0.05% TFA, 30 min run, 25 µL injection volume; (C) Calculation of percentage of NCoH
in pellet and supernatant for both the hEGF‐(His)6‐containing sample and NCoH only
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NCoH is known to elute between 16 and 17 minutes on a Luna C18 column. Thus,
the peak at 16.4 min corresponds to NCoH in each trace. For each sample set, the pellet
will contain the microflorettes, whereas the supernatant will contain the NCoH peptide
that failed to form florettes. By computing the fraction of the area of the NCoH peak to

A)

B)

C)

D)

Figure 2.36. Effect of hEGF‐(His)6 attachment on NCoH microflorette formation: (A)
Bright field microscopy visualization of NCoH microflorettes with hEGF‐(His)6 bound
to the inner core, (B) Bright field microscopy image of NCoH microflorettes with
hEGF‐(His)6 bound to the outer surface, (C) Bright field microscopy visualization of
NCoH microflorettes with hEGF‐(His)6 bound to the outer surface and Rho‐(Gly)3‐
(His)6 bound to the inner core, (D) Red fluorescence microscopy image of (C) (all scale
bars = 200 µm)
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the total area of all the peaks in the trace, one can determine the relative amount of
NCoH in the sample (Figure 2.35C). Doing this for both the pellet and the supernatant
allows one to arrive at a relative ratio of NCoH that formed florettes to NCoH that failed
to form florettes. Using this method, it was found that, for both samples of NCoH with
hEGF‐(His)6, the pellet contained 60% of the NCoH, whereas the supernatant contained
the remaining 40%. For the control sample (NCoH alone), the pellet contained 50% of
the NCoH, and the supernatant contained the remaining 50%. Thus, the addition of
hEGF‐(His)6 to NCoH did not negatively affect florette formation.
NCoH microflorettes were also successfully formed when hEGF‐(His)6 (400 ng /
mL) was selectively bound to the interior (through addition during florette formation, as
described previously) (Figure 2.36A). Optical microscopy confirmed that these
microflorettes were of roughly the same size and shape to those formed when hEGF‐
(His)6 was bound to the outer surface (Figure 2.36B).

Importantly, comparable

microflorettes were formed upon dual decoration with two different biomolecules: the
fluorophore Rho‐(Gly)3‐(His)6 in the interior and hEGF‐(His)6 on the exterior (Figure
2.36C).

Fluorescence microscopy confirmed that these florettes exhibited red

fluorescence (Figure 2.36D). Such florettes can be utilized for visualization of GF‐
promoted differentiation of bound hMSCs.
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2.4 Conclusions
Metal‐promoted self‐assembly of the collagen mimetic peptide NCoH produces
microflorettes, which hold great promise as versatile, injectable cell carriers. The red
fluorescent peptide Rho‐(Gly)3‐(His)6 selectively bound to the interior of NCoH
microflorettes and enabled fluorescent confocal microscopy visualization of the surface‐
to‐membrane points of contact between the florettes and cells. These studies revealed
that NCoH microflorettes form small aggregates with HeLa cells and, crucially, with
human mesenchymal stem cells in cellular media within three hours, but minimal
interactions were observed with MCF10a cells, MCF‐7 cells, and NIH / 3T3 fibroblasts.
Furthermore, NCoH microflorettes can be efficiently decorated with hEGF‐(His)6
without affecting their morphology. Once reproducible quantitative release profiles are
determined, differentiation studies can be undertaken with mesenchymal stem cells and
functional tissue development can be confirmed with histological staining and RT‐PCR
with known genetic markers.

2.5 Materials and Methods
The Rink Amide ChemMatrix resin, used in solid phase peptide synthesis, was
commercially obtained from Pcas‐Biomatrix Inc (Quebec, Canada). Fmoc‐protected
amino acids and O‐benzotriazole‐N,N,N’,N’‐tetramethyluraniumhexafluorophosphate
(HBTU) were both purchased from AAPPTec (Louisville, KY, USA), ChemPep, Inc.
(Wellington, FL, USA), and Chem‐Impex International (Wood Dale, IL, USA). Piperidine
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and diisopropylethylamine (DIEA) were procured from Alfa Aesar (Ward Hill, MA, USA).
Acetonitrile,

triisopropylsilane

(TIPS),

trifluoroacetic

acid

(TFA),

poly(2‐

hydroxyethylmethacrylate) (pHEMA), nickel(II) chloride hexahydrate, and zinc chloride
were obtained from Sigma Aldrich (St. Louis, MO, USA). N,N‐dimethyl formamide (DMF),
dichloromethane (DCM), methanol (MeOH), and dimethylsulfoxide (DMSO) were
purchased from AVANTOR (Center Valley, PA, USA) and Fisher Scientific (Pittsburgh, PA,
USA). 200‐proof ethanol was procured from KOPTEC (King of Prussia, PA, USA).
Ethylenediaminetetraacetic acid disodium salt (EDTA) was purchased from Mallinckrodt
JT Baker (Hazelwood, MO, USA).

H‐Glu(OBzl)‐OtBu was bought from BACHEM

(Torrance, CA, USA).
His‐tagged human epidermal growth factor (hEGF‐(His)6) was obtained from
Aviscera Bioscience (Santa Clara, CA, USA). Calcein AM was purchased from Biotium
(Hayward, CA, USA). NHS‐rhodamine was bought from Thermo Scientific (Waltham, MA,
USA). Cholera toxin, hydrocortisone, and propidium iodide (PI) were obtained from
Sigma‐Aldrich (St. Louis, MO, USA). Dulbecco’s modified eagle media (DMEM),
Dulbecco’s modiefied eagle media / Ham’s F12 nutrient mixture (DMEM/F12), L‐
glutamine, penicillin / streptomycin (Pen‐Strep), fetal bovine serum (FBS), horse serum,
phosphate buffered saline (PBS), and human recombinant insulin were all procured
from Life Technologies (Manasas, VA, USA). Mesenchymal Stem Cell Basal Media
(MSCBM), Mesenchymal Stem Cell Growth Supplement (MSCGS), and GA‐1000 were
purchased from Lonza Inc. (Allendale, NJ, USA).
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HeLa cells were obtained as a gift from Manish Nepal (Purdue University).
MCF10A cells, human mesenchmal stem cells (hMSCs), as well as the peptides HBN,
HBRGDS, and RGDS‐(His)6 were procured as gifts from Victor Hernández‐Gordillo
(Purdue University).
Synthesis of Compound 2 (NTA Intermediate). Into a 500 mL round‐bottom flask was
placed H‐Glu(OBzl)‐OtBu (15.15 mmol, 5g) 1, and DMF (100 mL). To this solution, tert‐
butyl‐2‐bromoacetate (46.96 mmol, 8 mL) and DIEA (60.6 mmol, 22.5 mL) were added
with stirring and heating over an oil bath at 70°C for 19 h. The mixture was extracted
with ethyl acetate (3X), and the combined organic layers were washed with saturated
LiCl (3 X 50 mL). The organic layer was dried over sodium sulfate, and the solvent was
removed in vacuo. Purification of the residue by silica gel flash column chromatography
(85: 15 hexane: ethyl acetate, detection by UV on TLC) afforded 2 as a light yellow oil
with 69% yield. 1H NMR (300 MHz, CDCl3): δ7.33 (m, 5H), δ5.11 (s, 2H), δ3.43 (s, 4H),
δ3.34 (d, J = 12 Hz, 1H), δ2.62 (m, 2H), δ1.99 (m, 2H), δ1.48 (s, 27 H). 13C NMR (75 MHz,
CDCl3): δ173.36, δ171.66, δ170.34, δ136.06, δ128.35, δ128.05, δ126.83, δ81.17, δ80.53,
δ65.96, δ64.19, δ60.27, δ53.68, δ30.39, δ27.89, δ25.22.
Synthesis of NTA, Compound 3. In a 250 mL round‐bottom flask, compound 2 (10.2
mmol, 5.31g) was dissolved in EtOH (100 mL). To this solution was added Pd / C (0.53 g,
10% by weight). The solution was stirred under 1 atm of H2 for 12 h. The reaction was
monitored by TLC (85: 15 hexane: ethyl acetate). The solution was filtered through celite
and gravity filtered to remove any remaining Pd. The solvent was removed in vacuo,
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affording NTA, 3, as a light yellow oil with 95% yield. 1H NMR (300 MHz, CDCl3): δ3.42 (s,
4H), δ3.33 (d, J = 12 Hz, 1H), δ2.56 (m, 2H), δ1.93 (m, 2H), δ1.44 (s, 27 H). 13C NMR (75
MHz, CDCl3): δ171.53, δ170.56, δ81.37, δ80.94, δ64.39, δ60.27, δ53.83, δ30.77, δ28.99,
δ27.98, δ25.27. ESI MS Calculated: 445.55. Observed (M+1): 454.54.
Synthesis of NCoH. Into a 15 mL glass peptide synthesis flask was loaded 500 mg (0.52
mmol / g) of H‐Rink Amide ChemMatrix resin. The resin was washed with DMF (15 mL, 5
min). The solvent was drained, and the flask was loaded with the desired Fmoc‐
protected amino acid (first coupling with Fmoc‐His(Trt)‐OH for NCoH) (6 eq., 4.95
mmol), HBTU (6 eq., 4.95 mmol, 0.60 g), and DIEA (12 eq., 9.9 mmol, 0.55 mL) in DMF
(13 mL). The flask was agitated for three hours at room temperature to induce coupling.
The solution was drained, and the resin was washed with DMF (3 X 15 mL), DCM (3 X 15
mL), MeOH (3 x 15 mL), and again with DCM (3 X 15 mL). Amino acid coupling was
verified with the Kaiser13 or chloranil test14. The resin was then washed once more with
DMF (3 x 15 mL), and Fmoc deprotection was accomplished by agitating the flask with
25% piperidine: DMF (15 mL) for 30 min. The solution was drained, and the resin was
washed with DMF (3 X 15 mL), DCM (3 X 15 mL), MeOH (3 x 15 mL), and again with DCM
(3 X 15 mL). Fmoc deprotection was verified with the Kaiser13 or chloranil test14. The
resin was then washed again with DMF (3 X 15 mL). This procedure was repeated for the
entire chain length of the peptide. The final coupling with NTA, 3, was accomplished by
loading the flask with NTA (4 eq., 1.1 mmol, 0.37 mL), HBTU (6 eq., 4.95 mmol, 0.60 g),
and DIEA (12 eq., 9.9 mmol, 0.55 mL) in DMF (13 mL) and agitating for three hours at
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room temperature. Upon completion of the final coupling and subsequent washing, a
TFA cocktail (95% TFA, 2.5% TIPS, 2.5% H2O, 15 mL) was added to the resin. The resin
was agitated at room temperature for 2.5 hours. The resin was washed with DMF (15
mL X 2 X 5 min) and DCM (15 mL X 2 X 5 min). The solvent was removed in vacuo and
precipitated with cold diethyl ether (50 mL X 2 X 30 min). The solution was centrifuged
at high speed for 10 min, and the solvent was removed by decanting. This process was
repeated once. The pellet was left to dry on a hi‐vac overnight. The dry pellet was
massed and then dissolved in H2O to form a 10 mg / mL crude peptide solution. This
crude material was characterized by MALDI‐TOF MS, and analytical HPLC (Beckman,
Luna C18 column, 30 min run, 5‐25% ACN / H2O with 0.05% TFA, monitored at 214 nm,
25 µL injection volume). It was then purified on a semi‐prep HPLC (Waters) equipped
with a Luna C18 column. It was run for 60 min through a solvent gradient of 5‐25% ACN
/ H2O with 0.1% TFA at a flow rate of 12 mL / min. The injection volume was 1.5 mL, and
monitoring took place at 214 nm and 254 nm. The pure peptide was collected and
reconstituted from the fractions that eluted at 34 min (18% ACN). The solvent was
removed in vacuo.

Lyophilization for 3 days afforded pure NCoH, which was

characterized by MALDI‐TOF MS and analytical HPLC (Beckman, Luna C18 column, 30
min run, 5‐25% ACN / H2O with 0.05% TFA, monitored at 214 nm, 25 µL injection
volume). MALDI‐TOF MS Calculated: 2942.02. Observed: 2936.16.
Synthesis of Rho‐(Gly)3 – (His)6. Into a 15 mL glass peptide synthesis flask was loaded
500 mg (0.52 mmol / g) of H‐Rink Amide ChemMatrix resin. The resin was washed with
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DMF (15 mL, 5 min). The solvent was drained, and the flask was loaded with the desired
Fmoc‐protected amino acid (6 eq., 4.95 mmol), HBTU (6 eq., 4.95 mmol, 0.60 g), and
DIEA (12 eq., 9.9 mmol, 0.55 mL) in DMF (13 mL). The flask was agitated for three hours
at room temperature to induce coupling. The solution was drained, and the resin was
washed with DMF (3 X 15 mL), DCM (3 X 15 mL), MeOH (3 x 15 mL), and again with DCM
(3 X 15 mL). Amino acid coupling was verified with the Kaiser13 or chloranil test14. The
resin was then washed once more with DMF (3 x 15 mL), and Fmoc deprotection was
accomplished by agitating the flask with 25% piperidine: DMF (15 mL) for 30 min. The
solution was drained, and the resin was washed with DMF (3 X 15 mL), DCM (3 X 15 mL),
MeOH (3 x 15 mL), and again with DCM (3 X 15 mL). Fmoc deprotection was verified
with the Kaiser13 or chloranil test14. The resin was then washed again with DMF (3 X 15
mL). This procedure was repeated until the peptide (Gly)2‐(His)6 was formed. 61.8 mg of
this resin‐bound peptide was placed in a 5 mL glass peptide flask. The next coupling
took place with Fmoc‐Gly‐OH (6 eq., 57.5 mg), HBTU (6 eq., 77.3 mg), and DIEA (12 eq.,
67.0 µL) in DMF (3 mL). After agitation for 3 hours, the coupling solution was drained,
and the resin was washed with DMF (3 X 5 mL), DCM (3 X 5 mL), MeOH (3 X 5 mL), and
again with DCM (3 X 5 mL). Coupling was verified with the Kaiser test13. The resin was
again washed with DMF (3 X 5 mL). The solution was drained, and Fmoc deprotection
was accomplished through agitation with 25% piperidine: DMF (3 mL) for 30 min. The
solution was drained, the resin was washed as before, and deprotection was verified
with the Kaiser test13. The solution was washed again with DMF (3 X 5 mL). The final
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coupling was accomplished by loading the flask with NHS‐rhodamine (1.5 eq., 25.0 mg),
HBTU (6 eq., 78.8 mg), and DIEA (67.0 µL) in DMF (3 mL) and agitating for 3 hours. The
solution was drained, and the resin was washed as before. Coupling was verified with
the Kaiser test13. Upon completion of the final coupling and subsequent washing, a TFA
cocktail (95% TFA, 2.5% TIPS, 2.5% H2O, 5 mL) was added to the resin. The resin was
agitated at room temperature for three hours. The resin was washed with DMF (5 mL X
2 X 5 min) and DCM (5 mL X 2 X 5 min). The solvent was removed in vacuo and
precipitated with cold diethyl ether (50 mL X 2 X 30 min). The solution was centrifuged
at high speed for 10 min, and the solvent was removed by decanting. This process was
repeated once. The pellet was left to dry on a hi‐vac overnight. The dry pellet was
massed and then dissolved in H2O to form a 10 mg / mL crude peptide solution. This
crude material was characterized by MALDI‐TOF MS, and analytical HPLC (Beckman,
Luna C18 column, 30 min run, 5‐45% ACN / H2O with 0.05% TFA, monitored at 214 nm,
25 µL injection volume). It was then purified on a semi‐prep HPLC (Waters) equipped
with a Luna C18 column. It was run for 60 min through a solvent gradient of 5‐45% ACN
/ H2O with 0.1% TFA at a flow rate of 12 mL / min. The injection volume was 1.5 mL, and
monitoring took place at 214 nm and 254 nm. The pure peptide was collected and
reconstituted from the fractions that eluted at 30 min. The solvent was removed in
vacuo.

Lyophilization for 3 days afforded pure Rho‐(Gly)3‐(His)6, which was

characterized by MALDI‐TOF MS and analytical HPLC (Beckman, Luna C18 column, 30
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min run, 5‐45% ACN / H2O with 0.05% TFA, monitored at 214 nm, 25 µL injection
volume). MALDI‐TOF MS Calculated: 1424.49. Observed: 1424.76.
Kaiser Test13. Into a small test tube was placed 10‐15 peptide resin beads. Two drops
of each of the three solutions (ninhydrin solution: 500 mg ninhydrin in 10 mL n‐BuOH,
potassium cyanide solution: 2 mL of 0.01 M KCN diluted to 100 mL in pyridine, phenol
solution: 80 g phenol in 20 mL n‐BuOH) were added to the tube. A water bath at 100°C
was used to heat the tube for 1 min. After this time, the tube was removed and
examined.

A positive result, indicative of a free amine, was determined by the

appearance of purple beads in a purple solution. A negative result, indicative of a
protective amine was denoted by a lack of color change; i.e., the beads and solution
remained clear.
Chloranil Test14. Into a small test tube was placed 15‐20 peptide resin beads. Two
drops of the two testing solutions (2% acetaldehyde in DMF and 2% chloranil in DMF)
were added to the tube. The tube was mixed for a few seconds by shaking. It was then
immediately visualized. A positive result, indicative of a free secondary amine, was
determined by the appearance of dark blue beads and a dark blue solution. A negative
result, indicative of a protected secondary amine, was denoted by the lack of color
change; i.e., the beads and solution remained clear.
CD Spectroscopy. CD wavelength scan spectra were recorded on a Jasco circular
dichroism spectropolarimeter (Model J810) at 4°C using a 0.1 cm path length quartz cell.
The spectra were averaged over three scans taken from 260 to 190 nm with a resolution
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of 0.1 nm at a scan rate of 10 nm / min. The CD data were processed to convert the
data from degrees of rotation to mean residue ellipticity by dividing by the appropriate
path length, peptide concentration, and number of residues in the peptide. Thermal
stability of the peptide was determined by measuring the mean residue ellipticity at 225
nm. Temperature was varied from 4°C to 90°C at 6°C / hr for solutions containing
peptide (167 µm) in 20 mM MOPS buffer, pH 7.1.
NCoH Microflorette Assembly and Decoration. Fluorescently‐labeled microflorettes
were formed in a total volume of 50 µL. Into a sterile 1.5 mL eppendorf tube was placed
MOPS buffer (20 mM, 10 µL), deionized H2O (27 µL), NCoH peptide (1.6 mM, 8 µL), Rho‐
(Gly)3‐(His)6 (500 nM, 2.5 µL), and, lastly, ZnCl2 (500 µM, 2.5 µL). The solution was
thoroughly mixed after each successive addition followed by a final solution mix. The
solution was incubated for 18‐24 hours at room temperature in the dark without further
mixing. Microflorette formation was confirmed through bright field and fluorescent
microscopy using an Olympus BX51 optical microscope. The florettes were centrifuged
at 10,000g for three minutes at 4°C. The supernatant (48 µL) was removed, and the
pellet was resuspended in DI H2O (48 µL). This process was repeated two more times.
For experiments requiring RGDS‐coated florettes, solutions of NCoH microflorettes (50
µL) were washed at 10,000g, and the supernatant was removed (48 µL). The pellet was
resuspended in MOPS buffer, pH 7.1 (43 µL) and NiCl2 (10 mM, 5 µL) and incubated at
room temperature in the dark for one hour.

After this time, the solution was

centrifuged at 10,000g, and the supernatant was removed (48 µL). The pellet was

123
resuspended in MOPS buffer, pH 7.1 (47 µL) and RGDS‐(His)7 (10 mM, 1 µL) and
incubated at room temperature in the dark for three hours. Following this, the solution
was centrifuged at 10,000g, and the supernatant was removed (48 µL). The pellet was
resuspended in PBS (48 µL), and the solution was stored at 4°C.
pHEMA Coating of Cell Plates. 2% pHEMA solution was prepared in 95% ethanol.
Complete dissolution of the pHEMA crystals was achieved through placement on an
orbital shaker overnight. In a previously sterilized biosafety hood, 2% pHEMA solution
(1 mL) was added to each well of a sterile 24‐well cell culture plate. The plate was
allowed to sit for 1‐2 minutes. After this period, the wells were drained to dryness, and
the cell culture plate was UV‐sterilized without a lid for 20 minutes.
HeLa‐NCoH Confocal Binding Study. HeLa cells were cultured in a T‐75 flask containing
DMEM media supplemented with 10% FBS, 2 mM L‐glutamine, and 50 units / mL
penicillin and 50 µg / mL streptomycin. Upon reaching 70‐80% confluency, the cells
were trypsinized, resuspended in 3 mL of media, and counted on a hemocytometer.
Rho‐decorated NCoH microflorettes in PBS were prepared as described previously and
counted on a hemocytometer. HeLa cells (1.0 x 105) and NCoH microflorettes (1.0 x 105)
were combined in RPMI serum‐free media, supplemented with 2 mM L‐glutamine and
50 units / mL penicillin and 50 µg / mL streptomycin, in a sterile 1.5 mL eppendorf tube
to form a cell‐florette suspension with a total volume of 500 µL. Control samples were
produced containing HeLa cells only (1.0 x 105) in RPMI serum‐free media and NCoH
microflorettes only (1.0 x 105) in RPMI serum‐free media. Each control sample also had
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a total solution volume of 500 µL. All samples were incubated at 37°C with 5% CO2 for
three hours with mixing through inversion every 30 minutes. After this period, Calcein
AM (1.0 µM, 1.0 µL) was added to each sample. The samples were visualized as
suspensions on 22 x 50 mm glass slides using a Nikon A1R‐MP confocal microscope with
red (561 nm), green (488 nm), and transmittance channels active and at 20X zoom.
MCF10A‐NCoH Confocal Binding Study. MCF10A cells were cultured in a T‐75 flask
containing DMEM / F12 media supplemented with 5% horse serum, 10 mg / mL
hydrocortisone, 1 mg / mL cholera toxin, 4 mg / mL insulin, 50 units / mL penicillin and
50 µg / mL streptomycin, and 200 µg / mL hEGF (0.01% total volume). Upon reaching
80% confluency, the cells were trypsinized, resuspended in 3 mL of media, and counted
on a hemocytometer. Rho‐decorated NCoH microflorettes in PBS were prepared as
described previously and counted on a hemocytometer. MCF10A cells (5.0 x 104) and
NCoH microflorettes (5.0 x 104) were combined in MCF10A complete media in a UV‐
sterilized 24‐well plate, pretreated with 2% pHEMA solution, to form a cell‐florette
suspension with a total volume of 500 µL. Control samples were produced containing
MCF10A cells only (1.0 x 105) in MCF10A complete media and NCoH microflorettes only
(1.0 x 105) in MCF10A complete media. Each control sample had a total volume of 500
µL. All samples were incubated at 37°C with 5% CO2 for three days. After this period,
Calcein AM (1.0 µM, 1.0 µL) and PI (600 nM, 3.0 µL) was added to each sample. The
samples were visualized as suspensions on 22 x 50 mm glass slides using a Nikon A1R‐
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MP confocal microscope with red (561 nm), green (488 nm), and transmittance channels
active and at 20X zoom
MCF10A‐HBN Confocal Binding Study6 (Control). Cell seeding on the HBN: HBRGDS
scaffold was accomplished by mixing HBN (1.0 mM, 5 µL), HBRGDS (0.4 mM, 2.0 µL), PB
buffer (20 mM, 10 µL), and deionized water (18 µL) in a sterile 1.5 mL eppendorf tube.
This mixture was plated onto a UV‐sterilized 24‐well plate, pretreated with 2% pHEMA,
and mixed with MCF10A cells (22,400 in 10 µL). Scaffold formation was initiated
through addition of NiCl2 (1.0 mM, 5.0 µL). The solution was allowed to sit at room
temperature for 2 min to allow the scaffold to form. Then 450 µL of MCF10A complete
media was added gradually to lift the scaffold up from the bottom of the plate. Each
control sample had a total solution volume of 500 µL. All samples were incubated at
37°C with 5% CO2 for three days. After this period, Calcein AM (1.0 µM, 1.0 µL) and PI
(600 nM, 3.0 µL) was added to each sample.

The samples were visualized as

suspensions on 22 x 50 mm glass slides using a Nikon A1R‐MP confocal microscope with
red (561 nm), green (488 nm), and transmittance channels active and at 20X zoom.
hMSC‐NCoH Confocal Binding Study. hMSCs were cultured in a T‐75 flask containing
Mesenchymal Stem Cell Basal Media (MSCBM) supplemented with Mesenchymal Stem
Cell Growth Supplement (MSCGS), 2 mM L‐glutamine, and GA‐1000 from the LONZA
MSCGMTM BulletKitTM. Upon reaching 80‐90% confluency, the cells were trypsinized,
resuspended in 3 mL of media, and counted on a hemocytometer. Rho‐decorated NCoH
microflorettes in PBS were prepared as described previously and counted on a

126
hemocytometer. hMSCs (1.0 x 104) and NCoH microflorettes (1.0 x 104 – 5.0 x 104) were
combined in Mesenchymal Stem Cell Growth Medium (MSCGM) in a UV‐sterilized 24‐
well plate, pretreated with 2% pHEMA solution, to form a cell‐florette suspension with a
total volume of 500 µL. Control samples were produced containing hMSCs only (1.0 x
104) in MSCGM and NCoH microflorettes only (1.0 x 104) in MSCGM. Each control
sample had a total solution volume of 500 µL. All samples were incubated at 37°C with
5% CO2 for 24 hours. After this period, Calcein AM (500 nM, 1.0 µL) and PI (600 nM, 3.0
µL) was added to each sample. The samples were visualized as suspensions on 22 x 50
mm glass slides using a Nikon A1R‐MP confocal microscope with red (561 nm), green
(488 nm), and transmittance channels active and at 20X zoom.
hMSC‐HBN Confocal Binding Study9 (Control). Cell seeding on the HBN: HBRGDS
scaffold was accomplished by mixing HBN (1.0 mM, 5 µL), HBRGDS (0.4 mM, 2.0 µL), PB
buffer (20 mM, 10 µL), and deionized water (18 µL) in a sterile 1.5 mL eppendorf tube.
This mixture was plated onto a UV‐sterilized 24‐well plate, pretreated with 2% pHEMA,
and mixed with hMSCs (10 µL, 1.0 x 104 cells). Scaffold formation was initiated through
addition of NiCl2 (1.0 mM, 5.0 µL). The solution was allowed to sit at room temperature
for 2 min to allow the scaffold to form. Then 450 µL of MSCGM was added gradually to
let the scaffold lift off of the plate. Each control sample had a total solution volume of
500 µL. All samples were incubated at 37°C with 5% CO2 for 24 hours. After this period,
Calcein AM (500 nM, 1.0 µL) and PI (600 nM, 3.0 µL) was added to each sample. The
samples were visualized as suspensions on 22 x 50 mm glass slides using a Nikon A1R‐

127
MP confocal microscope with red (561 nm), green (488 nm), and transmittance channels
active and at 20X zoom.
NIH / 3T3, MCF‐7, and NCoH Microflorette Mixed Cell Culture Confocal Study. NIH /
3T3 fibroblasts were cultured in a T‐75 flask containing RPMI complete media
(supplemented with 10% FBS). MCF‐7 cells were cultured in a separate T‐75 flask
containing DMEM complete media (supplemented with 10% FBS). Upon reaching 70‐
80% confluency, each cell line was trypsinized, resuspended in 3 mL of media, and
counted on a hemocytometer. NCoH microflorettes decoarated with Rho‐HIS (4.0 µM)
in PBS were prepared as described previously and counted on a hemocytometer. NIH /
3T3 fibroblasts (5.0 x 104), MCF‐7 cells (5.0 x 104), and NCoH microflorettes (1.0 x 105)
were plated onto separate wells (containing DMEM complete media) of a UV‐sterilized
24‐well plate, pretreated with 2% pHEMA solution. The total volume of all three wells
was 500 µL. The fibroblasts were immediately stained with Calcein AM (250 nM), and
the MCF‐7 cells were treated with Hoescht 3352 (4.0 µM). The cell‐containing wells
were thoroughly mixed and allowed to sit for thirty minutes. After this time, the cell‐
containing wells were combined with the well containing the microflorettes to yield a
single 500 µL cell‐florette suspension. Control samples were produced containing NIH /
3T3 fibroblasts only (5.0 x 104) in DMEM complete media, MCF‐7 cells only (5.0 x 104) in
DMEM complete media, NCoH microflorettes only (1.0 x 105) in DMEM complete media,
and NIH‐3T3 fibroblasts (5.0 x 104) and MCF‐7 cells (5.0 x104) in DMEM complete media.
All samples were incubated at 37°C with 5% CO2 for three hours. The samples were
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visualized as suspensions on 22 x 50 mm glass slides using a Nikon A1R‐MP confocal
microscope with red (561 nm), green (488 nm), blue (405 nm), and transmittance
channels active and at 20X zoom.
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CHAPTER 3 . METAL‐PROMOTED SELF‐ASSEMBLY OF NOVEL, MIXED COLLAGEN
MIMETIC PEPTIDE ASSEMBLIES

3.1 Introduction
A three‐fold design approach has been taken for the metal‐promoted self‐
assembly of collagen mimetic peptides1 (Figure 3.1). One approach is radial design, in
which ligands are placed at the center of the (POG)n backbone. This strategy was
employed to produce the H(byp) series, which, upon incubation with Fe (II), has formed
extended fibers2, round disks3, hollow microspheres4 capable of biomolecular delivery5,
and puckered microspheres6.

A cross‐linked design approach can also be taken, in

which metal‐binding ligands are placed at both the termini and the center of the
peptide. This approach was used to produce HBN, which consists of a (POG)9 backbone
with a di‐histidine ligand at the C‐terminus, a nitrilotriacetic acid (NTA) moiety at the N‐
terminus, and a bipyridal ligand at the center. Incubation with Zn2+, Co2+, Cu2+, or Ni2+
produces a thick, interwoven, fibrous mesh7. Lastly, one could design a CMP linearly by
placing metal‐binding ligands at the N‐ and C‐terminus only. This approach was used to
fabricate the microflorette‐producing peptide NCoH8, as well as its variants HisCol and
IdaCol, which, when combined in a 1:1 ratio, undergo metal‐promoted self‐assembly
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into a variety of exquisite, intertwined network structures9. These latter CMPs will be
explored extensively in the work that follows.

Figure 3.1. Three design strategies for metal‐promoted self‐assembly of CMPs. Linear
design produces NCoH, which self‐assembles into microflorettes, and HisCol and
IdaCol, which jointly assemble into an exquisite, banded mesh. Radial design
produces the H(byp) series, which self‐assembles into round disks and hollow
spheres. Cross‐linked design produces HBN, which self‐assembles into a 3D mesh
(modified from References 1, 3, 7, 9, and 12)

We hypothesize that, in the presence of a divalent metal ion, individual triple
helices of NCoH assemble in a head‐to‐tail fashion (Figure 3.2A). Within each strand of
the triple helix, a stable metal‐ligand complex forms between the metal ion, the NTA
moiety at the N‐terminus of one helix, and the dihistidine moiety at the end of another
helix.

This process is repeated for each triple helix in solution, allowing for the
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formation of assemblies on the order of several microns. Similarly, we believe that
individual triple helices in a 1:1 solution of HisCol and IdaCol also assemble in a head‐to‐
tail fashion (Figure 3.2B). In the presence of a metal ion, the dihistidine moieties at one
end of HisCol forms a metal‐ligand complex with the iminodiacetic acid (Ida) moieties at
one end of IdaCol. This process is repeated for each triple helical unit, allowing for
micron‐sized assemblies with distinct, well‐ordered periodicity.

(A)

(B)

Figure 3.2 (A) Proposed head‐to‐tail mechanism of assembly of NCoH, (B) Proposed
alternating head‐to‐tail mechanism of assembly of 1:1 HisCol: IdaCol
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3.2 Design of Peptides

Figure 3.3. Linearly designed collagen mimetic peptides for metal‐promoted self‐
assembly: (A) Cartoon of the triple helical form of a linearly designed CMP with metal‐
binding ligands clustered at both termini, (B) Structures of linear CMPs NCoH, HisCol,
and IdaCol (N‐terminal metal‐binding ligands are in green, C‐terminal metal‐binding
ligands are shown in blue)

The experiments described in this chapter make use of several collagen mimetic
peptides: the linearly‐designed peptides NCoH (described in Chapter 2), HisCol, and
IdaCol (Figure 3.3), as well as the cross‐linked peptide HBN (Figure 3.4). Each of these
peptides include variants of the (POG)9 backbone in their design, which is responsible
for the formation of the highly stable triple helix morphology associated with natural
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collagen10. However, they differ in the type and locations of their metal‐binding ligands,
which contributes to the differences observed in their respective three‐dimensional
morphologies resulting from metal‐promoted self‐assembly. NCoH has an NTA moiety at
the N‐terminus and a dihistidine moiety at the C‐terminus. HisCol has dihistidine
moieties at both the N‐terminus and the C‐terminus. IdaCol contains iminodiacetic acid
moieties at both termini. HBN, like NCoH, has a N‐terminal NTA and C‐terminal
dihistidine moiety; however, it also contains a bipyridine moiety placed in the central
portion of the (POG)9 backbone, resulting in a cross‐linked morphology.

Figure 3.4. A cross‐linked designed collagen mimetic peptide for metal‐promoted
self‐assembly: (A) Cartoon of the triple helical form of a collagen mimetic peptide
with cross‐linked design with metal‐binding ligands at both termini and in the
central portion of the helix, (B) Structure of the CMP HBN (the N‐terminal metal‐
binding ligand is depicted in green, the C‐terminal metal‐binding ligand is in blue,
and the central metal‐binding ligand is in tan)
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Each of these peptides independently undergoes metal‐promoted self‐assembly
into well‐characterized three‐dimensional morphologies. However, co‐incubating two
or more of these peptides with metal could result in far more diverse morphologies.
Earlier work11 revealed that HBN is able to encapsulate pre‐formed NCoH
microflorettes. However, metal‐promoted co‐assembly of HBN and NCoH has not been
previously attempted. Since these peptides, on their own, form distinct assemblies by
two entirely different mechanisms, we sought to determine which assembly would
dominate upon co‐incubation: mesh or microflorettes, or whether both morphologies
would be observed simultaneously. The first series of experiments presented in this
chapter describes our findings on this matter, with respect to metal type and relative
peptide concentration.
Peptides from the same design class can, nonetheless, form distinct
morphologies from metal‐promoted self‐assembly. This is the case with the linearly‐
designed peptide NCoH and its analogs HisCol and IdaCol. As previously described,
NCoH forms microflorettes in the presence of a variety of divalent metal ions12.
However, HisCol and IdaCol, when mixed in an equimolar ratio, form elaborate petal‐
like clusters9. Due to their similarities in structure, it is conceivable that NCoH could be
substituted for either HisCol or IdaCol in a 1:1 mixture to produce novel assemblies
upon co‐assembly with metal. The back half of this chapter explores our studies of the
self‐assembly of NCoH / HisCol and NCoH / IdaCol in the presence of metal ions.
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3.3 Results and Discussion

3.3.1 Synthesis of Peptides
Collagen mimetic peptides were prepared using traditional Fmoc‐based solid‐
phase peptide synthesis with H‐Rink Amide ChemMatrix resin (Figure 3.5). Amino acid
couplings were catalyzed by N,N,N′,N′‐Tetramethyl‐O‐(1H‐benzotriazol‐1‐yl)uronium
hexafluorophosphate (HBTU) in the presence of the base diisopropylethylamine (DIEA)
through a well‐characterized mechanism13. The Fmoc protecting group was removed
using 25% piperidine in DMF. Coupling was confirmed with the Kaiser Test14 (negative)
(or the Chloranil Test15). For peptides with linear design, couplings continued in this
manner until the entire sequence was generated. The peptide was then cleaved from
the resin using a TFA cocktail.
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Figure 3.5. General solid‐phase peptide synthesis. Resin bead is shown in yellow.

For the peptide HBN, which has a cross‐linked design, upon completion of the C‐
terminal dihistidine moiety, the (POG)n backbone was fabricated, resulting in
(POG)4PK(Mtt)G(POG)4HH‐NH2‐Resin. Of special note was the substitution of a Lys(Mtt)
residue for a hydroxyproline residue in the central portion of the backbone sequence.
Upon completion of the backbone, the metal‐binding ligand NTA (synthesized as
described in the previous chapter) was coupled to the N‐terminus. The Mtt protecting
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group of the central lysine residue was then removed using a mildly acidic treatment
(1.8% TFA in DCM), and the resulting free ε‐amino group was coupled to 4’‐methyl‐(2,2’‐
bipyridine)‐4‐carboxylic acid (Byp) (Figure 3.6).

Figure 3.6. Distinguishing steps in the solid phase synthesis of HBN. Cleavage
with TFA cocktail generates unbound HBN. Resin bead is shown in yellow
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For the peptide IdaCol, Fmoc‐Lys(Mtt)‐OH is coupled to the handle of H‐Rink
Amide resin, and the Fmoc protecting group is removed with 25% piperidine solution.
Synthesis of the (POG)9 backbone proceeds as before, followed by coupling of another
unit of Fmoc‐Lys(Mtt)‐OH. Upon deprotection, the peptide is capped using 5% acetic
anhydride and 8.5% DIEA. The Mtt protecting groups are then removed using mildly
acidic solution (1% TFA and 5% TIPS in DCM), and the resulting free amines are coupled
with t‐butylbromoacetate (Figure 3.7). Crude peptides were purified using RP‐HPLC,
and their masses were confirmed by MALDI‐TOF mass spectrometry.

Figure 3.7. Distinguishing steps in the solid‐phase synthesis of IdaCol. Resin bead
is shown in yellow.
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3.3.2 Metal‐Promoted Self‐Assembly Protocol
Metal‐promoted self‐assembly of collagen mimetic peptides was accomplished
using a general protocol (Figure 3.8). First, the necessary components (MOPS buffer (pH
7.1), DI H2O, aqueous peptide, and aqueous metal ions) were added to a 1.5 mL
Eppendorf tube in 50 µL total volume.

The solution was vigorously mixed.

The

Eppendorf tube was sealed and allowed to incubate overnight (~16 hours).

The

following day, a cloudy precipitate was visible. This precipitate was washed three times
with DI H2O. The resulting pellets were resuspended in DI H2O and prepared for
imaging.

Figure 3.8. Protocol for metal‐promoted self‐assembly of collagen mimetic
peptides in a 1.5 mL Eppendorf tube
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3.3.3 Metal‐Promoted Assemblies formed from NCoH
When 1.0 mM NCoH is incubated overnight in the presence of 400 µM ZnCl2, it
self‐assembles into microflorettes, 10‐20 µm‐sized spheres, as confirmed by SEM12.
Closer inspection reveals that the surface of these spheres are not smooth, but rather
ruffled, full of many heavily intertwined fibrils12 Likewise, overnight incubation of 1.0
mM NCoH with 400 µM of either CuCl2 or CoCl2 also results in the formation of
microflorettes12 Intriguingly, when 1.0 mM NCoH is incubated with 400 µM of either
CaCl2 or MgCl2, no significant structures are formed12. However, when 1.0 mM NCoH
encounters 400 µM MnCl2, some scattered microflorettes are generated after overnight
incubation (Figure 3.9A, B). Increasing the concentration of MnCl2 to 800 µM results in
more plentiful microflorette formation (Figure 3.9C). Closer inspection reveals that
these florettes possess a ruffled surface morphology that closely matches that which
was previously observed with ZnCl2, CuCl2, and CoCl2 (Figure 3.9D).
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Figure 3.9. Visualization of assemblies formed upon overnight incubation of 1.0 mM
NCoH with a variety of metals at room temperature and neutral pH: (A, B) SEM
micrographs of 400 µM MnCl2 (scale bars = 10 µm and 4 µm), (C) SEM micrograph of
800 µM MnCl2 (scale bar = 20 µm), and (D) Zoom‐in of (C) showcasing surface
morphology (scale bar = 3 µm); (E) AFM visualization of 1.0 mM NCoH with 400 µM
NiCl2 (adapted from Reference 25). (F) TEM visualization of 1.0 mM NCoH with 400 µM
NiCl2 (scale bar = 600 nm), (G) Zoom‐in of (B) (scale bar = 100 nm), (H) Close‐up of
individual nanosphere (scale bar = 50 nm); (I, K) SEM visualization of 1.0 mM NCoH
with 400 µM CrCl3 (scale bars = 3 µm and 5 µm, respectively), (J) Zoom‐in of (I) (scale
bar = 500 nm), (L) Zoom‐in of (K) (scale bar = 1 µm)

Curiously, incubation of 1.0 mM NCoH with 400 µM NiCl2 does not produce the
expected microflorette morphology. Previously, atomic force microscopy confirmed the
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presence of clusters of nanospheres12 (Figure 3.9E). A subsequent TEM study confirmed
the existence of nanospheres (Figure 3.9F). These nanospheres had no discernable
surface patterning. This could have been the case because they were too thick to be
fully visualized by TEM, or they could truly have had smooth morphologies (Figure 3.9G).
In contrast to true florettes, which measure 10‐20 µm, the Ni2+‐containing spheres were
considerably smaller, measuring 150‐200 nm in diameter (Figure 3.9H).
We also examined whether microflorettes could be produced with Cr3+.
Interestingly, incubating 1.0 mM NCoH with 400 µM CrCl3 produces an extensive mesh‐
like structure in place of florettes (Figure 3.9I, K). Closer examination reveals that the
surface of this mesh is smooth with many spherical “nubs” projecting outward from the
otherwise flat mesh (Figure 3.9J, L). The formation of this mesh suggests that Cr3+, being
the first trivalent metal ion to be examined, promotes assembly through a different, as
yet undetermined, mechanism than the linear, head‐to‐tail assembly proposed for
divalent metal ions. 400 µM LaCl3 was also used to probe for florette and / or mesh
formation, but no notable structures resulted in this case.
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3.3.4 Metal‐Promoted Assemblies formed from Equimolar NCoH and HBN
It has been established that, in the presence of many divalent metal ions, NCoH
forms microflorettes, while HBN forms a heavily cross‐linked mesh. We next sought to
determine what morphology would result when both peptides were coincubated with
metal ions.

Since NCoH and HBN form their unique assemblies via competing

mechanisms, which morphology would dominate? Or would both florettes and mesh be
observed in equal ratios? Or, more intriguingly, would an entirely new morphology be
uncovered? Earlier work11 revealed that metal‐promoted self‐assembly of HBN results
in the encapsulation of pre‐formed NCoH microflorettes, but assemblies resulting from
coincubation of the two peptides was not previously attempted.

A

B

C

Figure 3.10. SEM visualization of (A) 1.0 mM NCoH and 1.0 mM HBN with 1.0 mM
ZnCl2 in 40 mM PB buffer (scale bar = 50 µm), (B) Zoom‐in of (A) (scale bar = 20
µm), (C) Nanosphere “background” (scale bar = 1 µm).
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When 1.0 mM NCoH and 1.0 mM HBN were incubated with 1.0 mM ZnCl2, SEM
visualization revealed the presence of clusters of microspheres (Figure 3.10A). Closer
inspection revealed that the surface of these spheres did not correspond to the ruffled
character of microflorettes (Figure 3.10B, compare to Figure 3.6). Instead, it appeared
that the spheres were entirely coated with a mesh‐like structure that ran around and
between the spheres. Curiously, clusters of smooth nanospheres were also observed in
the sample (Figure 3.10C).

A

B

C

Figure 3.11. (A) SEM visualization of 1.0 mM NCoH and 1.0 mM HBN with 1.0 mM
CoCl2 (scale bar = 300 µm), (B) Zoom‐in of (A) (scale bar = 50 µm), (C) Zoom‐in of (B)
(scale bar = 10 µm)

Coincubation of 1.0 mM NCoH and 1.0 mM HBN with 1.0 mM CoCl2 resulted in
significant microsphere formation (Figure 3.11A). However, closer inspection revealed
that these microspheres were also surrounded by a thick mesh (Figure 3.11B).
Moreover, distinct branch‐like structures were observed, extending from the mesh to
the surface of each microsphere (Figure 3.11C). But, rather than merely halting at the
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microsphere interface, the mesh continued to grow around the microsphere, giving it an
extra layer of surface morphology. This suggested that there was indeed a direct
interaction between the microspheres and the mesh, and that they were not merely
occupying the same space.
Intriguingly, when this 1:1 NCoH‐HBN peptide mixture was incubated with 1.0
mM NiCl2, the mesh morphology clearly dominated (Figure 3.12A). Moreover, the
resulting mesh bore a strong resemblance to that formed from incubation of 1.0 mM
HBN alone with Ni2+ (Figure 3.12B, C, D). Interestingly, many nanospherical projections
were observed deep within the gaps in the mesh (Figure 3.12C). It can be hypothesized
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Figure 3.12. (A) SEM visualization of 1.0 mM NCoH and 1.0 mM HBN with 1.0 mM
NiCl2 (scale bar = 30 µm), (B) Zoom‐in of (A) (scale bar = 5 µm), (C) Zoom‐in of (B)
(scale bar = 1 µm), (D) SEM visualization of 1.0 mM HBN with 1.0 mM NiCl2 (for
comparison) (scale bar = 2 µm)
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that these nanospheres were self‐assembled from NCoH, as NCoH alone is known to
form nanospherical clusters in the presence of Ni2+ (Figure 3.6E, F, G, H). However, the
isolated HBN control sample also contained embedded nanospheres

3.3.5 The Effect of Strand Exchange on Mixed NCoH / HBN Metal‐Peptide Assemblies
In the mixed NCoH / HBN metal‐promoted self‐assemblies performed this far, for
the most part, a dual morphology has been observed, as both microflorettes
(characteristic of NCoH) and mesh (characteristic of HBN) have formed. The working
hypothesis is that these characteristic assemblies are reliant on the precise placement of
metal ligands along the triple helix. Disrupting this ordering should alter the resulting
metal‐promoted assembly. This can be accomplished through a process known as
thermal annealing. In short, the peptides are mixed together and then heated to a
temperature well above their melting points for thirty minutes, leading to denaturation
of the triple helices. The peptides are then incubated overnight at 4°C to allow the triple
helices to reform. However, the helices are reconstituted in such a way that strand
exchange results.
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Figure 3.13. SEM visualization of the effect of thermal annealing on assemblies
formed from 1.0 mM NCoH: 1.0 mM HBN (A) with 1.0 mM ZnCl2 and no thermal
annealing (scale bar = 50 µm), (B, C), thermally annealed prior to adding 1.0 mM
ZnCl2 (scale bars = 40 µm and 10 µm, respectively), (D) with 1.0 mM CoCl2 and no
thermal annealing (scale bar = 50 µm), and (E, F) thermally annealed prior to adding
1.0 mM CoCl2 (scale bars = 5 µm and 2 µm, respectively)

In the absence of any thermal annealing, incubation of 1.0 mM NCoH and 1.0
mM HBN with 1.0 mM ZnCl2 resulted in clusters of microspheres coated with mesh
(Figure 3.13A). However, when these peptides were thermally annealed prior to adding
1.0 mM ZnCl2, a thick mesh predominated, and no microspheres were observed (Figure
3.13B, C). A similar trend was observed in the Co2+‐promoted assemblies. Incubation of
1.0 mM NCoH and 1.0 mM HBN with 1.0 mM CoCl2 without thermal annealing resulted
in microspheres embedded in mesh (Figure 3.13D). However, when this sample was
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thermally annealed prior to adding 1.0 mM NCoH, a dense, highly cross‐linked mesh was
observed (Figure 3.13E, F). Thus, after random strand exchange, it appears that the
peptides exclusively underwent cross‐linked assembly, as no obvious linearly‐assembled
structures were visible.

3.3.6 Metal‐Promoted Assemblies formed from Unequal Mixtures of NCoH and HBN
Up to this point, we examined equimolar NCoH‐HBN metal‐promoted
assemblies. However, we presently sought to characterize the assemblies formed from
unequal mixtures of NCoH and HBN. In particular, we wished to determine whether the
resulting assembly would indeed reflect the morphology of the more concentrated
peptide. Incubation of 1.3 mM NCoH and 0.66 mM HBN with 1.0 mM CoCl2 resulted in
extensive microsphere formation. However, these spheres were again embedded in a
thick surrounding mesh (Figure 3.14A). Closer inspection revealed that the microspheres
were thoroughly engulfed by the mesh, as not only were branching arms observed
extending from the mesh to the microsphere interface but the mesh continued to grow
all along the surface of the microsphere (Figure 3.14B).
Interestingly, incubation of 1.3 mM NCoH and 0.66 mM HBN with 1.0 mM ZnCl2
led to almost exclusive formation of microspheres, which aggregated into dense clusters
(Figure 3.14C). Curiously, sharply‐pointed fibrous bundles were also observed (Figure
3.14D). These overlapping fibers extended in all directions, and, in some cases,
appeared to be associated with the surrounding microspheres. The individual fibers
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appeared to be smooth in nature with no further surface details apparent. Conceivably,
these “spiky” bundles are a precursor to the formation of the HBN cross‐linked mesh.
Alternatively, these bundles could be an initial structure formed on the way toward the
generation of microflorettes, whose assembly was interrupted by the overcrowding of
surrounding microspheres. Perhaps the excessive cluttering of microspheres prevented
the fibrous bundles from folding in on themselves to yield a spherical morphology.
However, further experiments will need to be performed to elucidate the precise
mechanism of microflorette and mesh formation, as much remains unknown.
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Figure 3.14. SEM visualization of (A) 1.3 mM NCoH: 0.66 mM HBN with 1.0 mM CoCl2
(scale bar = 400 µm), (B) Zoom‐in of (A) (scale bar = 10 µm), (C) 1.3 mM NCoH: 0.66
mM HBN with 1.0 mM ZnCl2 (scale bar = 400 µm), (D) Zoom‐in of (C) (scale bar = 40
µm)

In cases in which HBN is the dominant peptide, radically different morphologies
are observed. When 1.3 mM HBN and 0.66 mM NCoH are incubated with 1.0 mM ZnCl2,
fragmented patches of mostly flat, amorphous mesh are observed (Figure 3.15A).
However, within these patches of mesh are observed microspherical outgrowths,
suggesting the persistence of NCoH microflorettes in even these conditions (Figure
3.15B). When 1.3 mM HBN and 0.66 mM NCoH are, instead, exposed to 1.0 mM CoCl2,
fragmented patches of mesh are again observed (Figure 3.15C). However, a second,
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microspherical assembly is also seen (Figure 3.15D). These microspheres, despite being
about the same size, are not microflorettes, as they do not possess their characteristic
ruffled surface (Figure 3.6). Moreover, these microspheres have a smooth but grooved
surface, reminiscent of armor plating.
As expected, in cases in which NCoH is the more concentrated peptide,
microspheres dominate the resulting metal‐promoted assemblies, particularly in the
presence of Zn2+, which yields the most abundant and well‐formed microflorettes when
mixed with NCoH alone. However, at least in the presence of Co2+, the HBN‐promoted
mesh was still very apparent. And, what quite possibly could be a cross‐linked mesh
precursor was observed in the presence of Zn2+. Likewise, in cases in which HBN was
present in greatest concentration, flat, mesh‐like structures dominated. However,
intriguingly, even in these conditions, structures that resembled microspheres were still
visible.
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Figure 3.15. SEM visualization of 1.3 mM HBN: 0.66 mM NCoH (A) with 1.0 mM ZnCl2
(scale bar = 500 µm), (B) Zoom‐in of (A) (scale bar = 40 µm), (C) with 1.0 mM CoCl2
(scale bar = 100 µm), and (D) Zoom‐in of (C) (scale bar = 4 µm)

3.3.7 Metal‐Peptide Assemblies formed from 1:1 Mixtures of HisCol and IdaCol
Assemblies were formed from HisCol and IdaCol in the presence of metal ion, as
described previously9. SEM visualization of 1.0 mM HisCol and 1.0 mM IdaCol in the
presence of 2.0 mM NiCl2 revealed an elaborate assembly composed of smooth,
intricate “petals,” resembling those of open flowers (Figure 3.16A, B). Individual petals
ranged from 100‐500 nm in length. However, when a 1:1 mixture of these two peptides
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was incubated with 2.0 mM ZnCl2, a flatter, more interconnected assembly was
observed. Individual networks were several microns in length. (Figure 3.16C). Curiously,
closer inspection of this assembly revealed the presence of spherical “nubs,” protruding
outward from the assembly (Figure 3.16D). One could speculate that these nubs could
be a precursor to the more elaborate petals found in the nickel assemblies. In addition,
the individual strands that made up this mesh had a generally smooth surface
morphology, with no notable additional structure. Furthermore, incubation of 1.0 mM
HisCol and 1.0 mM IdaCol with 2.0 mM CuCl2 produced a very “chunky,” far more
disordered network (Figure 3.16E, F). Again, the surface morphology was quite smooth,
with no notable additional structure.

These findings correlated well with those

previously reported by Pires et. al9. Intriguingly, when 1.0 mM HisCol and 1.0 mM
IdaCol was incubated with 2.0 mM CoCl2, no precipitation was observed.
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Figure 3.16. SEM visualization of 1.0 mM HisCol and 1.0 mM IdaCol with (A, B) 2.0 mM
NiCl2 (scale bars = 1.0 µm and 500 nm, respectively), (C, D) 2.0 mM ZnCl2 (scale bars = 2
µm and 500 nm, respectively), and (D, E) 2.0 mM CuCl2 (scale bars = 2.0 µm and 1.0
µm, respectively)

Due to the nature of the unique mechanism of assembly involved (Figure 3.2B),
we would expect to observe a periodic banding pattern within assemblies formed from
a 1:1 mixture of HisCol and IdaCol (Figure 3.17A), and that was indeed what was seen.
TEM visualization of the petal‐like assemblies formed in samples of 1.0 mM HisCol and
1.0 mM IdaCol with 2.0 mM NiCl2 revealed a distinct banding pattern (Figure 3.17B).
Closer inspection of individual petals revealed that the bands were approximately 9 nm
apart (Figure 3.17C), which corresponds to the length of the collagen triple helix (Figure
3.22A). TEM inspection of 1.0 mM HisCol and 1.0 mM IdaCol with 2.0 mM ZnCl2
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revealed an interconnected network of fibers with a clearly visible banding pattern
observed all throughout the assembly (Figure 3.17D). Closer inspection of an individual
fiber again revealed that the bands were approximately 9 nm wide. (Figure 3.17E). TEM
visualization of assemblies formed from 2.0 mM CuCl2 also revealed interconnected
assemblies (Figure 3.17F). Unfortunately, banding was difficult to observe due to
thickness of the assemblies observed. However, what appeared to be faint, periodic
banding was seen around the fringes of the network (Figure 3.17G). The observation of
this periodic banding pattern, with individual band lengths corresponding to the length
of an individual triple helix, provides strong evidence for the proposed, alternating
head‐to‐tail assembly mechanism (Figure 3.2B) and agrees with the results published by
Pires et. al.9
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Figure 3.17 (A) Cartoon of head‐to‐tail assembly of HisCol / IdaCol triple helices with
helix length (modified from Reference 9); TEM visualization of 1.0 mM HisCol and 1.0
mM IdaCol with (B) 2.0 mM NiCl2 (scale bar = 100 nm) , (C) Zoom‐in of (B) with band
width measurements (scale bar = 50 nm), (D) 2.0 mM ZnCl2 (scale bar = 50 nm), (E)
Zoom‐in of (D) with band width measurements (scale bar = 20 nm), (F) 2.0 mM CuCl2
(scale bar = 200 nm), (G) Zoom‐in of (F) (scale bar = 20 nm)

3.3.8 Metal‐Promoted, Two‐Peptide Assemblies formed from NCoH, HisCol, and IdaCol
Up to now, we’ve established that incubation of NCoH with a variety of divalent
metal ions results in the formation of microflorettes, and 1:1 mixtures of HisCol and
IdaCol undergo metal‐promoted self‐assembly to form banded petals and cross‐linked
meshes. Mixing NCoH with HisCol in the presence of metal could thus produce new
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head‐to‐tail assemblies in which the NTA ligands on NCoH trap metal ions and form
complexes with the dihistidine ligands on HisCol. Disappointingly, when 1.0 mM NCoH
and 1.0 mM HisCol were combined in the presence 2.0 mM ZnCl2, 2.0 mM NiCl2, or 2.0
mM CuCl2, no notable structures were observed. However, when this mixture was
presented with 2.0 mM CoCl2, a very cloudy white precipitate was observed within thirty
minutes. After overnight incubation, the sample was visualized by SEM. Upon initial
inspection, it appeared that the assembly was a petal‐like network (Figure 3.18A) much
like that previously observed upon incubation of 1:1 HisCol: IdaCol with 2.0 mM NiCl2
(Figure 3.16A, B); however, closer inspection revealed that these petals were ruffled in
nature, and, in fact, more closely resembled spiraled horns (Figure 3.18B, C). These
“unicorn horns” were roughly the same size as the petals observed for the Ni2+ HisCol‐
IdaCol material (200‐700 nm long) but formed thicker and more structurally intricate
bundles (Figure 3.18D).
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Figure 3.18. (A, C) SEM visualization of 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM
CoCl2 (scale bars = 5 µm and 500 nm, respectively), (B) Zoom‐in of (A) (scale bar = 500
nm), (D) Zoom‐in of (C) (scale bar = 200 nm)

Examination of this assembly with TEM revealed an intertwined network of the
“horn” structures (Figure 3.19B). Closer inspection of this material revealed a periodic
banding pattern all throughout the assembly and within each “horn” (Figure 3.19C, D).
Moreover, each band was found to be around 9 nm wide (Figure 3.19E, F),
corresponding to the length of each triple helix (Figure 3.19A).

161

A

B

C

50 nm

0.2 µm

D

F

E
9.08 nm
8.82 nm

9.84 nm

8.55 nm

20 nm

20 nm

20 nm

Figure 3.19. (A) Cartoon of head‐to‐tail assembly of HisCol / IdaCol with band width;
(B) TEM visualization of 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM CoCl2 (scale bar
= 200 nm), (C, D) Close‐ups of (B) (scale bars = 50 nm and 20 nm, respectively), (E, F)
Close‐ups of (C) and (D) with band width measurements (scale bar = 20 nm)

Since NCoH has a dihistidine moiety at the C‐terminus, it could also substitute for
HisCol and form assemblies with IdaCol. To probe this hypothesis, a mixture of 1.0 mM
NCoH and 1.0 mM IdaCol was incubated overnight with different metal ions and
visualized by SEM. In the presence of 2.0 mM CoCl2, microflorette‐like particles were
observed (Figure 3.20A, B). However, these 2‐6 µm‐sized particles were somewhat
smaller than the typical 10‐20 µm‐sized florettes. Moreover, these spheres appeared
incomplete with a rougher surface morphology and, in some cases, holes (Figure 3.20B).
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Incubation with 2.0 mM CuCl2 resulted in the formation of a thick, spiky network
(Figure 3.20C) that was very reminiscent of the assemblies formed from 1:1 HisCol:
IdaCol with 2.0 mM CuCl2 (Figure 3.16E, F). Closer inspection of the network revealed
that the majority of the “spikes” did not have a ruffled surface morphology. Some small
horn‐like projections could be observed, but, by and large, the structure appeared to be
composed of tiny (<200 nm long) petals condensed into thick aggregates (Figure 3.20D).
Interestingly enough, incubation of 1.0 mM NCoH and 1.0 mM IdaCol with 2.0
mM ZnCl2 led to the formation of microflorettes (Figure 3.20E, F). While these florettes
were slightly smaller (~5 µm in diameter) than those typically observed when NCoH
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Figure 3.20. SEM visualization of 1.0 mM NCoH and 1.0 mM IdaCol with (A, B) 2.0 mM
CoCl2 (scale bars = 5 µm and 2 µm), (C, D) 2.0 mM CuCl2 (scale bars = 3 µm and 500
nm), (E, F) 2.0 mM ZnCl2 (scale bars = 30 µm and 4 µm)
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alone is incubated with Zn2+ (10‐20 µm in diameter), the surface morphology closely
resembled what is seen with normal microflorettes (Figure 3.9).

3.3.9 Metal‐Promoted, Three‐Peptide Assemblies formed from NCoH, HisCol, and IdaCol
Having observed interesting assemblies with NCoH alone and with 1:1 mixtures
of HisCol: IdaCol, NCoH: HisCol, and NCoH: IdaCol, we decided to probe metal‐promoted
self‐assembly with a mixture of all three peptides. The optimal metal concentration for
the formation of NCoH microflorettes is 0.4 mM and that for forming assemblies with
HisCol: IdaCol is 2.0 mM. Hence, we theorized that we could maximize the potential for
structure formation by incubation of 1.0 mM NCoH, 500 µM HisCol, and 500 µM IdaCol
with 2.4 mM of metal.
In the case in which the metal in question was CoCl2, a thick, cloudy, white
precipitate was observed within thirty minutes.

After overnight incubation, SEM

visualization revealed the presence of numerous spherical clusters (Figure 3.21A).
However, moving to higher magnification made clear that these particles were most
definitely not microflorettes, as they were nanoscale in nature (500‐800 nm in diameter)
and had a radically different surface morphology (Figure 3.21B, C, D). While these
nanospheres appeared ruffled like florettes, florettes, by contrast, generally have a
much more compact morphology with greater entanglement of the fibrous strands
(Figure 3.9). These nanospheres, on the other hand, appear relatively loosely‐packed
and “puffy.” However, while these puffy nanospheres were, by far, the dominant
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morphology, there was also evidence of partial microflorette formation (Figure 3.21 E,
F). Curled, ruffled microscale structures were observed in a number of areas, forming
within and around the nanosphere clusters. These curled carpet‐like structures were
previously observed as NCoH microflorette precursors12.
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Figure 3.21. SEM visualization of 1.0 mM NCoH, 500 µM HisCol, and 500 µM IdaCol
with 2.4 mM CoCl2 (A) Scale bar = 20 µm, (B) Scale bar = 2 µm, (C) Scale bar = 2 µm,
(D) Scale bar = 500 nm, (E) Scale bar = 2 µm, (F) Scale bar = 1 µm

Incubation of 1.0 mM NCoH, 500 µM HisCol, and 500 µM IdaCol with 2.4 mM
CuCl2 also resulted in a very thick, cloudy white precipitate.

Moreover, SEM

visualization likewise revealed nanosphere clusters, but these were somewhat more
disordered and less well‐defined than those observed previously. More interestingly,
these clusters were coated with a fine, fibrous web (Figure 3.22A, B). Incubation of this
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three‐peptide mixture with 2.4 mM NiCl2 yielded a very chaotic assembly composed of
nanosphere clusters with petal‐like projections aggregated with smooth nanospheres
(Figure 3.22C, D). Finally, incubation of the three peptides with 2.4 mM ZnCl2 resulted in
patches of ruffled petal‐like mesh (Figure 3.22E), reminiscent of the “horned” bundles
previously observed with 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM CoCl2 (Figure
3.18). Isolated smooth nanospheres were also visible (Figure 3.22F).
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Figure 3.22. SEM visualization of 1.0 mM NCoH, 500 nM HisCol, and 500 nM IdaCol (A,
B) with 2.4 mM CuCl2 (scale bars = 5 µm and 2 µm, respectively), (C, D) with 2.4 mM
NiCl2 (scale bars = 4 µm and 1 µm, respectively), (E, F) with 2.4 mM ZnCl2 (scale bars = 1
µm and 2 µm, respectively).
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3.3.10 Metal Concentration Dependency on Mixed Peptide Assembly Morphology
Having established that metal‐promoted self‐assembly of NCoH, HisCol, and / or
IdaCol results in unique morphologies, we decided to examine the effects that altering
the concentration of the metal would have on the resulting morphology. Earlier, it was
demonstrated that incubation of 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM CoCl2
led to the formation of an intricate bundles composed entirely of distinct, spiraled
“unicorn horns.” (Figure 3.18), and this morphology was replicated for the present study
(Figure 3.23C). Surprisingly, it was found that lowering the Co2+ concentration to 1.0
mM resulted in very little change to the established morphology (Figure 3.23B). Once
again, a thick, very cloudy, white precipitate was observed within 30 minutes of addition
of the metal, and SEM visualization revealed a dense network composed of spiraled
horns. Moreover, these horns were found to be on the same size scale as those
observed previously, being 200‐600 nm long.

Similarly, lowering the metal

concentration even further, to 0.5 mM, also resulted in negligible structural change
(Figure 3.23A). Abundant patches of horned bundles were observed throughout this
sample, with no noticeable difference in the surface morphology. When the metal
concentration was raised to 3.0 mM, the bundles appeared somewhat flatter and more
loosely packed, but horns were still abundant throughout the sample. No further
morphological changes were observed upon increasing the metal concentration to 4.0
mM (Figure 3.23E). Yet again, a interconnected bundle of ruffled, spiraled “horns” was
observed all throughout the sample, although with the same looser packing
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arrangement seen in the presence of 3.0 mM Co2+. Thus, we can conclude that the 1.0
mM NCoH – 1.0 mM HisCol tolerates a wide range of metal concentrations, as Co2+
concentrations ranging from 0.5 mM to 2.0 mM failed to alter the previously reported
morphology in any significant way. It was only when the metal concentration reached
3.0 mM and above that any real structural deviation was observed, but, even then, the
observed differences were relatively minor.
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Figure 3.23. SEM visualization of 1.0 mM NCoH and 1.0 mM HisCol with (A) 0.5 mM
CoCl2, (B) 1.0 mM CoCl2, (C) 2.0 mM CoCl2, (D) 3.0 mM CoCl2, (E) 4.0 mM CoCl2 (scale
bars = 500 nm).
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Earlier, we established that incubation of 1.0 mM NCoH and 1.0 mM IdaCol with
2.0 mM CoCl2 resulted in the formation of somewhat irregular microspheres that could
be precursors to microflorettes (Figure 3.24B). However, upon lowering the metal
concentration to 1.0 mM, no such spheres were observed. Instead, we saw a few
isolated fragments and large, structurally‐amorphous regions spanning at least 30 µm
(Figure 3.24A). Curiously, when the concentration of Co2+ was increased to 3.0 mM,
only a few isolated microspheres were observed, amidst a background of thin, loose,
scattered fibers (Figure 3.24C).
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Figure 3.24. SEM visualization of 1.0 mM NCoH and 1.0 mM IdaCol with (A) 1.0 mM
CoCl2 (scale bar = 4 µm), (B) 2.0 mM CoCl2 (scale bar = 5 µm), (C) 3.0 mM CoCl2 (scale
bar = 5 µm).

3.3.11 The Effect of Strand Exchange on Mixed Peptide Assembly Morphology
Our working model for the metal‐promoted self‐assembly of the linearly
designed peptides NCoH, HisCol, and IdaCol relies on the precise placement of the
metal‐binding ligands along individual triple helical units. We sought to test the limits of
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this model by promoting strand exchange through joint thermal annealing of the
peptides involved. We have already established that, in the absence of any thermal
annealing, overnight incubation of 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM CoCl2
results in the formation of an intricate network composed of unique, spiraled, horn‐like
projections (Figure 3.25A). However, when 1.0 mM NCoH and 1.0 mM HisCol are
thermally annealed together, followed by addition of 2.0 mM CoCl2, all such structural
intricacy vanishes. In its place, we observe by SEM a large, thick, flat, mostly amorphous
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mesh (Figure 3.25B, C). It bears no resemblance to the morphology observed with the
non‐annealed peptides. The only notable structural features are layers of flat, smooth,
intertwined mesh‐like areas and a few isolated, smooth microspherical projections
(Figure 3.25B).
An analogous morphological disparity was observed for the 1.0 mM NCoH – 1.0
mM IdaCol system. Previously, it was noted that incubating 1.0 mM NCoH and 1.0 mM
IdaCol with 2.0 mM CoCl2, in the absence of any thermal annealing, produced
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Figure 3.25. SEM visualization of (A) 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM
CoCl2, no annealing (scale bar = 5 µm), (B, C) 1.0 mM NCoH and 1.0 mM HisCol
thermally annealed prior to adding 2.0 mM CoCl2 (scale bars = 20 µm and 5 µm,
respectively), (D) 1.0 mM NCoH and 1.0 mM IdaCol with 2.0 mM CoCl2, no annealing
(scale bar = 5 µm), (E, F) 1.0 mM NCoH and 1.0 mM IdaCol thermally annealed prior to
adding 2.0 mM CoCl2 (scale bars = 3 µm and 1 µm, respectively).
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microspheres with a more irregular and less fully‐formed morphology than those of
typical microflorettes (Figure 3.25D). However, when 1.0 mM NCoH and 1.0 mM IdaCol
were jointly thermally annealed, followed by addition of 2.0 mM CoCl2, SEM
visualization revealed dense clusters of nanospheres (Figure 3.25E). Closer inspection of
these nanospheres demonstrated that they were adorned with short, pointed “spikes,”
smaller and smoother than the horns typically observed in the NCoH‐HisCol system
(Figure 3.25F).
These findings provide a strong validation for the proposed mechanism, as they
serve to confirm the significance of the precise localization of metal‐binding ligands on
the collagen triple helix for metal‐promoted self‐assembly. Strand exchange between
the same two peptides, facilitated through thermal annealing, followed by exposure to
an identical concentration of metal ions resulted in radically different morphologies for
both the NCoH‐HisCol and the NCoH‐IdaCol system. Thus, it is only through careful
control of the collagen peptide triple helix does one arrive at the desired self‐assembled
three‐dimensional morphology.
3.3.12 Time Course Study of Metal‐Promoted Mixed Peptide Self‐Assembly
Thus far, we had examined the metal‐promoted self‐assembly of a variety of
mixed peptide samples after overnight incubation; however, we sought to examine
more closely the time scale of this assembly and whether precursors could be
discovered in order to further elucidate the mechanism of assembly. Incubation of 1.0
mM NCoH and 1.0 mM HisCol with 2.0 mM CoCl2 overnight (sixteen hours) was
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previously shown to form a network full of spiraled horn‐like pieces (Figure 3.26D). We
wished to uncover the precise moment at which such unique structures first form. To
do so, samples were washed (with the metal ion removed), spotted onto glass coverslips
at a variety of time points, and visualized by SEM. Incredibly, upon examining our first
time point, a mere two‐minutes after adding Co2+, we discovered that the horned
bundle morphology had already formed (Figure 3.26A). The bundles held distinct,
ruffled horns (Figure 3.26B) that appeared virtually identical to those observed after the
usual 16‐hour incubation period (Figure 3.26D). Examination of this sample after two
hours resulting in very little change in morphology from the initial time point (Figure
3.26C). Thus, the intricate “unicorn horn” morphology formed by the 1:1 NCoH: HisCol
system in the presence of Co2+ completes its assembly quite rapidly, with no clear
precursor structures visible at the earliest time point examined (two minutes).
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Figure 3.26. SEM visualization of 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM CoCl2
after (A, B) two minutes (scale bars = 1 µm and 500 nm, respectively), (C, D) two hours
(scale bars = 1 µm and 500 nm, respectively), (E, F) sixteen hours (scale bars = 1 µm
and 500 nm, respectively)

3.3.13 Attachment of a Fluorophore to Mixed Peptide Self‐Assemblies
Having successfully characterized a variety of three‐dimensional morphologies
resulting from tandem metal‐promoted self‐assembly of two collagen mimetic peptides,
we next wondered whether unsatisfied metal‐ligand interactions on the surface could
be exploited for decoration by His Tag‐containing biomolecules, a process we described
for NCoH microflorettes in Chapter 2. Using a protocol analogous to that used for
selective surface decoration of microflorettes, in which free ligands were first activated
with Ni2+,

the fluorophore Rho‐HIS was attached to networks formed from Zn2+‐
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promoted assembly of 1:1 HisCol: IdaCol. Fluorescent micrographs taken of the sample
confirmed that the assemblies exhibited red fluorescence (Figure 3.27).
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Figure 3.27. Visualization of Rho‐HIS‐labeled HisCol / IdaCol networks (1.0 mM
HisCol, 1.0 mM IdaCol, 2.0 mM ZnCl2): (A, C) Transmittance (scale bars = 200 and 100
µm, respectively), (B) Fluorescence micrograph of (A), (D), Fluorescence micrograph
of (C), (E, F) SEM micrographs (scale bars = 1 µm and 500 nm, respectively)
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SEM visualization of the sample revealed a morphology identical to that observed in the
absence of Rho‐HIS, confirming that Rho‐HIS attachment does not disrupt the
established morphology (Figure 3.27 E,F).
Using the same protocol, Rho‐HIS was also bound to “horned bundles” formed
from tandem Co2+‐promoted self‐assembly of 1:1 NCoH: HisCol. Fluorescent microscopy
confirmed that the sample exhibited red fluorescence (Figure 3.28). SEM visualization
of the sample verified that abundant “horns” were still present throughout the sample,
once again affirming that Rho‐HIS addition to the surface of the assembly is not
detrimental to its three‐dimensional assembly (Figure 3.28 E,F). These results open up
the possibility for further modification by a wide variety of His Tag‐containing
biomolecules, including growth factors and the cell‐adhesive RGDS sequence.
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Figure 3.28. Visualization of Rho‐HIS‐labeled, self‐assembled NCoH / HisCol
“horns” (1.0 mM NCoH, 1.0 mM HisCol, 2.0 mM CoCl2): (A, C) Transmittance (scale
bar = 100 µm), (B) Fluorescence micrograph of (A), (D) Fluorescence micrograph of
(C), (E, F) SEM micrographs (scale bars = 1 µm and 500 nm, respectively)
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3.3.14 Cell Adhesion to a Mixed Peptide Scaffold
Up to this point, we have established that overnight incubation of 1.0 mM
NCoH and 1.0 mM HisCol with 2.0 mM CoCl2 results in the formation of an intricate
“horned bundle” morphology. These bundles tend to be extended in nature and be
multi‐layered, with “horns” stacked upon other horns. Moreover, the horns have a
ruffled surface, ensuring that these bundles possess maximum surface area for
functionalization. Furthermore, collagen is a natural component of the extracelluar
matrix, meaning that these bundles formed from collagen mimetic peptides should be
biodegradable, biocompatible, non‐immunogenic, and non‐toxic. In combination, these
properties ensure that NCoH / HisCol horned bundles have great potential as a
biomimetic scaffold for regenerative medicine.
To probe the cell adhesive functionality of these horned bundles, a study was
designed in which freshly prepared Rho‐HIS‐labeled bundles lacking the cell‐adhesive
RGDS sequence were combined with HeLa cells in 500 µL total volume. Interestingly, it
was found that, in the presence of DMEM media supplemented with 10% FBS, the
bundles degraded very rapidly, as little to no material remained after three hours. The
same effect was observed with the HisCol / IdaCol meshwork produced after overnight
incubation with Zn2+. Because of this, in the present study, samples were incubated in
RPMI media without added serum at 37°C with 5% CO2. After two hours, live cells were
stained green with Calcein AM (500 nM). Samples were plated onto glass coverslips and
visualized in suspension by confocal microscopy (Figure 3.29). Under these conditions,
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horned bundles persisted (Figure 3.29A, B), and HeLa cells continued to survive in
serum‐lacking suspension culture (Figure 3.29C). Upon examining the mixed HeLa /
bundle samples, sure enough, green HeLa cells were shown to interact with the red
bundles in fluorescent overlay micrographs (Figure 3.29D, G), suggesting that NCoH /
HisCol horned bundles can indeed be utilized as a cell‐adhesive scaffold. Further
experiments will need to be performed with human stem cells and bound growth
factors in order to probe the ability of the bundles to generate new, functional tissue for
implantation, but the current findings provide great hope for greater biomedical
applications.
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Figure 3.29. Fluorescent confocal visualization of Rho‐HIS‐labeled NCoH / HisCol
“horned bundles” with HeLa cells: (A, B) “Horns” only, (C) 50,000 HeLa cells only;
50,000 HeLa cells with “Horns”: (D, G) Overlay, (E, H) Green channel only, (F, I) Red
channel only (Horned bundles labeled red with 20 µM Rho‐HIS, live cells stained green
with 500 nM Calcein AM) (scale bar = 25 µm)
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3.3.15 Metal‐Promoted Peptide Assembly on Glass
All of the metal‐promoted self‐assemblies described thus far were performed in
suspension in 1.5 mL Eppendorf tubes using the same fundamental protocol (Figure
3.5).

However, in recent years, small molecule and polymer‐based monolayers

assembled on flat surfaces have generated much interest for their ability to create a
unique, highly customizable chemical environment that can be microfabricated for
large‐scale production16. Peptide‐based monolayers have been particularly attractive
for use as bioactive substrates. For instance, Lom et. al.17 lithographically manufactured
ethylenediaminepropylsilane (EDS)‐coated glass coverslips conjugated with fibronectin,
laminin, and collagen IV, which promoted N1E‐115 neuroblastoma cell adhesion and
spreading. More recently, Hasenbein et. al18. used microcontact printing to generate
monolayers of N1[3‐(trimethoxysilyl)‐propyl]diethylenetriamine (DETA) monolayers with
octadecyltrichlorosilane (OTS) on borosilicate glass coverslips. These monolayers were
subsequently modified with the cell‐adhesive ligand RGDS and were found to promote
cell adhesion. When the osteoblast‐selective sequence KRSR was used instead, only
osteoblasts adhered to the coverslips.

Thus, it is possible to fabricate peptide‐

functionalized surfaces that exhibit region and cell‐specific cellular binding for
biomedical engineering. Consequently, we sought to examine whether our collagen
mimetic peptide assemblies could be performed on a glass coverslip. To this end, we
developed a novel protocol for the surface‐based, metal‐promoted self‐assembly of
collagen mimetic peptides (Figure 3.30).
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Figure 3.30. Protocol for the metal‐promoted self‐assembly of collagen mimetic
peptides on a glass coverslip

First, we added each of the necessary components (MOPS buffer (pH 7.1), DI
H2O, peptide, and metal) in 50 µL total volume in a 1.5 mL Eppendorf tube as before.
The components were mixed and then immediately spotted onto a glass coverslip
affixed to a SEM stub via copper tape. The stub was placed upright in a Petri dish
containing water. The dish was covered and allowed to incubate overnight. The
surrounding water and the enclosed environment ensured that the peptide‐metal
droplet remained wet during the incubation period in order to facilitate assembly. The
following day, a visible precipitate formed. The solution was then carefully wicked
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away, and the precipitate was resuspended in DI H2O. Lastly, the stub was lyophilized,
and the assembly was visualized by SEM.
We opted to use this methodology to examine the peptide‐metal combinations
that had previously generated relatively flat, microscale networks, as we hypothesized
that such assemblies would spread well across an even surface and would be most
susceptible to modification for potential future applications. The first system that was
probed in this manner was 1.0 mM HisCol and 1.0 mM IdaCol in the presence of 2.0 mM
ZnCl2.

Overnight incubation of this system in an Eppendorf tube generated an

extensive, flat, highly‐interconnected, fibrous assembly (Figure 3.31A).

Each unit

spanned several microns. When this same system was prepared on a glass coverslip, as
described above, it produced an even more extensive and interconnected network
(Figure 3.31B). This fibrous network covered the expanse of the area of the surface
previously occupied by the droplet. Closer examination of this network revealed that its
morphology was virtually identical to that previously observed when it was assembled in
suspension (Figure 3.31C). Curiously, beneath and between this microscale network

A

B

C

D

Figure 3.31. SEM visualization of 1.0 mM HisCol and 1.0 mM IdaCol with 2.0 mM
ZnCl2 assembled (A) in an Eppendorf tube (scale bar = 500 nm), (B) on a glass
coverslip (scale bar = 20 µm), (C) Zoom‐in of (B) (scale bar = 4 µm), (D) Zoom‐in of (C)
(scale bar = 1 µm)
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was observed another nanoscale network, which also bore a close structural similarity
to the original network assembled in suspension (Figure 3.31D). It can be hypothesized
that this nanoscale network is a precursor to the more familiar microscale network.
While the nanoscale network was not apparent when the assembly took place in
suspension, perhaps the nature of the flat surface promoted the network to, in some
cases, adhere to the surface before it had fully formed.
The 1:1 HisCol: IdaCol system was also examined in this manner in the presence
of Ni2+. Previously, incubating 1.0 mM HisCol and 1.0 mM IdaCol in the presence 2.0
mM NiCl2 overnight in an Eppendorf tube generated a network with an exquisite,
smooth petal‐like assembly (Figure 3.32A). This assembly was then performed on a
glass coverslip using the above methodology. Unfortunately, SEM visualization of the
resulting assembly revealed a radically different morphology (Figure 3.32B, C, D). The
assembled material was spread out extensively across the glass but it was very flat and
amorphous. There was no sign of any petal‐like structures. The highest points in the
sample resembled a series of flat fragments stacked on top of each other, rather than
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Figure 3.32. SEM visualization of 1.0 mM HisCol and 1.0 mM IdaCol with 2.0 mM NiCl2
assembled (A) in an Eppendorf tube (scale bar = 500 nm), (B, C, D) on a glass coverslip
(scale bars = 4 µm, 4 µm, and 500 nm, respectively)
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any sort of well‐ordered structure (Figure 3.32B). Overall, the aggregated material
appeared very smooth, with few discernable surface details (Figure 3.32D). Perhaps,
the failure of this system to adopt the expected petal‐like morphology is due to the fact
that, as the droplet spread out across the glass surface, any petals formed were
compressed just prior to adhering to the glass. A few regions in particular resemble
compressed, fractured petals (Figure 3.32B).
This surface assembly methodology was further utilized with the 1:1 NCoH:
HisCol system in the presence of Co2+. When 1.0 mM NCoH and 1.0 mM HisCol were
mixed with 2.0 mM CoCl2, after overnight incubation in an Eppendorf tube, it formed
highly unique bundles composed entirely of ruffled horn‐like fibrils (Figure 3.33A).
When this same system was assembled on a glass coverslip, SEM visualization revealed
a very extensive, exquisitely‐structured network that effectively coated the surface
(Figure 3.33B). Closer inspection of the networked bundles revealed the presence of the
spiraled “unicorn horns” as well as petal‐like projections (Figure 3.33C), which bore
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Figure 3.33. SEM visualization of 1.0 mM NCoH and 1.0 mM HisCol with 2.0 mM CoCl2
assembled (A) in an Eppendorf tube (scale bar = 500 nm), (B) on a glass coverslip (scale
bar = 5 µm), (C) Zoom‐in of (B) (scale bar = 500 nm), (D) Close‐up of nanoscale
background (scale bar = 1 µm)
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close resemblance with those previously observed in suspension‐based assembly.
However, as was the case with the HisCol‐IdaCol‐Zn2+ system, a fine nanoscale network
was also observed between and around the microscale network (Figure 3.33D). But, in
contrast to the intricately‐assembled microscale network, the nanoscale network
appeared relatively flat and fibrous with far less structural complexity. It can again be
hypothesized that this nanoscale network is a precursor to the more familiar microscale
network and that the fact that it is visualized on glass but was not apparent in the
suspension‐based assemblies results from the notion that more points‐of‐contact on the
surface facilitates adherence of prematurely‐formed networked nanostructures.

3.4 Conclusions
Metal‐mediated self‐assembly of collagen mimetic peptides (CMPs) in
suspension results in a variety of morphologies, which can be fine‐tuned by altering the
following variables: (1) peptide structure, (2) peptide concentration (3) metal type, (4)
metal concentration, and (5) the possibility of strand exchange. NCoH, designed with a
linear arrangement of metal‐binding ligands, forms microflorettes in the presence of Zn
(II), Co (II), Cu (II)12, and Mn (II), nanospheres in the presence of Ni (II)12, and a network
architecture in the presence of Cr (III). HBN forms a highly cross‐linked mesh in the
presence of Ni (II)7. An equimolar mixture of HisCol and IdaCol forms an intricate petal‐
like network with periodic banding in the presence of Ni (II) and less‐defined but still
periodically banded networks in the presence of Zn (II) and Cu (II)9. Coincubation of
equimolar NCoH and HBN results in thick meshes with encapsulated microflorettes.
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When these peptides are coincubated in unequal concentrations, the characteristic
morphology of the peptide in higher concentration dominates. NCoH can also be
substituted for either HisCol or IdaCol in a 1:1 mixture to yield assemblies with novel
morphologies. Of these, the most intriguing are networked bundles composed of
spiraled horns formed from 1:1 NCoH: HisCol in the presence of Co (II). These horned
bundles readily form at a large range of metal concentrations, from 0.5 mM – 2.0 mM,
in as little as two minutes. In addition, assemblies formed from NCoH / HisCol and
HisCol / IdaCol can be labeled with a His Tag‐containing fluorophore, and NCoH / HisCol
“horned bundles” demonstrate positive interactions with live HeLa cells in suspension
culture. Strand exchange facilitated through thermal annealing results in drastically
different morphologies for all combinations of peptides examined, validating the
hypothesis that precise placement of metal‐binding ligands is responsible for the
formation of particular metal‐mediated, self‐assembled morphologies. Moreover, all of
the three‐dimensional morphologies that were imaged in this work formed at room
temperature and neutral pH in less than 24 hours.
Interestingly, it is possible to perform at least some of these metal‐mediated
assemblies within a droplet on a glass surface, as opposed to suspended in an
Eppendorf tube. Such assemblies display mostly uniform coverage across the glass, and
nanostructures are visualized beneath the dominant microstructure. More intriguingly,
experiments performed with 1:1 NCoH: HisCol in the presence of CoCl2 revealed that the
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highly intricate horned bundle morphology, previously observed in suspension, can
successfully be prepared on glass.

3.5 Future Directions
The ability to carry out metal‐promoted self‐assembly of collagen mimetic
peptides on a flat surface holds great promise for future developments. The next step in
this work would be to examine the ability to customize the surface of peptides by
exploiting unsatisfied metal‐ligand interactions using His‐tag‐containing small
biomolecules, as has previously been done with NCoH microflorettes12 and as we have
presently demonstrated with Rho‐HIS on NCoH / HisCol and HisCol / IdaCol networks.
The attachment of RGDS‐(His)7 and growth factors (i.e., hEGF‐(His)6 and TGF‐β1‐(His)6)
would be particularly significant for use as a cell‐supportive, bioactive scaffold. Further
experiments will need to be performed with human stem cells in order to determine the
ability of these mixed peptide assemblies to support and preserve functional tissue.

3.6 Materials and Methods
The Rink Amide ChemMatrix resin, used in solid phase peptide synthesis, was
commercially obtained from Pcas‐Biomatrix Inc. (Quebec, Canada). Fmoc‐protected
amino acids and O‐benzotriazole‐N,N,N’,N’‐tetramethyluraniumhexafluorophosphate
(HBTU) were purchased from AAPPTec (Louisville, KY, USA), ChemPep, Inc. (Wellington,
FL, USA), and Chem‐Impex International (Wood Dale, IL, USA). Piperidine and
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diisopropylethylamine (DIEA) were procured from Alfa Aesar (Ward Hill, MA, USA).
Acetonitrile, triisopropylsilane (TIPS), trifluoroacetic acid (TFA), nickel (II) chloride
hexahydrate, zinc chloride, copper (II) chloride dihydrate, cobalt (II) chloride
hexahydrate, and manganese (II) chloride tetrahydrate were all obtained from Sigma
Aldrich (St. Louis, MO, USA). Chromium (III) chloride hexahydrate and lanthanum (III)
chloride heptahydrate were obtained from Alfa Aesar (Ward Hill, MA, USA). N,N‐
dimethylformamide (DMF), dichloromethane (DCM), and methanol (MeOH) were
purchased from AVANTOR (Center Valley, PA, USA) and Fisher Scientific (Pittsburgh, PA,
USA). 200‐proof ethanol was procured from KOPTEC (King of Prussia, PA, USA).
Ethylenediaminetetraacetic acid disodium salt (EDTA) was purchased from Mallinckrodt
JT Baker (Hazelwood, MO, USA).

H‐Glu(OBzl)‐OtBu was bought from BACHEM

(Torrance, CA, USA). SEM stubs, round glass coverslips, and TEM grids were obtained
from Ted Pella, Inc. (Redding, CA, USA).
Synthesis of Compound 2 (NTA Intermediate).
(Described in Chapter 2)
Synthesis of NTA, Compound 3.
(Described in Chapter 2)
Synthesis of NCoH.
(Described in Chapter 2)
Synthesis of HBN7. Into a 15 mL glass peptide synthesis flask was loaded 500 mg (0.52
mmol / g) of H‐Rink Amide ChemMatrix resin. The resin was washed with DMF (15 mL, 5
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min). The solvent was drained, and the flask was loaded with the desired Fmoc‐
protected amino acid (first coupling with Fmoc‐His(Trt)‐OH for HBN) (6 eq., 4.95 mmol),
HBTU (6 eq., 4.95 mmol, 0.60 g), and DIEA (12 eq., 9.9 mmol, 0.55 mL) in DMF (13 mL).
The flask was agitated for three hours at room temperature to induce coupling. The
solution was drained, and the resin was washed with DMF (3 X 15 mL), DCM (3 X 15 mL),
MeOH (3 x 15 mL), and again with DCM (3 X 15 mL). Amino acid coupling was verified
with the Kaiser test14 or the chloranil test15. The resin was then washed once more with
DMF (3 x 15 mL), and Fmoc deprotection was accomplished by agitating the flask with
25% piperidine: DMF (15 mL) for 30 min. The solution was drained, and the resin was
washed with DMF (3 X 15 mL), DCM (3 X 15 mL), MeOH (3 x 15 mL), and again with DCM
(3 X 15 mL). Fmoc deprotection was verified with the Kaiser or chloranil test. The resin
was then washed again with DMF (3 X 15 mL). This procedure was repeated for the
entire

chain

length

of

the

peptide.

Upon

arrival

at

the

sequence

(POG)4PK(Mtt)G(POG)4HH‐NH2‐resin, N‐terminal ligand attachment was accomplished
by loading the flask with NTA (4 eq., 1.1 mmol, 0.37 mL), HBTU (6 eq., 4.95 mmol, 0.60
g), and DIEA (12 eq., 9.9 mmol, 0.55 mL) in DMF (13 mL) and agitating for three hours at
room temperature. After washing, the Mtt protecting group on the central lysine
residue was removed through repeated treatment with 1.8% TFA in DCM (12 times, 5
min each).

Mild acidic treatment continued until the yellow color had entirely

disappeared from the solution. When this had occurred, the free ε‐amino group was
coupled with 4’‐methyl‐(2,2’‐bipyridine)‐4‐carboxylic acid (Byp) (5 eq, 1.37 mmol) in the
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presence of HBTU (5 eq., 1.37 mmol) and DIEA (10 eq., 2.74 mmol). Upon completion of
the final coupling and subsequent washing, a TFA cocktail (95% TFA, 2.5% TIPS, 2.5%
H2O, 15 mL) was added to the resin. The resin was agitated at room temperature for
three hours. The resin was washed with DMF (15 mL X 2 X 5 min) and DCM (15 mL X 2 X
5 min). The solvent was removed in vacuo and precipitated with cold diethyl ether (50
mL X 2 X 30 min). The solution was centrifuged at high speed for 10 min, and the
solvent was removed by decanting. This process was repeated once. The pellet was left
to dry on a hi‐vac overnight. The dry pellet was massed and then dissolved in H2O to
form a 10 mg / mL crude peptide solution. This crude material was characterized by
MALDI‐TOF MS and analytical HPLC (Beckman, Luna C18 column, 30 min run, 5‐35% ACN
/ H2O with 0.05% TFA, monitored at 214 nm, 25 µL injection volume). It was then
purified on a semi‐prep HPLC (Waters) equipped with a Luna C18 column. It was run for
60 min through a solvent gradient of 5‐35% ACN / H2O with 0.1% TFA at a flow rate of 12
mL / min. The injection volume was 1.5 mL, and monitoring took place at 214 nm and
254 nm. The pure peptide was collected and reconstituted from the fractions that
eluted at 28 min. The solvent was removed in vacuo. Lyophilization for 3 days afforded
pure HBN, which was characterized by MALDI‐TOF MS and analytical HPLC (Beckman,
Luna C18 column, 30 min run, 5‐35% ACN / H2O with 0.05% TFA, monitored at 214 nm,
25 µL injection volume). MALDI‐TOF MS Calculated: 3151. Observed: 3147.
Synthesis of HisCol9. Generation of HisCol proceeded in the same manner as that
described above for NCoH to yield the sequence (POG)9‐HH‐NH2‐resin. Two additional
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histidine residues were then coupled to the N‐terminus to form HH‐(POG)9‐HH‐NH2‐
resin. Upon completion of the final coupling and subsequent washing, the peptide was
capped using 5% acetic anhydride and 8.5% DIEA (10 mL in DMF) through agitation for
one hour. A TFA cocktail (95% TFA, 2.5% TIPS, 2.5% H2O, 15 mL) was then added to the
resin. The resin was agitated at room temperature for three hours. The resin was
washed with DMF (15 mL X 2 X 5 min) and DCM (15 mL X 2 X 5 min). The solvent was
removed in vacuo and precipitated with cold diethyl ether (50 mL X 2 X 30 min). The
solution was centrifuged at high speed for 10 min, and the solvent was removed by
decanting. This process was repeated once. The pellet was left to dry on a hi‐vac
overnight. The dry pellet was massed and then dissolved in H2O to form a 10 mg / mL
crude peptide solution. This crude material was characterized by MALDI‐TOF MS, and
analytical HPLC (Beckman, Luna C18 column, 30 min run, 2‐25% ACN / H2O with 0.05%
TFA, monitored at 214 nm, 25 µL injection volume). It was then purified on a semi‐prep
HPLC (Waters) equipped with a Luna C18 column. It was run for 60 min through a
solvent gradient of 2‐25% ACN / H2O with 0.1% TFA at a flow rate of 8 mL / min. The
injection volume was 3.0 mL, and monitoring took place at 214 nm and 254 nm. The
pure peptide was collected and reconstituted from the fractions that eluted at 38 min
(17% ACN). The solvent was removed in vacuo. Lyophilization for 3 days afforded pure
HisCol, which was characterized by MALDI‐TOF MS and analytical HPLC (Beckman, Luna
C18 column, 30 min run, 2‐25% ACN / H2O with 0.05% TFA, monitored at 214 nm, 25 µL
injection volume). MALDI‐TOF MS Calculated: 3013.20. Observed: 3013.55.
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Synthesis of IdaCol9. Into a 15 mL glass peptide synthesis flask was loaded 500 mg (0.52
mmol / g) of H‐Rink Amide ChemMatrix resin. The resin was washed with DMF (15 mL, 5
min).

Fmoc‐Lys(Mtt)‐OH was coupled to the free amine handle of the resin and

deprotected using the standard Fmoc‐based solid phase peptide synthesis protocol
described earlier (for NCoH and HBN). The (POG)9 backbone sequence was installed in
the same manner. Following this, Fmoc‐Lys(Mtt)‐OH was added to the N‐terminal end
of the peptide. The peptide as capped using 5% acetic anhydride and 8.5% DIEA (10 mL
in DMF) through agitation for one hour. The Mtt protecting groups were removed from
both the N‐terminal and C‐terminal lysine residues using repeated treatments (12 times)
with 1% TFA and 5% TIPS in DCM (10 mL for 2 min each time). Mild acidic treatment
continued until the yellow color was completely removed from the solution. The free ε‐
amino groups were reacted with t‐butylbromoacetate (20 equiv., 4.8 mmol) with DIEA
(20 equiv., 4.8 mmol) in DMF (10 mL) for 2 hours. Following this, a TFA cocktail (95%
TFA, 2.5% TIPS, 2.5% H2O, 15 mL) was added to the resin. The resin was agitated at
room temperature for three hours. The resin was washed with DMF (15 mL X 2 X 5 min)
and DCM (15 mL X 2 X 5 min). The solvent was removed in vacuo and precipitated with
cold diethyl ether (50 mL X 2 X 30 min). The solution was centrifuged at high speed for
10 min, and the solvent was removed by decanting. This process was repeated once.
The pellet was left to dry on a hi‐vac overnight. The dry pellet was massed and then
dissolved in H2O to form a 10 mg / mL crude peptide solution. This crude material was
characterized by MALDI‐TOF MS, and analytical HPLC (Beckman, Luna C18 column, 30
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min run, 2‐25% ACN / H2O with 0.05% TFA, monitored at 214 nm, 25 µL injection
volume). It was then purified on a semi‐prep HPLC (Waters) equipped with a Luna C18
column. It was run for 60 min through a solvent gradient of 2‐22% ACN / H2O with 0.1%
TFA at a flow rate of 10 mL / min. The injection volume was 3.0 mL, and monitoring
took place at 214 nm and 254 nm. The pure peptide was collected and reconstituted
from the fractions that eluted at 40 min (17% ACN). The solvent was removed in vacuo.
Lyophilization for 3 days afforded pure IdaCol, which was characterized by MALDI‐TOF
MS and analytical HPLC (Beckman, Luna C18 column, 30 min run, 2‐22% ACN / H2O with
0.05% TFA, monitored at 214 nm, 25 µL injection volume). MALDI‐TOF MS Calculated:
2953.13. Observed: 2948.58.
Kaiser Test
(See Chapter 2)
Chloranil Test.
(See Chapter 2)
NCoH Microflorette Metal‐Promoted Self‐Assembly12. Microflorettes were formed in a
total volume of 50 µL. Into a 1.5 mL eppendorf tube was placed MOPS buffer (20 mM,
10 µL), deionized H2O (27 µL), NCoH peptide (1.0 mM, 5 µL), and, lastly, MCl2 (500 µM,
2.5 µL), where M is a metallic species (i.e, Zn, Cu, Co). The solution was thoroughly
mixed after each successive addition followed by a final solution mix. The solution was
incubated for 18‐24 hours at room temperature in the dark without further mixing. The
resulting precipitate was centrifuged at 10,000g for three minutes at 4°C.

The

194

supernatant (45 µL) was removed, and the pellet was resuspended in DI H2O (45 µL).
This process was repeated two more times. Microflorette formation was confirmed
through bright field and fluorescent microscopy using an Olympus BX51 optical
microscope.
HBN Mesh Metal‐Promoted Self‐Assembly7. The HBN mesh was formed in a total
volume of 50 µL. Into a 1.5 mL eppendorf tube was placed phosphate buffer (20 mM,
10 µL), deionized H2O (30 µL), HBN peptide (1.0 mM, 5 µL), and, lastly, NiCl2 (1.0 mM,
5.0 µL). The solution was thoroughly mixed after each successive addition followed by a
final solution mix. The solution was incubated for 18‐24 hours at room temperature in
the dark without further mixing. Mesh formation was confirmed by visual inspection
and by SEM.
HisCol / IdaCol Mesh Metal‐Promoted Self‐Assembly9. The HisCol / IdaCol assembly
was performed in a total volume of 50 µL. Into a 1.5 mL eppendorf tube was placed
MOPS buffer (20 mM, 10 µL), deionized H2O (25 µL), 1:1 HisCol: IdaCol (1.0 mM, 5 µL),
and, lastly, MCl2 (2.0 mM, 10 µL), where M is a metallic species (i.e, Zn, Cu, Co). The
solution was thoroughly mixed after each successive addition followed by a final
solution mix. The solution was incubated for 18‐24 hours at room temperature in the
dark without further mixing. Upon observation of a visible precipitate, assemblies were
centrifuged at 10,000 g for three minutes at 4°C. The supernatant (45 µL) was removed,
and the pellet was resuspended in DI H2O (45 µL). This process was repeated two more
times. The resulting material was characterized by SEM.
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General Protocol for Metal‐Promoted Self‐Assembly of Peptides in Suspension for
Mixed Peptide Morphology Studies. To a 1.5 mL Eppendorf tube was added the
desired concentrations of MOPS buffer (pH 7.1), DI H2O, peptides, and metal ions in 50
µL total volume. The solution was vigorously mixed. The Eppendorf tube was sealed
and allowed to incubate overnight (~16 hours). The following day, a cloudy precipitate
was visible. This precipitate was washed with DI H2O (45 µL, 3 x 10,000 g). The resulting
pellets were resuspended in DI H2O (45 µL) and prepared for imaging.
General Protocol for Metal‐Promoted Self‐Assembly of Peptides on Glass. To a 1.5 mL
Eppendorf tube was added MOPS buffer (pH 7.1), DI H2O, peptide, and metal in 50 µL
total volume. Concentrations of each component were identical to those used for
assemblies performed in suspension.

The components were mixed and then

immediately spotted onto a glass coverslip affixed to a SEM stub via copper tape. The
stub was placed upright in a Petri dish containing water. The dish was covered and
allowed to incubate overnight. The surrounding water and the enclosed environment
ensured that the peptide‐metal droplet remained wet during the incubation period in
order to facilitate assembly. The following day, a visible precipitate formed. The
solution was then carefully wicked away, and the precipitate was resuspended in DI H2O
(50 µL). Lastly, the stub was lyophilized, and the assembly was visualized by SEM.
Scanning Electron Microscopy (SEM). Metal‐peptide assemblies were prepared in 50 µL
volume as described above. For each sample to be examined, a round glass coverslip
was affixed to the surface of an SEM stub by means of double‐sided copper tape. A 10
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µL aliquot of each sample was plated onto separate stubs. Samples on stubs were then
freeze‐dried to prevent flattening of 3D morphology. Immediately prior to imaging,
samples were sputter‐coated with platinum for 60 seconds. Samples were visualized
using a FEI Nova nanoSEM field emission SEM (FEI Company, Hillsboro, OR, USA)
equipped with an Everhart‐Thornley detector (ETD) for lower resolution scans and a
through‐the‐lens (TLD) detector for higher resolution, immersion imaging.

For all

experiments, the instrument was operated at an accelerating voltage of 5 kV with a
working distance of 5 mm, a spot size of 3, and a 30 µm aperture.
Transmission Electron Microscopy (TEM). Metal‐peptide assemblies were prepared in
50 µL volume as described above. Prior to sample mounting, 400‐mesh copper grids
coated in Formvar with a carbon film (Ted Pella, Inc., Redding, CA, USA) were glow
discharged. A 3 µL aliquot of sample was affixed directly to the grid. The grid was
allowed to sit with the droplet for three minutes. The liquid was then wicked away with
filter paper. The grid was treated with 2% uranyl acetate (pH~4) by using forceps to
pass the grid through a droplet of the stain. Excess stain was then wicked away with
filter paper. Grids were allowed to air dry for one minute. This process was repeated
for every sample to be examined. Samples were visualized using a Tecnai T20 (FEI
Company, Hillsboro, OR, USA) at an accelerating voltage of 200 kV, a spot size of 1, and
with a 200 µm condenser aperture and a 70 µm objective aperture in place. Images
were obtained with a SIA L3C 4‐megapixel CCD camera (Scientific Instruments and
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Application, Duluth, GA, USA). Images were processed using Digital Micrograph Version
3.0 software (Gatan, Inc., Pleasanton, CA, USA).
Rho‐HIS Decoration of Mixed Peptide Assemblies. Mixed peptide assemblies were
prepared in 50 µL solution and washed with DI H2O as described above. The solid
residue was then resuspended in MOPS buffer, pH 7.1 (80 mM, 40 µL) and coated with
NiCl2 (1.0 mM, 5.0 µL) for one hour. The solution was centrifuged at 10,000g for three
minutes at 4°C. The supernatant (45 µL) was removed once. The solid residue was
resuspended in MOPS buffer, pH 7.1 (70 mM, 35 µL) and incubated with Rho‐HIS (20
µM, 10 µL) for three hours. The solution was centrifuged at 10,000g for three minutes
at 4°C. The supernatant (45 µL) was removed, and the solid residue was resuspended in
DI H2O (45 µL). This process was repeated twice.
HeLa‐“Horned Bundles” Cell Adhesion Study. Rho‐HIS‐labeled “horned bundles” were
prepared in 50 µL volume in a 1.5 mL Eppendorf tube as described above. HeLa cells,
upon reaching 70‐80% confluency, were trypsinized and neutralized with RPMI media
without added serum. 5.0 x 104 HeLa cells were combined with the horned bundles and
diluted with RPMI media to 500 µL total volume. Samples were mixed by inversion and
incubated at 37°C with 5% CO2 for two hours. Immediately prior to imaging, live cells
were stained with Calcein AM (500 nM). Cells / bundle suspensions were plated onto
glass cover slips and visualized using a Nikon A1R‐MP confocal microscope, equipped
with 488 nm (green) and 561 nm (red) lasers.
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